##GENOME_BUILD=GRCh38
##CREATION_DATE=2022-12-12
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 2022_08-136-gb420d277
##SAMPLE=<ID=NA12878_03,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=affected>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_mappability=Variants in reads with low mapping score.
##FILTER=mosaic=Putative mosaic variants.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=NA12878_03=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), quality divided by depth (QD), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_het=Heterozygous counts of the gnomAD project (genome data).
##DESCRIPTION=gnomAD_wt=Wildtype counts of the gnomAD project (genome data).
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	gnomAD	gnomAD_sub	gnomAD_hom_hemi	gnomAD_het	gnomAD_wt	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	27355949	27355949	-	G	het	off-target	QUAL=2544;DP=191;QD=13.32;AF=0.52;MQM=60;SAP=30;ABP=4;SAR=32;SAF=67	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron27/28:c.3711+76_3711+77insC::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron26/27:c.3687+76_3687+77insC::					L2 (LINE/L2)	rs36035221	0.4272	0.6567,0.3480,0.1251,0.3658,0.2011	15649,	33525	86933				12.93				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27355990	27355990	G	A	het	off-target	QUAL=2190;DP=168;QD=13.04;AF=0.51;MQM=60;SAP=15;ABP=3;SAR=32;SAF=54	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::						rs12569127	0.2714	0.2146,0.2606,0.1239,0.3216,0.1580	5878,	29481	110707	-0.4890			0.35			COSV58872155	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"sdsds"	SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27359572	27359572	G	C	hom	off-target	QUAL=6130;DP=198;QD=30.96;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=106;SAF=92	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::						rs7521552	0.9878	0.9653,0.9954,1.0000,0.9958,0.9967	74221,	1809	1863	-0.1950			3.40				0.79		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27360975	27360975	G	T	het		QUAL=9725;DP=729;QD=13.34;AF=0.52;MQM=60;SAP=4;ABP=5;SAR=182;SAF=194	MAP3K6	missense	MAP3K6:ENST00000357582.3:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:ENST00000374040.7:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:	regulatory_region_variant:promoter		403071 [benign DISEASE=not specified];			rs35659744	0.2105	0.0579,0.1987,0.0961,0.3028,0.1469	4303,	23416	120092	0.1830	T(0.18),T(0.20)	B(0.00),B(0.00)	13.87	0.05		COSV62887042,COSV62889375	0	24033266,34059054	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahchera1 17.06.2021"		"3"	MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363272	27363272	C	T	het	off-target	QUAL=362;DP=33;QD=10.97;AF=0.48;MQM=60;SAP=8;ABP=3;SAR=5;SAF=11	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron6/28:c.971+170G>A::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron5/27:c.947+170G>A::						rs4525067	0.2261	0.0620,0.2324,0.1214,0.3204,0.1573	4912,	24510	117504	-0.2130			2.99			COSV62890052	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363806	27363806	G	T	het	off-target	QUAL=548;DP=54;QD=10.15;AF=0.48;MQM=60;SAP=59;ABP=3;SAR=0;SAF=26	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron5/28:c.864+111C>A::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron4/27:c.840+111C>A::					MIRb (SINE/MIR)	rs4075731	0.4247	0.6718,0.3342,0.1227,0.3559,0.1964	15775,	33037	87483	-0.5370			0.39			COSV62890056	0	23048207	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363868	27363868	T	C	het	off-target	QUAL=1456;DP=111;QD=13.12;AF=0.53;MQM=60;SAP=4;ABP=4;SAR=32;SAF=27	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron5/28:c.864+49A>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron4/27:c.840+49A>G::					MIRb (SINE/MIR)	rs4307592	0.3044	0.3222,0.2770,0.1237,0.3237,0.1613	7286,	31722	105804	-0.0450			5.97			COSV62890059	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27364153	27364153	A	G	het	off-target	QUAL=644;DP=88;QD=7.32;AF=0.35;MQM=60;SAP=4;ABP=20;SAR=14;SAF=17	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron4/28:c.695+51T>C::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron3/27:c.671+51T>C::		604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]				rs12727507	0.4246	0.6711,0.3342,0.1239,0.3562,0.1972	15760,	33041	87479	0.0210			3.13			COSV54641801	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	45330597	45330597	G	C	hom	off-target	QUAL=264;DP=10;QD=26.40;AF=1.00;MQM=60;SAP=25;ABP=0;SAR=0;SAF=10	MUTYH	intron	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-1160C>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	439920 [benign DISEASE=not provided];			rs3219493	0.9295	0.9569,0.9291,0.9005,0.9110,0.9263	65830,	9767	10731	0.2630			4.74				0	27153553,26273655,28173856,22297469,24799981,17207658,32821650,33343895,34967580	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45331833	45331833	C	G	het		QUAL=3115;DP=231;QD=13.48;AF=0.51;MQM=60;SAP=5;ABP=3;SAR=64;SAF=54	MUTYH	intron,missense	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000372104.5:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:ENST00000448481.5:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000456914.7:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000354383.10:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:ENST00000355498.6:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000372098.7:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372110.7:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:ENST00000672818.3:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372115.7:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-2396G>C::,MUTYH:ENST00000528013.6:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	41767 [benign DISEASE=Carcinoma of colon,MUTYH-related attenuated familial adenomatous polyposis,Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,not specified,not provided];	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH];		rs3219489	0.2694	0.2636,0.3996,0.4117,0.2432,0.2376	5824,	29310	111058	-0.2650	 ,T(0.10),T(0.09),T(0.10),T(0.10),T(0.10),T(0.08),T(0.09),T(0.08),T(0.08), , ,T(0.08)	 ,B(0.21),B(0.29),B(0.21),B(0.15),B(0.21),B(0.29),B(0.38),B(0.29),B(0.21), , ,B(0.21)	8.88	0.04		COSV58343790	0.06	25741868,24728327,23946381,27713515,23757202,23202958,19536092,28391539,16465622,27588484,23565320,18547414,16774938,18271935,26900293,22703879,26273655,28173856,22297469,19443904,19902366,29458332,32072083,18823566,19781088,20149637,20843780,21195504,21777424,22466227,22469746,22641385,22720119,22922830,23443124,24039736,24799981,26074017,26159902,27217144,27471558,29664240,22926731,31374908,28749454,29445914,19888426,27105872,26528356,27209488,31027119,30271482,31924810,26511139,27081525,27324896,28599464,31031852,27630279,19161591,18848840,17055652,28628107,29844566,30564557,32821650,25998844,33942220,32265040,32461665,33240400,34295994,24058721,24377542,33343895	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"dfdfdfdf"	HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45332883	45332883	T	C	hom	off-target	QUAL=5838;DP=189;QD=30.89;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=94;SAF=95	MUTYH	intron	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.115+1508A>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron6/15:c.462+35A>G::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	257529 [benign DISEASE=not specified,not provided];			rs3219487	0.9326	0.9658,0.9322,0.9005,0.9115,0.9276	66268,	9336	10246	-1.2610			0.66			COSV58343750	0.01	25741868,23565320,22297469,30218772,24799981,17207658,23504502,31031852,32821650,33343895	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	62238462	62238462	A	G	het	off-target	QUAL=2105;DP=137;QD=15.36;AF=0.59;MQM=60;SAP=4;ABP=13;SAR=38;SAF=43	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2884-81T>C::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.298-81T>C::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.952-81T>C::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.1000-81T>C::			1249680 [benign DISEASE=not provided];			rs41289438	0.3565	0.3537,0.3334,0.1723,0.3741,0.2451	9836,	34431	97673	-1.2140			0.91				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247305	62247305	T	-	het	off-target	QUAL=94;DP=6;QD=15.67;AF=0.33;MQM=60;SAP=7;ABP=4;SAR=0;SAF=2	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2883+167del::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.297+167del::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.951+167del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.999+167del::			1231277 [benign DISEASE=not provided];			rs371644915	0.0744	0.1882,0.0436,0.0270,0.0237,0.0214	673,	8764	125846	-0.9790			0.24				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247305	62247306	TT	-	het	off-target	QUAL=94;DP=6;QD=15.67;AF=0.50;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2883+166_2883+167del::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.297+166_297+167del::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.951+166_951+167del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.999+166_999+167del::					FLAM_C (SINE/Alu)	rs371644915	0.0006	0.0015,0.0004,0.0000,0.0003,0.0002	0,	86	136156	0.1070			0.79				0.01		1	0	0 / 0					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247328	62247328	G	-	het	off-target	QUAL=42;DP=7;QD=6.00;AF=0.43;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2883+144del::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.297+144del::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.951+144del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.999+144del::			1279369 [benign DISEASE=not provided];		FLAM_C (SINE/Alu)	rs111297754	0.4309	0.4285,0.4097,0.1725,0.4533,0.3370	13896,	35760	83950	0.1120			0.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247552	62247552	C	G	hom		QUAL=1165;DP=37;QD=31.49;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=21;SAF=16	KANK4	missense	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000317477.8:missense_variant:MODERATE:exon3/4:c.217G>C:p.Val73Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000371150.5:missense_variant:MODERATE:exon6/7:c.871G>C:p.Val291Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon8/9:c.919G>C:p.Val307Leu:PF13857 [Ankyrin repeats (many copies)]	regulatory_region_variant:open_chromatin_region		1257820 [benign DISEASE=not provided];			rs2941679	0.9767	0.9936,0.9831,0.9998,0.9632,0.9748	72601,	3418	3542	0.7870	T(0.94),T(0.37),T(0.31),T(0.28)	B(0.00),B(0.00),B(0.00),B(0.00)	14.11	0.04			0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247574	62247574	G	A	het		QUAL=1316;DP=117;QD=11.25;AF=0.44;MQM=60;SAP=3;ABP=7;SAR=26;SAF=25	KANK4	synonymous	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000317477.8:synonymous_variant:LOW:exon3/4:c.195C>T:p.His65=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000371150.5:synonymous_variant:LOW:exon6/7:c.849C>T:p.His283=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000354381.3:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:PF13857 [Ankyrin repeats (many copies)]	regulatory_region_variant:open_chromatin_region		1272744 [benign DISEASE=not provided];			rs10889315	0.3843	0.3241,0.3632,0.1722,0.4207,0.3940	11539,	35304	93540	-0.0850			0.70			COSV58092010	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"dfgdfgdfgdg"	KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247797	62247797	T	C	het	off-target	QUAL=277;DP=41;QD=6.76;AF=0.41;MQM=60;SAP=40;ABP=6;SAR=17;SAF=0	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron8/9:c.2683-125A>G::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron2/3:c.97-125A>G::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron5/6:c.751-125A>G::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron7/8:c.799-125A>G::			1243108 [benign DISEASE=not provided];			rs10789108	0.4292	0.4351,0.4058,0.1747,0.4393,0.4293	14118,	36697	86371	-0.1910			1.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62262956	62262956	C	T	het	off-target	QUAL=54;DP=14;QD=3.86;AF=0.29;MQM=60;SAP=3;ABP=9;SAR=2;SAF=2	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron7/9:c.2539+136G>A::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron1/3:c.-48+136G>A::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron4/6:c.607+136G>A::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron6/8:c.655+136G>A::			1182710 [benign DISEASE=not provided];		L1PB3 (LINE/L1)	rs59025845	0.2526	0.1293,0.2247,0.1328,0.3243,0.2847	5445,	27508	113618	0.2060			3.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263112	62263112	A	G	hom		QUAL=38141;DP=1196;QD=31.89;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=581;SAF=615	KANK4	missense,5'UTR	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:PF00023 [Ankyrin repeat],KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-68T>C::,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon4/7:c.587T>C:p.Val196Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1239401 [benign DISEASE=not provided];			rs2666472	0.7043	0.5574,0.7889,0.8353,0.7409,0.7219	38394,	30196	44908	2.8390	T(0.93), ,T(0.35),T(0.32)	B(0.06), ,B(0.06),B(0.04)	9.67	0.16		COSV58093169	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263166	62263166	T	C	hom		QUAL=35318;DP=1135;QD=31.12;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=554;SAF=581	KANK4	missense,5'UTR	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-122A>G::,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon4/7:c.533A>G:p.His178Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1270534 [benign DISEASE=not provided];			rs2258470	0.7040	0.5565,0.7890,0.8355,0.7408,0.7211	38311,	30195	44911	2.7470	T(0.22), ,T(0.43),T(0.41)	B(0.00), ,B(0.00),B(0.00)	18.45	0.10			0	28487959	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263189	62263189	T	C	hom		QUAL=35829;DP=1143;QD=31.35;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=556;SAF=586	KANK4	synonymous,5'UTR	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-145A>G::,KANK4:ENST00000371150.5:synonymous_variant:LOW:exon4/7:c.510A>G:p.Lys170=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1295500 [benign DISEASE=not provided];			rs2260581	0.7042	0.5570,0.7888,0.8348,0.7409,0.7212	38296,	30169	44843	0.5990			11.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263246	62263246	G	A	hom		QUAL=5604;DP=187;QD=29.97;AF=1.00;MQM=60;SAP=31;ABP=0;SAR=69;SAF=118	KANK4	synonymous,5'UTR	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-202C>T::,KANK4:ENST00000371150.5:synonymous_variant:LOW:exon4/7:c.453C>T:p.Pro151=:,KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:	regulatory_region_variant:enhancer		1262248 [benign DISEASE=not provided];			rs2262110	0.7044	0.5573,0.7889,0.8355,0.7411,0.7218	38368,	30157	44849	-1.7700			0.77			COSV58094416	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263343	62263343	G	A	hom	off-target	QUAL=7385;DP=225;QD=32.82;AF=1.00;MQM=60;SAP=11;ABP=0;SAR=127;SAF=98	KANK4	intron,5'UTR	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-299C>T::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron3/6:c.388-32C>T::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron5/8:c.436-32C>T::	regulatory_region_variant:enhancer		1295474 [benign DISEASE=not provided];			rs2262106	0.6963	0.5290,0.7871,0.8361,0.7408,0.7211	37689,	30335	46099	0.5880			13.85			COSV58091893	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62266749	62266749	T	C	het		QUAL=11402;DP=885;QD=12.88;AF=0.52;MQM=60;SAP=3;ABP=5;SAR=226;SAF=231	KANK4	missense	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon3/7:c.370A>G:p.Thr124Ala:,KANK4:ENST00000354381.3:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:			1295514 [benign DISEASE=not provided];			rs11207949	0.2647	0.2137,0.3498,0.5621,0.2522,0.1547	5876,	28499	111819	2.3690	T(0.12),T(0.54),T(0.55)	B(0.01),B(0.01),B(0.01)	17.77	0.02			0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62268267	62268267	G	A	het	off-target	QUAL=1684;DP=151;QD=11.15;AF=0.46;MQM=60;SAP=3;ABP=5;SAR=35;SAF=35	KANK4	splice_region&intron	KANK4:ENST00000371153.9:splice_region_variant&intron_variant:LOW:intron5/9:c.2231+20C>T::,KANK4:ENST00000371150.5:splice_region_variant&intron_variant:LOW:intron2/6:c.299+20C>T::,KANK4:ENST00000354381.3:splice_region_variant&intron_variant:LOW:intron4/8:c.347+20C>T::			1271177 [benign DISEASE=not provided];			rs11207950	0.4519	0.5751,0.3989,0.2729,0.4060,0.5664	16100,	36465	83281	-0.4840			0.35			COSV58092900	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62271700	62271700	A	C	het	off-target	QUAL=1498;DP=111;QD=13.50;AF=0.54;MQM=60;SAP=4;ABP=5;SAR=33;SAF=27	KANK4	intron,5'UTR	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron3/9:c.1901-111T>G::,KANK4:ENST00000371150.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-143T>G::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-111T>G::	regulatory_region_variant:enhancer		1225071 [benign DISEASE=not provided];			rs4609464	0.3910	0.4313,0.3600,0.2726,0.3758,0.5165	11750,	35864	92460	0.2410			3.19			COSV62985665	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273232	62273232	T	C	hom		QUAL=1844;DP=63;QD=29.27;AF=1.00;MQM=60;SAP=9;ABP=0;SAR=38;SAF=25	KANK4	synonymous,intron	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::	regulatory_region_variant:enhancer		1265012 [benign DISEASE=not provided];			rs7516290	0.7556	0.8596,0.7616,0.8377,0.6864,0.7519	43916,	27054	37164	-0.8210			1.88				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273526	62273526	G	A	het		QUAL=1760;DP=140;QD=12.57;AF=0.49;MQM=60;SAP=10;ABP=3;SAR=42;SAF=27	KANK4	synonymous,intron	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::	regulatory_region_variant:enhancer		1270734 [benign DISEASE=not provided];			rs17855078	0.2783	0.1869,0.2471,0.1317,0.3308,0.4015	6374,	29522	109618	-1.1030			0.19			COSV62990033	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273897	62273897	C	T	het	mosaic	QUAL=0;DP=378;QD=0.00;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	KANK4	missense,intron	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon3/10:c.1207G>A:p.Ala403Thr:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-2308G>A::						rs761058067	0.0000	0.0000,0.0000,0.0000,0.0000,0.0000	0,	1	152169	-1.0770	T(1.00), 	B(0.01), 	0.01	0.03		COSV62987999	0		0	1	0 / 1					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274393	62274393	A	G	het		QUAL=1459;DP=128;QD=11.40;AF=0.48;MQM=60;SAP=3;ABP=4;SAR=32;SAF=29	KANK4	synonymous,intron	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::			1265023 [benign DISEASE=not provided];			rs12127930	0.4810	0.6193,0.4099,0.2736,0.4307,0.5707	18375,	36326	78836	-1.1560			0.28			COSV105915634,COSV62986848	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274774	62274774	T	C	hom		QUAL=7500;DP=239;QD=31.38;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=125;SAF=113	KANK4	synonymous,intron	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::			1262658 [benign DISEASE=not provided];			rs2666506	0.7557	0.8596,0.7614,0.8516,0.6861,0.7524	43743,	26964	37004	-0.6950			3.59			COSV62988812	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274777	62274777	T	C	hom		QUAL=7500;DP=239;QD=31.38;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=125;SAF=113	KANK4	synonymous,intron	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::			1182584 [benign DISEASE=not provided];			rs2666507	0.7320	0.7775,0.7526,0.8516,0.6859,0.7515	40797,	29256	40592	-2.2680			0.25			COSV62988817	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62275109	62275109	A	-	het	off-target;low_conf_region	QUAL=275;DP=116;QD=2.37;AF=0.20;MQM=60;SAP=3;ABP=95;SAR=11;SAF=12	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron2/9:c.17-22del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3520del::	regulatory_region_variant:open_chromatin_region					rs761923018	0.0006	0.0011,0.0006,0.0002,0.0003,0.0000	0,	90	144528	0.0400			2.59				0.05		0	1	0 / 0					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	78112493	78112493	T	C	het		QUAL=4986;DP=413;QD=12.07;AF=0.46;MQM=60;SAP=4;ABP=10;SAR=99;SAF=89	GIPC2	intron	GIPC2:ENST00000370759.4:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	regulatory_region_variant:open_chromatin_region					rs6666954	0.3776	0.6078,0.2900,0.6102,0.2757,0.2795	12754,	31863	94575	-1.1960			0.35			COSV66129252	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a oe_syn=1.00 oe_mis=1.06 oe_lof=1.01)
chr1	119915381	119915381	A	T	het		QUAL=1771;DP=130;QD=13.62;AF=0.55;MQM=60;SAP=3;ABP=6;SAR=35;SAF=37	NOTCH2	synonymous	NOTCH2:ENST00000256646.7:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	261705 [benign DISEASE=Hajdu-Cheney syndrome,not specified,not provided];			rs6685892	0.1680	0.3257,0.1064,0.0317,0.1063,0.1908	2968,	19591	126467	-0.7840			5.31			COSV56683182	0	25741868,29593342	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119918630	119918630	C	T	het	off-target	QUAL=275;DP=20;QD=13.75;AF=0.70;MQM=60;SAP=33;ABP=10;SAR=14;SAF=0	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron31/33:c.5782-77G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1239541 [benign DISEASE=not provided];			rs2793829	0.1674	0.3249,0.1064,0.0319,0.1059,0.1903	2947,	19552	126522	1.7540			7.57			COSV104375006	0	30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119921542	119921542	C	T	het	off-target	QUAL=2286;DP=225;QD=10.16;AF=0.52;MQM=60;SAP=255;ABP=3;SAR=0;SAF=116	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron29/33:c.5310+171G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1239830 [benign DISEASE=not provided];			rs835573	0.2185	0.4245,0.1623,0.0977,0.1255,0.3024	5047,	23123	118783	-0.3850			0.70			COSV56701749	0	28714469	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119922762	119922762	C	T	het		QUAL=273;DP=563;QD=0.48;AF=0.33;MQM=60;SAP=403;ABP=150;SAR=0;SAF=184	NOTCH2	missense	NOTCH2:ENST00000256646.7:missense_variant:MODERATE:exon27/34:c.4876G>A:p.Glu1626Lys:PF07684 [NOTCH protein]		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]				rs1447900658						6.1530	D(0.00)	D(1.00)	31.00	0.48			0.01		0	194	0 / 194					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119923485	119923485	G	A	het	off-target	QUAL=2689;DP=429;QD=6.27;AF=0.46;MQM=60;SAP=433;ABP=9;SAR=0;SAF=198	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron26/33:c.4859+152C>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1230128 [benign DISEASE=not provided];			rs2793830	0.3064	0.7272,0.1921,0.1062,0.1268,0.3150	12443,	21700	105436	-3.2970			0.00			COSV104375039	0	32341527	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119929234	119929234	C	T	het	off-target	QUAL=530;DP=29;QD=18.28;AF=0.69;MQM=60;SAP=5;ABP=12;SAR=12;SAF=8	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1265981 [benign DISEASE=not provided];			rs2493392	0.1677	0.3253,0.1063,0.0319,0.1061,0.1926	2962,	19587	126581	0.4450			5.44			COSV56687338	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119935375	119935375	C	A	het	off-target	QUAL=290;DP=19;QD=15.26;AF=0.63;MQM=60;SAP=3;ABP=6;SAR=6;SAF=6	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3655+97G>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1179326 [benign DISEASE=not provided];			rs2453056	0.2442	0.5135,0.1718,0.0977,0.1259,0.3032	6810,	23505	114897	-0.0250			2.76			COSV104375007	0	29434720	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119935662	119935662	T	C	het	off-target	QUAL=11660;DP=891;QD=13.09;AF=0.51;MQM=60;SAP=3;ABP=4;SAR=230;SAF=225	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron21/33:c.3523-58A>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1260068 [benign DISEASE=not provided];			rs5025718	0.6698	0.1897,0.8007,0.9019,0.8722,0.6843	40976,	19866	50204	-1.1160			5.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119938086	119938086	C	T	het	off-target	QUAL=4896;DP=368;QD=13.30;AF=0.51;MQM=60;SAP=3;ABP=4;SAR=94;SAF=95	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron19/33:c.3184-76G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1235242 [benign DISEASE=not provided];			rs2453058	0.1679	0.3257,0.1067,0.0320,0.1060,0.1915	2960,	19565	126343	-0.2200			1.90			COSV104375008	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119941798	119941798	G	A	het	off-target	QUAL=767;DP=65;QD=11.80;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=16;SAF=16	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron17/33:c.2753-44C>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1293670 [benign DISEASE=Hajdu-Cheney syndrome,Alagille syndrome due to a NOTCH2 point mutation,not provided];			rs2493420	0.2186	0.4247,0.1625,0.0972,0.1255,0.3031	5056,	23124	118802	-0.0270			5.76			COSV99862942	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119953496	119953496	A	T	het	off-target	QUAL=7162;DP=638;QD=11.23;AF=0.45;MQM=60;SAP=3;ABP=17;SAR=142;SAF=145	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron14/33:c.2365+47T>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1265607 [benign DISEASE=not provided];			rs7534585	0.1669	0.3236,0.1064,0.0320,0.1056,0.1915	2891,	19570	126552	0.4620			3.55			COSV56685993	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119953504	119953504	A	C	het	off-target	QUAL=7128;DP=638;QD=11.17;AF=0.45;MQM=60;SAP=3;ABP=17;SAR=142;SAF=145	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron14/33:c.2365+39T>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1245879 [benign DISEASE=not provided];			rs7534586	0.1668	0.3237,0.1064,0.0319,0.1055,0.1911	2888,	19561	126529	0.5980			5.95			COSV56686003	0.02	25135348	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119963373	119963373	G	C	het	off-target	QUAL=2528;DP=290;QD=8.72;AF=0.48;MQM=60;SAP=307;ABP=4;SAR=0;SAF=140	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron11/33:c.1915+201C>G::	regulatory_region_variant:enhancer	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1274327 [benign DISEASE=not provided];			rs10923929	0.6658	0.1753,0.7990,0.9015,0.8726,0.6854	40882,	19505	50841	0.3540			2.89			COSV56681705	0	18179887,28666004,31217584,34107879	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119963485	119963485	G	A	het	off-target	QUAL=2781;DP=296;QD=9.40;AF=0.52;MQM=60;SAP=335;ABP=4;SAR=0;SAF=153	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron11/33:c.1915+89C>T::	regulatory_region_variant:enhancer	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1276223 [benign DISEASE=not provided];			rs2934381	0.1676	0.3255,0.1062,0.0318,0.1058,0.1905	2959,	19554	126536	0.5720			1.51			COSV56687347	0	18372903,18591388,19056611,19794065,21124985,24932614,30328613	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119969481	119969481	T	C	hom	off-target	QUAL=18002;DP=571;QD=31.53;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=294;SAF=277	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron6/33:c.1108+30A>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1283582 [benign DISEASE=Hajdu-Cheney syndrome,Alagille syndrome due to a NOTCH2 point mutation,not provided];			rs2493409	0.9781	0.9236,0.9942,0.9998,0.9995,0.9986	72873,	3097	3329	-2.8650			0.02			COSV99862551	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119987127	119987127	A	C	het	off-target	QUAL=11317;DP=921;QD=12.29;AF=0.48;MQM=60;SAP=4;ABP=6;SAR=229;SAF=215	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron4/33:c.752-45T>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1283883 [benign DISEASE=not provided];			rs2453040	0.1652	0.3189,0.1052,0.0318,0.1048,0.1911	2870,	19374	126954	-0.0060			3.93			COSV56686013	0	28652462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr2	17760156	17760156	T	G	hom	off-target	QUAL=1007;DP=33;QD=30.52;AF=1.00;MQM=60;SAP=38;ABP=0;SAR=28;SAF=5	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-14205A>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron2/13:c.161+52T>G::			1261547 [benign DISEASE=not provided];			rs2555072	0.6113	0.4856,0.7225,0.9552,0.6184,0.8706	29355,	34062	58996	-0.5730			0.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17761508	17761508	T	A	hom		QUAL=3038;DP=92;QD=33.02;AF=1.00;MQM=60;SAP=14;ABP=0;SAR=35;SAF=57	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-15557A>T::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],GEN1:ENST00000381254.7:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain]			1169875 [benign DISEASE=not provided];			rs1812152	0.6977	0.7701,0.7588,0.9856,0.6242,0.8868	37688,	30626	45920	0.6630	 ,T(0.36),T(0.36)	 ,B(0.00),B(0.00)	9.80	0.03			0.09	20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17761748	17761748	T	C	hom	off-target	QUAL=583;DP=24;QD=24.29;AF=1.00;MQM=60;SAP=55;ABP=0;SAR=24;SAF=0	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-15797A>G::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron3/13:c.348+166T>C::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron3/13:c.348+166T>C::			1231264 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs2615047	0.6955	0.7622,0.7586,0.9854,0.6242,0.8868	37459,	30790	46292	-0.0400			3.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17772760	17772760	G	A	hom		QUAL=972;DP=30;QD=32.40;AF=1.00;MQM=60;SAP=22;ABP=0;SAR=7;SAF=23	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+15055C>T::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:			1169876 [benign DISEASE=not provided];			rs300175	0.9869	0.9566,0.9961,1.0000,0.9999,0.9795	74046,	1920	1990	-2.3000	 ,T(1.00),T(1.00)	 ,B(0.00),B(0.00)	0.00	0.02			0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17772873	17772873	A	G	hom	off-target	QUAL=1069;DP=32;QD=33.41;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=23;SAF=9	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14942T>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron8/13:c.953+89A>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron8/13:c.953+89A>G::			1234610 [benign DISEASE=not provided];			rs300176	0.6623	0.6470,0.7446,0.9854,0.6241,0.8861	33858,	32731	51215	-0.4490			1.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17773154	17773154	C	G	hom	off-target	QUAL=3002;DP=93;QD=32.28;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=43;SAF=50	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14661G>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron9/13:c.990+22C>G::			1276608 [benign DISEASE=not provided];			rs300177	0.6959	0.7625,0.7585,0.9854,0.6247,0.8862	37402,	30744	46132	-2.1750			0.06				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17773380	17773380	T	G	hom	off-target	QUAL=925;DP=30;QD=30.83;AF=1.00;MQM=60;SAP=8;ABP=0;SAR=19;SAF=11	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14435A>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron10/13:c.1071+81T>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron10/13:c.1071+81T>G::			1280388 [benign DISEASE=not provided];			rs300178	0.6513	0.6099,0.7380,0.9854,0.6237,0.8862	32834,	33125	52901	-1.6090			0.24				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17779783	17779783	A	G	hom	off-target	QUAL=581;DP=24;QD=24.21;AF=1.00;MQM=60;SAP=55;ABP=0;SAR=0;SAF=24	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+8032T>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron12/13:c.1265-195A>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron12/13:c.1265-195A>G::			1249180 [benign DISEASE=not provided];		AluSg (SINE/Alu)	rs300167	0.6960	0.7630,0.7586,0.9854,0.6247,0.8861	37439,	30736	46138	-0.7300			1.22				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781183	17781183	A	G	hom		QUAL=3083;DP=96;QD=32.11;AF=1.00;MQM=60;SAP=84;ABP=0;SAR=18;SAF=78	SMC6,GEN1	intron,synonymous	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6632T>C::,GEN1:ENST00000317402.11:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:ENST00000381254.7:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:			1169877 [benign DISEASE=not provided];			rs300168	0.4694	0.2298,0.6170,0.9190,0.5138,0.7787	19073,	33179	80625	0.7070			6.44			COSV58057416	0	20150382,20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781251	17781251	C	T	hom		QUAL=3598;DP=112;QD=32.13;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=55;SAF=57	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6564G>A::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:			1169878 [benign DISEASE=not provided];			rs300169	0.6508	0.6082,0.7380,0.9852,0.6236,0.8854	32837,	33200	53056	0.1650	 ,T(1.00),T(1.00)	 ,B(0.00),B(0.00)	4.92	0.05			0	20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	47369714	47369714	-	G	het	off-target	QUAL=254;DP=35;QD=7.26;AF=0.40;MQM=60;SAP=4;ABP=6;SAR=8;SAF=6	EPCAM	intron	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron2/9:c.160+481dup::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron1/8:c.76+135dup::	regulatory_region_variant:promoter	185535_[GENE=EPCAM_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3), Autosomal dominant; Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive]	1225956 [benign DISEASE=not provided];			rs144077629	0.0925	0.0994,0.1112,0.2453,0.0720,0.1212	786,	12505	138067				7.15				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73)
chr2	47373967	47373967	T	C	het		QUAL=747;DP=42;QD=17.79;AF=0.71;MQM=60;SAP=3;ABP=20;SAR=15;SAF=15	EPCAM	missense	EPCAM:ENST00000405271.5:missense_variant:MODERATE:exon4/10:c.428T>C:p.Met143Thr:PF00086 [Thyroglobulin type-1 repeat],EPCAM:ENST00000263735.9:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:PF00086 [Thyroglobulin type-1 repeat]	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	185535_[GENE=EPCAM_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3), Autosomal dominant; Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive]	183700 [benign DISEASE=Lynch syndrome 1,Congenital diarrhea 5 with tufting enteropathy,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs1126497	0.5769	0.8308,0.4937,0.8169,0.4426,0.4981	27689,	32169	64219	0.0500	T(1.00),T(1.00)	B(0.00),B(0.00)	11.74	0.18		COSV55392922	0.02	25741868,24033266,22938532,28652652,29458332,27900359,26318430,20683652,22322561,26115884,31511551,30089705,24304228,22781090,24718422,28366820,33240400,34573430,35070966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47374118	47374118	T	C	het	off-target	QUAL=6235;DP=543;QD=11.48;AF=0.46;MQM=60;SAP=3;ABP=11;SAR=125;SAF=124	EPCAM	intron	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron4/9:c.509+70T>C::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron3/8:c.425+70T>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	185535_[GENE=EPCAM_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3), Autosomal dominant; Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive]	1297204 [benign DISEASE=not provided];		L1ME4b (LINE/L1)	rs4399765	0.1122	0.0879,0.1158,0.2576,0.1100,0.1276	1057,	14937	134965	0.5230			11.74			COSV55394939	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47375102	47375102	T	C	het	off-target	QUAL=228;DP=27;QD=8.44;AF=0.48;MQM=60;SAP=31;ABP=3;SAR=0;SAF=13	EPCAM	intron	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron4/9:c.510-132T>C::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron3/8:c.426-132T>C::		185535_[GENE=EPCAM_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3), Autosomal dominant; Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive]	1294299 [benign DISEASE=not provided];			rs35079997	0.1080	0.1575,0.1040,0.2539,0.0720,0.1212	1065,	14300	135638	-0.5780			0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47379635	47379635	A	G	het	off-target	QUAL=92;DP=12;QD=7.67;AF=0.50;MQM=60;SAP=16;ABP=3;SAR=0;SAF=6	EPCAM	intron	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron7/9:c.742-134A>G::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron6/8:c.658-134A>G::		185535_[GENE=EPCAM_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3), Autosomal dominant; Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive]	1292215 [benign DISEASE=not provided];			rs3923559	0.5717	0.8379,0.4932,0.8133,0.4292,0.4816	27505,	31881	65087	-0.5650			1.31				0	30089705	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47385017	47385017	A	G	het	off-target	QUAL=730;DP=75;QD=9.73;AF=0.43;MQM=60;SAP=5;ABP=7;SAR=13;SAF=19	EPCAM	intron	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron8/9:c.943-149A>G::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron7/8:c.859-149A>G::		185535_[GENE=EPCAM_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3), Autosomal dominant; Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive]	1244355 [benign DISEASE=not provided];			rs4952886	0.1031	0.1526,0.1011,0.1724,0.0717,0.1094	917,	13838	136416	-0.2420			1.36				0	21093899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73)
chr2	47408384	47408384	-	T	het	off-target	QUAL=53;DP=18;QD=2.94;AF=0.33;MQM=60;SAP=16;ABP=7;SAR=6;SAF=0	MSH2	splice_region&intron	MSH2:ENST00000543555.6:splice_region_variant&intron_variant:LOW:intron2/16:c.14-4dup::,MSH2:ENST00000645506.1:splice_region_variant&intron_variant:LOW:intron1/16:c.212-4dup::,MSH2:ENST00000406134.5:splice_region_variant&intron_variant:LOW:intron1/15:c.212-4dup::,MSH2:ENST00000233146.7:splice_region_variant&intron_variant:LOW:intron1/15:c.212-4dup::		609309_[GENE=MSH2_PHENOS=Muir-Torre syndrome, 158320 (3), Autosomal dominant; Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant; Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive]	491795 [benign DISEASE=Lynch syndrome 1,Hereditary cancer-predisposing syndrome,not specified,Breast and/or ovarian cancer];			rs746333570	0.0019	0.0005,0.0014,0.0004,0.0013,0.0115	1,	268	143532				5.55				0.01		0	8	0 / 0					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	47412708	47412708	T	-	het	off-target	QUAL=86;DP=235;QD=0.37;AF=0.17;MQM=60;SAP=90;ABP=225;SAR=40;SAF=0	MSH2	intron	MSH2:ENST00000543555.6:intron_variant:MODIFIER:intron5/16:c.594+161del::,MSH2:ENST00000645506.1:intron_variant:MODIFIER:intron4/16:c.792+161del::,MSH2:ENST00000406134.5:intron_variant:MODIFIER:intron4/15:c.792+161del::,MSH2:ENST00000233146.7:intron_variant:MODIFIER:intron4/15:c.792+161del::		609309_[GENE=MSH2_PHENOS=Muir-Torre syndrome, 158320 (3), Autosomal dominant; Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant; Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive]			AluSp (SINE/Alu)	rs1236136541	0.0047	0.0021,0.0031,0.0012,0.0060,0.0016	3,	666	141898	0.1840			1.30				0.02		1	29	0 / 3					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	47445430	47445430	G	A	het	off-target	QUAL=2070;DP=205;QD=10.10;AF=0.48;MQM=60;SAP=218;ABP=4;SAR=0;SAF=99	MSH2	intron	MSH2:ENST00000543555.6:intron_variant:MODIFIER:intron8/16:c.1079-118G>A::,MSH2:ENST00000645506.1:intron_variant:MODIFIER:intron7/16:c.1277-118G>A::,MSH2:ENST00000406134.5:intron_variant:MODIFIER:intron7/15:c.1277-118G>A::,MSH2:ENST00000233146.7:intron_variant:MODIFIER:intron7/15:c.1277-118G>A::		609309_[GENE=MSH2_PHENOS=Muir-Torre syndrome, 158320 (3), Autosomal dominant; Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant; Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive]	90599 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs1981929	0.7188	0.9072,0.7301,0.8536,0.6034,0.7058	40656,	27960	42744	0.0930			0.91				0	29936769,23565320,20386703,21093899,19930554,28093084,27090025,24578158,24114314,21566726,32742474,32756484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	47783349	47783349	G	A	het		QUAL=143;DP=14;QD=10.21;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=3;SAF=4	MSH6	intron,missense	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron3/11:c.-37-7578G>A::,MSH6:ENST00000234420.11:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000700000.1:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron1/9:c.-38+118G>A::,MSH6:ENST00000700002.1:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000540021.6:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:	regulatory_region_variant:promoter	600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]	36581 [benign DISEASE=Breast carcinoma,Carcinoma of colon,Lynch syndrome,Lynch syndrome 1,Colorectal cancer, hereditary nonpolyposis, type 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6];		rs1042821	0.1888	0.2154,0.1455,0.2462,0.1800,0.2068	2796,	23113	123337	1.7840	 ,T(1.00), , , ,T(0.62)	 ,B(0.00), , , ,B(0.00)	16.79	0.16		COSV52274018	0	25741868,24033266,25491747,26811195,30337837,23757202,22623965,18701435,21700777,23720673,21036793,26900293,22703879,29458332,19781088,20149637,29616133,27900359,31374908,28749454,18523027,19389263,24689082,22294770,22949387,25023197,24383517,17108146,26027715,10507723,10537275,10699937,15805151,1958276,8838326,16203774,16270383,16771955,17205513,18355840,19582761,19685280,25938433,28481244,29365312,31031852,23436172,18851982,32773772,21286719,32957448,32756484,32053874	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34)
chr2	47790891	47790891	A	G	het	off-target	QUAL=10791;DP=927;QD=11.64;AF=0.46;MQM=60;SAP=3;ABP=14;SAR=214;SAF=215	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron3/11:c.-37-36A>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron1/9:c.-37-36A>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.237+7421A>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-1451T>C::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89301 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs1800931	0.0357	0.0107,0.0380,0.0229,0.0552,0.0170	131,	5170	146752	0.4140			13.73			COSV104579250	0		40	1866	11 / 419					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47795761	47795761	A	G	hom	off-target	QUAL=179;DP=7;QD=25.57;AF=1.00;MQM=60;SAP=18;ABP=0;SAR=0;SAF=7	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron4/11:c.161-133A>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron2/9:c.161-133A>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.238-2850A>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-6321T>C::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	676475 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs3136316	0.7990	0.9284,0.7408,0.8909,0.7466,0.8094	48987,	23207	30483	-2.9530			1.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02), RPL36AP15 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47795842	47795842	G	T	het	off-target	QUAL=281;DP=26;QD=10.81;AF=0.46;MQM=60;SAP=15;ABP=3;SAR=2;SAF=10	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron4/11:c.161-52G>T::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron2/9:c.161-52G>T::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.238-2769G>T::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-6402C>A::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89532 [benign DISEASE=Lynch syndrome,not provided];		FLAM_C (SINE/Alu)	rs1800934	0.2084	0.2941,0.1569,0.2513,0.1742,0.2051	3539,	24576	120218	0.3750			2.12			COSV52273967	0	19906786,20386703,18723338,25329635,29290338,32858845	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02), RPL36AP15 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47803319	47803319	G	C	hom	off-target	QUAL=2021;DP=66;QD=30.62;AF=1.00;MQM=60;SAP=37;ABP=0;SAR=17;SAF=49	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron6/11:c.2876-101G>C::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron4/9:c.3173-101G>C::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron4/9:c.1607-101G>C::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron4/9:c.2876-101G>C::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron4/9:c.3179-101G>C::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron2/7:c.2783-101G>C::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4876C>G::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89345 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs2072447	0.7832	0.9212,0.7216,0.8789,0.7305,0.7633	47310,	24403	32955	-0.4200			1.43				0.01	27090025,18851982	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47803553	47803553	T	A	het		QUAL=247;DP=17;QD=14.53;AF=0.65;MQM=60;SAP=27;ABP=6;SAR=0;SAF=11	MSH6,FBXO11	synonymous,intron	MSH6:ENST00000652107.1:synonymous_variant:LOW:exon7/12:c.3009T>A:p.Thr1003=:,MSH6:ENST00000234420.11:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:,MSH6:ENST00000700000.1:synonymous_variant:LOW:exon5/10:c.1740T>A:p.Thr580=:,MSH6:ENST00000673637.1:synonymous_variant:LOW:exon5/10:c.3009T>A:p.Thr1003=:,MSH6:ENST00000700002.1:synonymous_variant:LOW:exon5/10:c.3312T>A:p.Thr1104=:,MSH6:ENST00000540021.6:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4642A>T::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	36589 [benign DISEASE=Carcinoma of colon,Lynch syndrome,Colorectal cancer, hereditary nonpolyposis, type 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs2020910	0.0115	0.0071,0.0071,0.1972,0.0016,0.0133	112,	1529	150327	-2.3440			0.17			COSV52275019	0.02	25741868,23757202,26900293,28093084,29434720,10537275,15805151,10413423,16010685,16638864,19685281,31660093,32742474	8	255	1 / 55	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47803699	47803699	A	T	het	off-target	QUAL=2490;DP=238;QD=10.46;AF=0.49;MQM=60;SAP=208;ABP=3;SAR=6;SAF=111	MSH6,FBXO11	splice_region&intron,intron	MSH6:ENST00000652107.1:splice_region_variant&intron_variant:LOW:intron7/11:c.3141+14A>T::,MSH6:ENST00000234420.11:splice_region_variant&intron_variant:LOW:intron5/9:c.3438+14A>T::,MSH6:ENST00000700000.1:splice_region_variant&intron_variant:LOW:intron5/9:c.1872+14A>T::,MSH6:ENST00000673637.1:splice_region_variant&intron_variant:LOW:intron5/9:c.3141+14A>T::,MSH6:ENST00000700002.1:splice_region_variant&intron_variant:LOW:intron5/9:c.3444+14A>T::,MSH6:ENST00000540021.6:splice_region_variant&intron_variant:LOW:intron3/7:c.3048+14A>T::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4496T>A::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	42471 [benign DISEASE=Lynch syndrome,Colorectal cancer, hereditary nonpolyposis, type 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,Breast and/or ovarian cancer,not provided];			rs2020911	0.3343	0.1750,0.4350,0.6182,0.3740,0.4940	9379,	32037	101131	-0.0370			3.84			COSV52273834	0	25741868,24033266,23757202,20386703,24689082,16847180,25938433,28481244,31660093	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47805736	47805739	CTAT	-	het	off-target	QUAL=603;DP=44;QD=13.70;AF=0.59;MQM=60;SAP=8;ABP=6;SAR=9;SAF=17	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron9/11:c.3349+35_3349+38del::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron7/9:c.3646+35_3646+38del::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron7/9:c.2080+35_2080+38del::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron7/9:c.3349+35_3349+38del::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron7/9:c.3652+35_3652+38del::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron5/7:c.3256+35_3256+38del::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+2456_169+2459del::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89429 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs1805181	0.7064	0.7969,0.5995,0.8589,0.6700,0.7409	38205,	30586	44480	1.3380			1.21				0	28481244	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47805798	47805798	T	C	hom	off-target	QUAL=1373;DP=44;QD=31.20;AF=1.00;MQM=60;SAP=13;ABP=0;SAR=15;SAF=29	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron9/11:c.3349+91T>C::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron7/9:c.3646+91T>C::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron7/9:c.2080+91T>C::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron7/9:c.3349+91T>C::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron7/9:c.3652+91T>C::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron5/7:c.3256+91T>C::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+2397A>G::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89432 [benign DISEASE=Lynch syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];	CS1714498 [CLASS=R MUT=ALT PHEN="Lynch syndrome" GENE=MSH6];		rs3136359	0.7777	0.9193,0.6667,0.8641,0.7301,0.7590	46722,	24774	33802	-2.1920			1.40			COSV52273843	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47806412	47806412	C	G	hom	off-target	QUAL=1514;DP=48;QD=31.54;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=27;SAF=21	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron10/11:c.3505-40C>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron8/9:c.3802-40C>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron8/9:c.2236-40C>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron8/9:c.3505-40C>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron8/9:c.3808-40C>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron6/7:c.3412-40C>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+1783G>C::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	36594 [benign DISEASE=Lynch syndrome,Colorectal cancer, hereditary nonpolyposis, type 5,not specified,not provided];			rs3136367	0.7725	0.9148,0.6604,0.8751,0.7253,0.7550	46108,	25180	34578	-1.0020			0.34			COSV52273637	0	25741868,16847180,10699937,14520694,11807791,21155762	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47806752	47806752	T	-	het	off-target;low_conf_region	QUAL=285;DP=31;QD=9.19;AF=0.48;MQM=60;SAP=7;ABP=3;SAR=5;SAF=10	MSH6,FBXO11	splice_region&intron,intron	MSH6:ENST00000652107.1:splice_region_variant&intron_variant:LOW:intron11/11:c.3705-10del::,MSH6:ENST00000234420.11:splice_region_variant&intron_variant:LOW:intron9/9:c.4002-10del::,MSH6:ENST00000700000.1:splice_region_variant&intron_variant:LOW:intron9/9:c.2436-10del::,MSH6:ENST00000673637.1:splice_region_variant&intron_variant:LOW:intron9/9:c.3705-10del::,MSH6:ENST00000700002.1:splice_region_variant&intron_variant:LOW:intron9/9:c.4008-10del::,MSH6:ENST00000540021.6:splice_region_variant&intron_variant:LOW:intron7/7:c.3612-10del::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+1443del::		600678_[GENE=MSH6_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89508 [likely benign DISEASE=Lynch syndrome,Colorectal cancer, hereditary nonpolyposis, type 5,not specified,not provided];		(T)n (Simple_repeat)	rs59056100	0.2762	0.3017,0.2000,0.2391,0.2806,0.2173	4785,	28616	100088	-1.0800			0.01				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	146839405	146839405	A	G	het		QUAL=10818;DP=817;QD=13.24;AF=0.51;MQM=60;SAP=3;ABP=4;SAR=211;SAF=205	LINC01911	intron&non_coding_transcript	LINC01911:ENST00000696349.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.259-7224A>G::,LINC01911:ENST00000656564.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.320+1359A>G::,LINC01911:ENST00000450667.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/10:n.229+1200A>G::,LINC01911:ENST00000670621.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.291+1359A>G::,LINC01911:ENST00000669097.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.280+1359A>G::,LINC01911:ENST00000696350.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/11:n.77+1200A>G::						rs4411641	0.4814	0.6371,0.5204,0.4560,0.3998,0.4353	18524,	36016	78722	0.2300			3.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LINC01911 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	189805813	189805813	-	A	het	off-target	QUAL=41;DP=44;QD=0.93;AF=0.18;MQM=60;SAP=20;ABP=42;SAR=0;SAF=8	PMS1	intron,frameshift	PMS1:ENST00000418224.7:intron_variant:MODIFIER:intron4/10:c.418+70dup::,PMS1:ENST00000432292.7:intron_variant:MODIFIER:intron2/10:c.-110-12193dup::,PMS1:ENST00000618056.4:intron_variant:MODIFIER:intron4/5:c.418+70dup::,PMS1:ENST00000624204.3:intron_variant:MODIFIER:intron3/11:c.-111+9873dup::,PMS1:ENST00000409985.5:frameshift_variant:HIGH:exon4/4:c.488dup:p.Leu164ValfsTer4:,PMS1:ENST00000441310.7:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:ENST00000409823.7:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:ENST00000374826.8:intron_variant:MODIFIER:intron4/4:c.418+70dup::,PMS1:ENST00000447232.6:intron_variant:MODIFIER:intron4/11:c.418+70dup::			1228750 [benign DISEASE=not provided];	CI229062 [CLASS=DM MUT=ALT PHEN="Constitutional mismatch repair deficiency syndrome" GENE=PMS1];		rs3214425	0.2285	0.2896,0.2524,0.2295,0.1988,0.1236	3953,	26107	114859				1.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD oe_syn=0.84 oe_mis=0.92 oe_lof=0.76)
chr2	189817906	189817906	G	C	het	off-target	QUAL=2264;DP=315;QD=7.19;AF=0.50;MQM=60;SAP=342;ABP=3;SAR=0;SAF=156	PMS1	intron	PMS1:ENST00000418224.7:intron_variant:MODIFIER:intron4/10:c.419-111G>C::,PMS1:ENST00000432292.7:intron_variant:MODIFIER:intron2/10:c.-110-111G>C::,PMS1:ENST00000618056.4:intron_variant:MODIFIER:intron4/5:c.419-111G>C::,PMS1:ENST00000624204.3:intron_variant:MODIFIER:intron3/11:c.-110-111G>C::,PMS1:ENST00000441310.7:intron_variant:MODIFIER:intron4/12:c.419-111G>C::,PMS1:ENST00000409823.7:intron_variant:MODIFIER:intron4/11:c.419-111G>C::,PMS1:ENST00000447232.6:intron_variant:MODIFIER:intron4/11:c.419-111G>C::			1283805 [benign DISEASE=not provided];			rs3791773	0.2246	0.2837,0.2495,0.2264,0.1966,0.1208	4027,	26064	117770	0.7580			8.80				0	25162662	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD oe_syn=0.84 oe_mis=0.92 oe_lof=0.76)
chr2	214728509	214728509	T	C	het	off-target	QUAL=1775;DP=202;QD=8.79;AF=0.46;MQM=60;SAP=205;ABP=6;SAR=0;SAF=93	BARD1	3'UTR	BARD1:ENST00000260947.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*167A>G::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1222105 [benign DISEASE=not provided];			rs5020511	0.6455	0.7704,0.5456,0.4436,0.6122,0.5818	31782,	33099	53093	-1.4770			1.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214728537	214728537	-	T	het	off-target	QUAL=1787;DP=275;QD=6.50;AF=0.29;MQM=60;SAP=82;ABP=107;SAR=13;SAF=67	BARD1	3'UTR	BARD1:ENST00000260947.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*138dup::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1292322 [benign DISEASE=not provided];			rs113789798	0.3874	0.2651,0.4768,0.6449,0.4158,0.4802	11461,	32819	88141				0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214729127	214729127	G	C	het	off-target	QUAL=477;DP=46;QD=10.37;AF=0.48;MQM=60;SAP=13;ABP=3;SAR=16;SAF=6	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron10/10:c.2002-119C>G::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron4/4:c.463-119C>G::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron9/9:c.1945-119C>G::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron5/5:c.592-119C>G::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron10/10:c.1594-119C>G::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron6/6:c.649-119C>G::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron9/9:c.*668-119C>G::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1292323 [benign DISEASE=not provided];		Tigger4b (DNA/TcMar-Tigger)	rs2075623	0.6416	0.7648,0.5372,0.4342,0.6113,0.5759	31964,	33572	54458	-0.8080			0.58				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214729147	214729147	T	G	het	off-target	QUAL=493;DP=46;QD=10.72;AF=0.48;MQM=60;SAP=13;ABP=3;SAR=16;SAF=6	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron10/10:c.2002-139A>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron4/4:c.463-139A>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron9/9:c.1945-139A>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron5/5:c.592-139A>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron10/10:c.1594-139A>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron6/6:c.649-139A>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron9/9:c.*668-139A>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1292324 [benign DISEASE=not provided];		Tigger4b (DNA/TcMar-Tigger)	rs2075622	0.6417	0.7649,0.5373,0.4333,0.6115,0.5756	31984,	33574	54470	-0.2930			0.73				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214730440	214730440	G	A	het		QUAL=261;DP=27;QD=9.67;AF=0.44;MQM=60;SAP=4;ABP=4;SAR=7;SAF=5	BARD1	missense,3'UTR	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:ENST00000619009.5:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys:,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys:,BARD1:ENST00000613374.5:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys:,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon10/11:c.1564C>T:p.Arg522Cys:,BARD1:ENST00000421162.2:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys:,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon9/10:c.*638C>T::	regulatory_region_variant:enhancer	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	136500 [benign(replaced by megSAP based on classifications:9x1,4x2,1x3) DISEASE=Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Triple-Negative Breast Cancer Finding,not specified,not provided];	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1];		rs3738888	0.0073	0.0022,0.0066,0.0098,0.0085,0.0039	15,	1084	150936	5.2690	D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00), 	B(0.36),B(0.38),P(0.52),P(0.78),D(0.99),B(0.01), 	24.30	0.10		COSV53616840	0.01	25741868,29458332,27153395,32039725,16741161,19584272,23056176,26315354,19412175,31258718,16061562,20077502,9425226,15342711,16333312,25994375,26350354,26307947,26329992,26010302,32708251	1	313	0 / 59	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214745589	214745589	G	T	het	off-target	QUAL=647;DP=58;QD=11.16;AF=0.53;MQM=60;SAP=47;ABP=4;SAR=28;SAF=3	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron8/10:c.1810+133C>A::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.365-15081C>A::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron7/9:c.1753+133C>A::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron3/5:c.400+133C>A::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron8/10:c.1402+133C>A::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron4/6:c.457+133C>A::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron7/9:c.*476+133C>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1251354 [benign DISEASE=not provided];			rs6730040	0.4889	0.5178,0.5388,0.5658,0.4686,0.4586	18297,	37640	77612	-0.5570			0.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214745914	214745914	A	G	het	off-target	QUAL=3825;DP=272;QD=14.06;AF=0.51;MQM=60;SAP=3;ABP=4;SAR=71;SAF=69	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron7/10:c.1678-60T>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.365-15406T>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron6/9:c.1621-60T>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron2/5:c.268-60T>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron7/10:c.1270-60T>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron3/6:c.325-60T>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron6/9:c.*344-60T>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	676478 [likely benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs4986842	0.0070	0.0022,0.0067,0.0012,0.0084,0.0035	15,	1036	151182	-1.4830			0.34				0		1	301	0 / 54					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767401	214767402	TT	-	het	off-target	QUAL=1470;DP=109;QD=13.49;AF=0.56;MQM=60;SAP=6;ABP=6;SAR=35;SAF=26	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron6/10:c.1568+80_1568+81del::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24895_364+24896del::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron5/9:c.1511+80_1511+81del::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14847_159-14846del::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron6/10:c.1160+80_1160+81del::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14847_216-14846del::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron5/9:c.*234+80_*234+81del::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1292325 [benign DISEASE=not provided];			rs5031008	0.3711	0.3709,0.3185,0.3714,0.3641,0.4113	10564,	35191	95459	0.6430			2.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767431	214767431	T	C	het	off-target	QUAL=1555;DP=109;QD=14.27;AF=0.57;MQM=60;SAP=5;ABP=7;SAR=35;SAF=27	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron6/10:c.1568+51A>G::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24866A>G::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron5/9:c.1511+51A>G::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14876A>G::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron6/10:c.1160+51A>G::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14876A>G::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron5/9:c.*234+51A>G::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1230936 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs5031009	0.3712	0.3706,0.3187,0.3718,0.3643,0.4105	10628,	35086	95424	-3.4800			0.07			COSV53611189	0	29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767468	214767468	G	A	het	off-target	QUAL=1787;DP=114;QD=15.68;AF=0.57;MQM=60;SAP=4;ABP=8;SAR=35;SAF=30	BARD1	splice_region&intron,intron	BARD1:ENST00000260947.9:splice_region_variant&intron_variant:LOW:intron6/10:c.1568+14C>T::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24829C>T::,BARD1:ENST00000617164.5:splice_region_variant&intron_variant:LOW:intron5/9:c.1511+14C>T::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14913C>T::,BARD1:ENST00000613706.5:splice_region_variant&intron_variant:LOW:intron6/10:c.1160+14C>T::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14913C>T::,BARD1:ENST00000620057.4:splice_region_variant&intron_variant:LOW:intron5/9:c.*234+14C>T::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	256214 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs5031011	0.3507	0.3457,0.3047,0.3727,0.3417,0.4041	9506,	34214	98534	-0.2950			1.75			COSV53615058	0.01	25741868,24033266,29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767531	214767531	C	T	het		QUAL=3056;DP=110;QD=27.78;AF=0.55;MQM=60;SAP=29;ABP=6;SAR=44;SAF=17	BARD1	missense,intron,3'UTR	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24766G>A::,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14976G>A::,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon6/11:c.1111G>A:p.Val371Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14976G>A::,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon5/10:c.*185G>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	140757 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1];		rs2070094	0.3712	0.3708,0.3190,0.3716,0.3639,0.4116	10590,	35226	95544	-5.2200	T(0.12), ,T(0.11), ,T(0.07), , 	B(0.03), ,B(0.01), ,B(0.30), , 	0.01	0.11		COSV53610001	0	25741868,23222812,29458332,29879995,19482343,19412175,25785002,14550946,17399677,33623049,23966609,33240400	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767532	214767532	A	G	hom		QUAL=3056;DP=110;QD=27.78;AF=0.55;MQM=60;SAP=18;ABP=9;SAR=32;SAF=14	BARD1	synonymous,intron,3'UTR	BARD1:ENST00000260947.9:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24765T>C::,BARD1:ENST00000617164.5:synonymous_variant:LOW:exon5/10:c.1461T>C:p.His487=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14977T>C::,BARD1:ENST00000613706.5:synonymous_variant:LOW:exon6/11:c.1110T>C:p.His370=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14977T>C::,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon5/10:c.*184T>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183704 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs2070093	0.7558	0.5994,0.7543,0.9487,0.8049,0.8400	44222,	26415	37121	-0.2410			4.69			COSV53617490	0	25741868,24033266,19536092,17399677	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214769331	214769331	C	T	het	off-target	QUAL=2564;DP=270;QD=9.50;AF=0.47;MQM=60;SAP=262;ABP=5;SAR=125;SAF=2	BARD1	splice_region&intron,intron	BARD1:ENST00000260947.9:splice_region_variant&intron_variant:LOW:intron4/10:c.1315-19G>A::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+22966G>A::,BARD1:ENST00000617164.5:splice_region_variant&intron_variant:LOW:intron3/9:c.1258-19G>A::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-16776G>A::,BARD1:ENST00000613706.5:splice_region_variant&intron_variant:LOW:intron4/10:c.907-19G>A::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-16776G>A::,BARD1:ENST00000620057.4:splice_region_variant&intron_variant:LOW:intron3/9:c.365-19G>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	256213 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs6704780	0.3715	0.3713,0.3193,0.3715,0.3643,0.4084	10597,	35220	95452	0.1260			0.84		10.09>9.72	COSV53612311	0.01	25741868,29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214780740	214780740	C	G	het		QUAL=1090;DP=79;QD=13.80;AF=0.53;MQM=60;SAP=8;ABP=4;SAR=26;SAF=16	BARD1	missense,intron	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+11557G>C::,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser:,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-28185G>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron4/10:c.906+228G>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.215+16321G>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron3/9:c.365-11428G>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	142769 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs2229571	0.5302	0.3985,0.4700,0.3729,0.6117,0.4820	22188,	36087	71287	-0.3950	T(0.24), ,T(0.25), , , , 	B(0.02), ,B(0.10), , , , 	4.32	0.11		COSV53612030	0.01	25741868,23554684,23222812,29458332,29879995,19482343,23056176,19412175,25785002,31258718,30071039,17028982,18059179,33623049,30976110,23966609,33603458,32708251,33240400,35084806	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214792151	214792151	A	-	het	off-target	QUAL=231;DP=45;QD=5.13;AF=0.24;MQM=60;SAP=3;ABP=29;SAR=6;SAF=5	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron3/10:c.364+146del::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+146del::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron2/9:c.307+146del::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.158+17261del::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron3/10:c.364+146del::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.215+4910del::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron3/9:c.364+146del::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]			FLAM_A (SINE/Alu)	rs536345234	0.0056	0.0083,0.0035,0.0013,0.0048,0.0010	0,	705	126261	0.6330			1.05			COSV53611842	0		1	163	0 / 42					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214809366	214809366	T	G	hom	off-target	QUAL=3869;DP=120;QD=32.24;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=60;SAF=60	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron1/4:c.158+46A>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron1/9:c.158+46A>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.158+46A>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron1/6:c.158+46A>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron1/9:c.158+46A>C::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1174423 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs35933323	0.7373	0.7597,0.7833,0.8051,0.7112,0.6674	41393,	29317	39939	0.1910			9.02				0	22328350	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809500	214809500	G	A	het		QUAL=8447;DP=788;QD=10.72;AF=0.48;MQM=60;SAP=3;ABP=5;SAR=193;SAF=189	BARD1	missense	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000619009.5:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser:,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,BARD1:ENST00000613374.5:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser:,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000421162.2:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser:,BARD1:ENST00000620057.4:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183698 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs1048108	0.3328	0.2123,0.3856,0.3608,0.3699,0.4091	8911,	32768	101438	0.9900	T(0.13),T(0.18),T(0.13),D(0.00),T(0.27),T(0.09),T(0.13)	B(0.01),B(0.07),B(0.03),P(0.81),P(0.76),D(0.99),B(0.09)	19.26	0.26		COSV53608734	0	25741868,23554684,21514219,23222812,29484706,29458332,29879995,19482343,23056176,24293394,30132831,19412175,25785002,31258718,33623049,23966609,32708251,34094541	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809599	214809599	C	G	hom	off-target	QUAL=3244;DP=106;QD=30.60;AF=1.00;MQM=60;SAP=13;ABP=0;SAR=64;SAF=42	BARD1	5'UTR	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000617164.5:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::,BARD1:ENST00000613374.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-30G>C::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000620057.4:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	334199 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not provided];			rs1129804	0.7368	0.7589,0.7835,0.8004,0.7109,0.6669	41325,	29344	40016	-0.2340			8.10				0	19252927,31258718	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809617	214809617	A	G	hom	off-target	QUAL=3155;DP=105;QD=30.05;AF=1.00;MQM=60;SAP=14;ABP=0;SAR=64;SAF=41	BARD1	5'UTR	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000617164.5:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::,BARD1:ENST00000613374.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-48T>C::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000620057.4:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	334200 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not provided];			rs17489363	0.7369	0.7590,0.7833,0.8036,0.7109,0.6667	41341,	29332	39998	-2.5770			3.11				0	23056176,30132831,31258718,32021290,30793172,32708251	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809647	214809647	C	T	hom	off-target	QUAL=255;DP=9;QD=28.33;AF=1.00;MQM=60;SAP=9;ABP=0;SAR=2;SAF=7	BARD1	5'UTR	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-78G>A::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-78G>A::	regulatory_region_variant:promoter	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	334201 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not provided];			rs34732883	0.6384	0.6067,0.6693,0.8022,0.6319,0.6087	31126,	34847	54993	-0.0320			9.70				0	31258718	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	219550874	219550875	GA	-	hom	off-target	QUAL=4860;DP=157;QD=30.96;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=80;SAF=75	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5684-33_5684-32del::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5408-33_5408-32del::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1276422 [benign DISEASE=3M syndrome 2,not provided];			rs146790993	0.4377	0.4013,0.4825,0.4024,0.4594,0.2516	14809,	36788	85296	1.2180			17.26				0.22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219550924	219550924	T	C	hom	off-target	QUAL=4813;DP=161;QD=29.89;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=80;SAF=79	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5684-82A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5408-82A>G::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1287989 [benign DISEASE=not provided];			rs1043582	0.4385	0.4021,0.4833,0.4061,0.4598,0.2516	14874,	36783	85191	0.2580			5.17			COSV54706169	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551442	219551442	T	C	hom	off-target	QUAL=2769;DP=94;QD=29.46;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=48;SAF=45	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5683+87A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5407+87A>G::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1247466 [benign DISEASE=not provided];			rs6761575	0.9399	0.8092,0.9639,0.9998,0.9933,0.9994	67547,	7654	9124	-1.7350			1.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551848	219551848	C	T	hom	off-target	QUAL=341;DP=13;QD=26.23;AF=1.00;MQM=60;SAP=31;ABP=0;SAR=13;SAF=0	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5138-50G>A::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1274171 [benign DISEASE=not provided];			rs4672931	0.9310	0.7789,0.9596,0.9998,0.9932,0.9988	66559,	8500	10494	-0.4130			6.49				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551869	219551869	C	T	hom	off-target	QUAL=331;DP=13;QD=25.46;AF=1.00;MQM=60;SAP=31;ABP=0;SAR=13;SAF=0	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5414-71G>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5138-71G>A::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1229527 [benign DISEASE=not provided];			rs4672932	0.9310	0.7789,0.9596,0.9998,0.9932,0.9990	66572,	8498	10494	0.6000			14.81				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552081	219552081	A	T	hom	off-target	QUAL=37753;DP=1163;QD=32.46;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=577;SAF=585	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5137+31T>A::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1261356 [benign DISEASE=3M syndrome 2,not provided];			rs4672933	0.9817	0.9389,0.9877,1.0000,0.9996,1.0000	73419,	2628	2788	-0.6360			5.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552220	219552220	G	C	hom		QUAL=1045;DP=34;QD=30.74;AF=1.00;MQM=60;SAP=34;ABP=0;SAR=6;SAF=28	OBSL1	splice_region&intron	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron17/19:c.5033-4C>G::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	194972 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs34490902	0.4450	0.4035,0.4874,0.4044,0.4669,0.2537	15411,	36894	84454	-0.2900			10.06		6.86>7.91	COSV54703179	0.24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552506	219552506	G	T	hom	off-target	QUAL=2373;DP=79;QD=30.04;AF=1.00;MQM=60;SAP=166;ABP=0;SAR=78;SAF=1	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron17/19:c.5032+30C>A::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1269748 [benign DISEASE=not provided];			rs60549465	0.4015	0.2539,0.4705,0.4051,0.4655,0.2513	13124,	34652	90796	0.1300			10.68				0.07		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552544	219552544	C	T	hom		QUAL=4420;DP=146;QD=30.27;AF=1.00;MQM=60;SAP=93;ABP=0;SAR=112;SAF=34	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:PF07679 [Immunoglobulin I-set domain]	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	288014 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs59332477	0.4319	0.3785,0.4824,0.4047,0.4598,0.2506	14500,	36601	86293	1.1840	T(0.33),T(0.81)	D(1.00),D(1.00)	25.60	0.24		COSV54703732	0.02	33230300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219553189	219553189	T	C	hom	off-target	QUAL=104;DP=4;QD=26.00;AF=1.00;MQM=60;SAP=12;ABP=0;SAR=4;SAF=0	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron16/20:c.4990-165A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron15/19:c.4714-165A>G::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1257901 [benign DISEASE=not provided];			rs6436157	0.9421	0.8168,0.9659,0.9998,0.9933,0.9990	67938,	7464	8808	0.0930			9.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219553844	219553844	T	G	hom	off-target;low_conf_region	QUAL=74;DP=4;QD=18.50;AF=1.00;MQM=59;SAP=12;ABP=0;SAR=4;SAF=0	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron15/20:c.4877-158A>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron14/19:c.4601-158A>C::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs1390279179	0.0445	0.0490,0.0371,0.0359,0.0471,0.0512	0,	836	17946	-1.7670			1.70				0		0	0	0 / 0					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219553850	219553850	T	G	het	off-target;low_conf_region	QUAL=48;DP=6;QD=8.00;AF=0.67;MQM=59;SAP=12;ABP=4;SAR=4;SAF=0	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron15/20:c.4877-164A>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron14/19:c.4601-164A>C::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs1171464930	0.0490	0.0490,0.0387,0.0513,0.0537,0.0344	0,	2123	41213	-0.9910			1.23				0		6	42	1 / 9					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554514	219554514	T	C	hom		QUAL=14216;DP=466;QD=30.51;AF=1.00;MQM=60;SAP=515;ABP=0;SAR=67;SAF=398	OBSL1	synonymous	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334466 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs10932813	0.9883	0.9617,0.9907,1.0000,0.9997,1.0000	74351,	1734	1782	-3.9870			2.14				0.11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554617	219554617	T	C	hom		QUAL=21571;DP=692;QD=31.17;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=344;SAF=348	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334469 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs10932814	0.9635	0.8897,0.9772,1.0000,0.9937,0.9994	70786,	5015	5547	0.1340	T(0.51),T(0.61)	B(0.00),B(0.00)	7.41	0.09			0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556234	219556234	A	G	hom		QUAL=1388;DP=52;QD=26.69;AF=1.00;MQM=60;SAP=91;ABP=0;SAR=3;SAF=49	OBSL1	synonymous	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain]		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334475 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs10932816	0.9706	0.9006,0.9829,1.0000,0.9994,1.0000	71824,	4055	4469	-3.1400			0.29	0.10		COSV54708888	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556695	219556695	C	G	hom		QUAL=23402;DP=732;QD=31.97;AF=1.00;MQM=60;SAP=10;ABP=0;SAR=390;SAF=342	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain]		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334483 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs1983210	0.7029	0.6222,0.6806,0.7176,0.7372,0.8948	37847,	31118	45140	0.6310	T(0.23),T(0.27),T(0.13)	P(0.76),P(0.77),D(0.95)	22.50	0.17		COSV54706342	0.01	30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556734	219556734	C	A	hom	off-target	QUAL=22586;DP=677;QD=33.36;AF=1.00;MQM=60;SAP=40;ABP=0;SAR=392;SAF=285	OBSL1	splice_region&intron	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron12/20:c.4067-11G>T::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron11/19:c.3791-11G>T::,OBSL1:ENST00000603926.5:splice_region_variant&intron_variant:LOW:intron12/13:c.4067-11G>T::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334484 [benign DISEASE=3M syndrome 2,not provided];			rs1983211	0.1379	0.0361,0.1785,0.1242,0.1826,0.1463	1807,	17361	131079	-0.6670			0.45		7.34>8.35	COSV54703188	0.08		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557307	219557307	G	A	hom	off-target	QUAL=4744;DP=163;QD=29.10;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=88;SAF=75	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3790+516C>T::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron12/13:c.4066+36C>T::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286959 [benign DISEASE=not provided];			rs55873563	0.1381	0.0365,0.1787,0.1226,0.1831,0.1472	1820,	17373	131113	-0.1870			9.37				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557678	219557678	C	G	hom	off-target	QUAL=10367;DP=381;QD=27.21;AF=1.00;MQM=60;SAP=472;ABP=0;SAR=47;SAF=334	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3790+145G>C::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron11/13:c.3791-60G>C::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286818 [benign DISEASE=not provided];			rs2278200	0.4558	0.4954,0.4974,0.4068,0.4432,0.2528	16092,	37053	82675	-0.4970			2.35			COSV54704518,COSV54704992	0	30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557964	219557964	C	T	het		QUAL=529;DP=61;QD=8.67;AF=0.44;MQM=60;SAP=38;ABP=5;SAR=24;SAF=3	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain]		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	193901 [benign/likely benign DISEASE=3M syndrome 2,not specified,not provided];			rs72957510	0.0071	0.0138,0.0024,0.0000,0.0061,0.0027	3,	1076	151114	0.7730	T(0.50),T(0.22),T(0.41)	P(0.77),P(0.79),B(0.01)	15.09	0.03		COSV105026433	0	25741868	5	328	2 / 74					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219558052	219558052	A	G	hom		QUAL=23993;DP=753;QD=31.86;AF=1.00;MQM=60;SAP=9;ABP=0;SAR=354;SAF=399	OBSL1	synonymous	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon11/20:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain]		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334496 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs2278201	0.4649	0.5265,0.5028,0.4062,0.4433,0.2532	16868,	36976	81406	-4.6040			0.08	0.23		COSV54706224	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219563274	219563274	T	C	hom	off-target	QUAL=3234;DP=108;QD=29.94;AF=1.00;MQM=60;SAP=8;ABP=0;SAR=62;SAF=46	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron7/20:c.2680+81A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron7/19:c.2680+81A>G::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron7/13:c.2680+81A>G::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron7/8:c.2680+81A>G::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron7/8:c.1441+81A>G::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286679 [benign DISEASE=not provided];			rs11904583	0.9791	0.9306,0.9865,1.0000,0.9995,0.9994	72965,	3011	3179	-2.5490			0.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219563659	219563659	A	T	het	off-target	QUAL=3399;DP=280;QD=12.14;AF=0.45;MQM=60;SAP=15;ABP=9;SAR=76;SAF=50	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron6/19:c.2408-32T>A::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron6/13:c.2408-32T>A::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron6/8:c.2408-32T>A::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron6/8:c.1169-32T>A::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1226510 [benign DISEASE=3M syndrome 2,not provided];			rs2303543	0.5662	0.3050,0.5440,0.6762,0.6779,0.7500	26428,	33008	65776	0.9790			7.05				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219565481	219565481	C	T	hom		QUAL=23710;DP=741;QD=32.00;AF=1.00;MQM=60;SAP=15;ABP=0;SAR=402;SAF=337	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373873.8:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000289656.3:missense_variant:MODERATE:exon6/9:c.929G>A:p.Arg310Lys:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334508 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs1039898	0.8212	0.6352,0.8338,0.9040,0.9045,0.8364	52358,	20137	27193	-0.3080	T(1.00),T(1.00),T(1.00),T(0.80),T(0.80)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.53	0.05		COSV54726542,COSV54731761	0.01	22371699,30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219567197	219567197	A	G	hom	off-target	QUAL=2115;DP=70;QD=30.21;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=33;SAF=37	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron4/20:c.1838-71T>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron4/19:c.1838-71T>C::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron4/13:c.1838-71T>C::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron4/8:c.1838-71T>C::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron4/8:c.599-71T>C::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1242247 [benign DISEASE=not provided];			rs4674412	0.9793	0.9293,0.9888,1.0000,0.9997,1.0000	73046,	2977	3157	0.2210			3.68				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219567987	219567987	A	T	het	off-target	QUAL=9163;DP=724;QD=12.66;AF=0.48;MQM=60;SAP=3;ABP=5;SAR=175;SAF=175	OBSL1	splice_region&intron	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron2/20:c.1283-18T>A::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron2/19:c.1283-18T>A::,OBSL1:ENST00000603926.5:splice_region_variant&intron_variant:LOW:intron2/13:c.1283-18T>A::,OBSL1:ENST00000373873.8:splice_region_variant&intron_variant:LOW:intron2/8:c.1283-18T>A::,OBSL1:ENST00000289656.3:splice_region_variant&intron_variant:LOW:intron2/8:c.44-18T>A::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1174895 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs2292360	0.3719	0.1882,0.3657,0.4986,0.4516,0.4317	11489,	33526	95416	-1.0910			2.08		6.52>5.43	COSV54726835	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570312	219570312	A	G	hom		QUAL=20371;DP=649;QD=31.39;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=321;SAF=328	OBSL1	synonymous,intron	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+1082T>C::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	193382 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs10180675	0.8141	0.6112,0.8299,0.9051,0.9044,0.8344	51711,	20423	28287	-0.3330			13.57			COSV54725784	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570653	219570653	G	A	het		QUAL=384;DP=19;QD=20.21;AF=0.84;MQM=60;SAP=4;ABP=22;SAR=7;SAF=9	OBSL1	synonymous,intron	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+741C>T::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	290129 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs1061399	0.3631	0.1629,0.3618,0.4937,0.4489,0.4304	11133,	32699	96431	3.2570			13.56			COSV54727864	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr3	10034299	10034299	T	C	het	off-target	QUAL=2188;DP=217;QD=10.08;AF=0.46;MQM=60;SAP=218;ABP=7;SAR=0;SAF=99	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron3/42:c.206-170T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron3/43:c.206-170T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron3/43:c.206-170T>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron2/7:c.206-170T>C::	regulatory_region_variant:open_chromatin_region	613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1286016 [benign DISEASE=not provided];		AluSc8 (SINE/Alu)	rs113771705	0.2084	0.3399,0.1818,0.0684,0.1651,0.1639	3039,	21106	103266	0.7930			5.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10034307	10034307	A	G	het	off-target	QUAL=1984;DP=211;QD=9.40;AF=0.45;MQM=60;SAP=207;ABP=8;SAR=0;SAF=94	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron3/42:c.206-162A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron3/43:c.206-162A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron3/43:c.206-162A>G::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron2/7:c.206-162A>G::	regulatory_region_variant:open_chromatin_region	613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251762 [benign DISEASE=not provided];		AluSc8 (SINE/Alu)	rs111392584	0.1830	0.2975,0.1306,0.0589,0.1574,0.1468	2950,	20664	118568	-0.9310			1.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10034325	10034325	A	-	het	off-target	QUAL=221;DP=96;QD=2.30;AF=0.15;MQM=60;SAP=33;ABP=108;SAR=0;SAF=14	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron3/42:c.206-124del::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron3/43:c.206-124del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron3/43:c.206-124del::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron2/7:c.206-124del::	regulatory_region_variant:open_chromatin_region	613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1219567 [likely benign DISEASE=not provided];		AluSc8 (SINE/Alu)	rs879221957	0.0168	0.0244,0.0076,0.0059,0.0128,0.0456	2,	881	51853	1.2420			3.65				0		18	155	2 / 25					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035159	10035160	TT	-	het	off-target	QUAL=1941;DP=168;QD=11.55;AF=0.45;MQM=60;SAP=10;ABP=7;SAR=45;SAF=30	FANCD2	splice_region&intron	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron5/42:c.378-6_378-5del::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000431693.1:splice_region_variant&intron_variant:LOW:intron4/7:c.378-6_378-5del::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342255 [benign/likely benign DISEASE=Fanconi anemia complementation group D2,Fanconi anemia,not provided];			rs55973240	0.2289	0.4225,0.1584,0.0663,0.1641,0.1649	4993,	24249	115323	0.3340			4.32				0.11	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035291	10035291	A	C	het	off-target	QUAL=1279;DP=99;QD=12.92;AF=0.48;MQM=60;SAP=12;ABP=3;SAR=17;SAF=31	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.438+58A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1271812 [benign DISEASE=not provided];			rs17032276	0.1969	0.3197,0.1454,0.0651,0.1619,0.1599	3454,	23022	122042	2.2790			14.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035339	10035339	T	C	het	off-target	QUAL=1117;DP=94;QD=11.88;AF=0.50;MQM=60;SAP=13;ABP=3;SAR=16;SAF=31	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.438+106T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.438+106T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.438+106T>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.438+106T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1259039 [benign DISEASE=not provided];			rs17032277	0.1971	0.3199,0.1455,0.0661,0.1619,0.1601	3457,	23020	121924	0.2960			8.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10036271	10036271	A	G	het	off-target	QUAL=553;DP=46;QD=12.02;AF=0.63;MQM=60;SAP=66;ABP=10;SAR=0;SAF=29	FANCD2	splice_region&intron	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron6/42:c.439-16A>G::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron6/43:c.439-16A>G::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron6/43:c.439-16A>G::,FANCD2:ENST00000431693.1:splice_region_variant&intron_variant:LOW:intron5/7:c.439-16A>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257083 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs17032278	0.1965	0.3201,0.1446,0.0655,0.1613,0.1589	3419,	22844	121338	-0.7230			0.15		10.11>10.91		0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10039861	10039861	G	C	het	off-target	QUAL=5185;DP=484;QD=10.71;AF=0.47;MQM=60;SAP=3;ABP=6;SAR=115;SAF=114	FANCD2	splice_region&intron,synonymous	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron9/42:c.695+16G>C::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron9/43:c.695+16G>C::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron9/43:c.695+16G>C::,FANCD2:ENST00000431693.1:synonymous_variant:LOW:exon8/8:c.711G>C:p.Leu237=:		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257086 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs17032283	0.1971	0.3199,0.1450,0.0656,0.1618,0.1599	3453,	22994	121836	-0.1270			2.65			COSV55047412	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10041485	10041485	C	T	het	off-target	QUAL=669;DP=119;QD=5.62;AF=0.35;MQM=60;SAP=94;ABP=25;SAR=0;SAF=42	FANCD2	intron,3'UTR	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron9/42:c.696-138C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron9/43:c.696-138C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron9/43:c.696-138C>T::,FANCD2:ENST00000431693.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1609C>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	439691 [benign DISEASE=not specified,not provided];			rs35220123	0.1970	0.3194,0.1452,0.0654,0.1620,0.1606	3445,	23048	122000	-1.3410			0.19				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10041843	10041844	TT	-	het	off-target	QUAL=171;DP=29;QD=5.90;AF=0.41;MQM=60;SAP=3;ABP=5;SAR=6;SAF=6	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron10/42:c.783+146_783+147del::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron10/43:c.783+146_783+147del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron10/43:c.783+146_783+147del::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251282 [benign DISEASE=not provided];			rs201603399	0.2287	0.4211,0.1584,0.0664,0.1670,0.1667	4579,	23037	108571	0.0510			0.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10042540	10042540	C	T	het	off-target	QUAL=14508;DP=1027;QD=14.13;AF=0.54;MQM=60;SAP=3;ABP=14;SAR=275;SAF=275	FANCD2	splice_region&intron	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron10/42:c.784-19C>T::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron10/43:c.784-19C>T::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron10/43:c.784-19C>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257087 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs9879080	0.2257	0.4192,0.1559,0.0655,0.1623,0.1605	5005,	24289	117647	0.8720			7.43		12.10>11.70	COSV55047416	0	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10043351	10043351	G	T	hom	off-target	QUAL=1703;DP=60;QD=28.38;AF=1.00;MQM=60;SAP=61;ABP=0;SAR=50;SAF=10	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron12/42:c.990-133G>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron12/43:c.990-133G>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron12/43:c.990-133G>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1226898 [benign DISEASE=not provided];			rs803335	0.9379	0.9738,0.9287,0.9981,0.9107,0.9237	67034,	8640	9448	0.2170			3.46				0.11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10043446	10043446	C	G	het	off-target	QUAL=62;DP=10;QD=6.20;AF=0.40;MQM=60;SAP=12;ABP=4;SAR=4;SAF=0	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron12/43:c.990-38C>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257088 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not specified,not provided];			rs9809061	0.2261	0.4204,0.1559,0.0654,0.1622,0.1620	5019,	24290	117508	-0.9250			4.88				0.05	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10043852	10043852	A	G	het		QUAL=2147;DP=293;QD=7.33;AF=0.43;MQM=60;SAP=182;ABP=15;SAR=114;SAF=12	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257065 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];			rs34046352	0.1929	0.3354,0.1409,0.0604,0.1482,0.1471	235,	28739	122185	-0.0460			1.33			COSV55037937	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10046838	10046838	G	A	het	off-target	QUAL=182;DP=34;QD=5.35;AF=0.41;MQM=36;SAP=33;ABP=5;SAR=14;SAF=0	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron15/42:c.1278+115G>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron15/43:c.1278+115G>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron15/43:c.1278+115G>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1679038 [benign DISEASE=Hereditary breast ovarian cancer syndrome];		L3 (LINE/CR1)	rs9825871	0.5089	0.5831,0.4603,0.4300,0.4892,0.4523	5052,	64405	71911	-0.3220			3.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10048039	10048039	G	A	het		QUAL=41;DP=135;QD=0.30;AF=0.15;MQM=56;SAP=3;ABP=148;SAR=10;SAF=10	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342267 [benign/likely benign DISEASE=Fanconi anemia complementation group D2,not specified,not provided];			rs12330369	0.4610	0.4802,0.4250,0.4133,0.4639,0.4123	0,	66829	78127	0.0140			4.83			COSV55032260	0.1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10048089	10048089	A	C	het	off-target;low_conf_region	QUAL=1149;DP=106;QD=10.84;AF=0.45;MQM=60;SAP=25;ABP=5;SAR=13;SAF=35	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257067 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not specified];			rs7615646	0.1074	0.1651,0.0914,0.0430,0.0884,0.1061	217,	15788	134762	0.4020			7.18			COSV55031871	0.03	25741868,22585858	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10049469	10049469	C	T	het	low_conf_region	QUAL=153;DP=27;QD=5.67;AF=0.41;MQM=40;SAP=27;ABP=5;SAR=0;SAF=11	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon17/43:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon17/44:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon17/44:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257070 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs6785756	0.1592	0.2614,0.1179,0.0520,0.1321,0.1424	1066,	18897	111105	0.8720			5.83			COSV55032395	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10049715	10049715	C	G	het	off-target	QUAL=145;DP=26;QD=5.58;AF=0.38;MQM=60;SAP=25;ABP=6;SAR=10;SAF=0	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron17/42:c.1545+210C>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron17/43:c.1545+210C>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron17/43:c.1545+210C>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1244631 [benign DISEASE=not provided];		L2c (LINE/L2)	rs17032306	0.2258	0.4196,0.1556,0.0659,0.1621,0.1617	5011,	24303	117699	-0.0100			1.59				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10052522	10052522	-	T	het	off-target	QUAL=110;DP=25;QD=4.40;AF=0.36;MQM=60;SAP=23;ABP=7;SAR=9;SAF=0	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron18/42:c.1656+38dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron18/43:c.1656+38dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron18/43:c.1656+38dup::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1294503 [benign DISEASE=not provided];			rs544799101	0.1737	0.3350,0.1280,0.0077,0.1220,0.1003	2965,	19497	120967				2.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10060167	10060167	-	A	het	off-target	QUAL=174;DP=55;QD=3.16;AF=0.24;MQM=60;SAP=17;ABP=36;SAR=2;SAF=11	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron18/42:c.1657-112dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron18/43:c.1657-112dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron18/43:c.1657-112dup::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1279487 [benign DISEASE=not provided];		AluSq2 (SINE/Alu)	rs111589951	0.2192	0.3506,0.1809,0.0167,0.1714,0.1597	2414,	18439	82875				1.00				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), CYCSP11 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10062350	10062350	C	T	het	off-target	QUAL=393;DP=49;QD=8.02;AF=0.39;MQM=60;SAP=3;ABP=8;SAR=10;SAF=9	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron20/42:c.1827+139C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron20/43:c.1827+139C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron20/43:c.1827+139C>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251257 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs6804967	0.2240	0.4141,0.1555,0.0653,0.1619,0.1609	4889,	24163	117587	-0.2030			0.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), CYCSP11 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10064848	10064848	C	T	het		QUAL=1275;DP=75;QD=17.00;AF=0.64;MQM=60;SAP=4;ABP=16;SAR=26;SAF=22	FANCD2	missense	FANCD2:ENST00000287647.7:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	134315 [benign/likely benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];	CM1814115 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCD2];		rs3864017	0.1880	0.2838,0.1431,0.0626,0.1625,0.1607	1866,	23913	119371	-0.0900	T(0.31),T(0.31),T(0.31)	B(0.00),B(0.00),B(0.00)	0.88	0.03		COSV55033303	0	25741868,24728327,26822197,32107087	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10065836	10065836	G	T	het	off-target	QUAL=12204;DP=1013;QD=12.05;AF=0.48;MQM=60;SAP=3;ABP=7;SAR=242;SAF=242	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron24/42:c.2270-28G>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257074 [benign DISEASE=Fanconi anemia complementation group D2,not specified,not provided];			rs34608006	0.1937	0.3079,0.1442,0.0641,0.1618,0.1638	3256,	22927	122535	1.0360			8.29				0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10073118	10073118	T	C	het	off-target	QUAL=121;DP=11;QD=11.00;AF=0.64;MQM=60;SAP=18;ABP=5;SAR=0;SAF=7	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron27/42:c.2606-135T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron27/43:c.2606-135T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron27/43:c.2606-135T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1252243 [benign DISEASE=not provided];			rs9824585	0.2340	0.4479,0.1592,0.0654,0.1621,0.1655	5540,	24486	116438	-0.7750			0.32			COSV55040085	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10077919	10077919	C	A	het	off-target	QUAL=246;DP=21;QD=11.71;AF=0.67;MQM=60;SAP=33;ABP=8;SAR=0;SAF=14	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron29/42:c.2860-162C>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron29/43:c.2860-162C>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron29/43:c.2860-162C>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1183813 [benign DISEASE=not provided];		AluJr (SINE/Alu)	rs6792951	0.2348	0.4493,0.1599,0.0669,0.1627,0.1654	5551,	24451	115839	-0.2140			2.26			COSV55037211	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10078233	10078233	T	C	het	off-target	QUAL=741;DP=72;QD=10.29;AF=0.46;MQM=60;SAP=4;ABP=4;SAR=15;SAF=18	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron30/42:c.2976+36T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257077 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not specified,not provided];			rs6805869	0.2258	0.4196,0.1560,0.0658,0.1621,0.1644	5011,	24274	117562	0.3540			6.45			COSV55037214	0	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10086951	10086951	A	G	het	off-target	QUAL=131;DP=37;QD=3.54;AF=0.30;MQM=60;SAP=27;ABP=16;SAR=0;SAF=11	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron33/42:c.3336-183A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron33/43:c.3336-183A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron33/43:c.3336-183A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-5420T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1231027 [benign DISEASE=not provided];			rs33972700	0.0659	0.0246,0.0590,0.0012,0.0963,0.0517	435,	9157	142055	0.3280			4.10				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10087281	10087281	-	T	het	off-target;low_conf_region	QUAL=92;DP=33;QD=2.79;AF=0.18;MQM=60;SAP=16;ABP=32;SAR=0;SAF=6	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron34/42:c.3466+36dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-5751dup::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1206308 [benign DISEASE=not specified,not provided];			rs371321981	0.0351	0.0198,0.0318,0.0141,0.0439,0.0743	94,	3989	114713				4.26				0.05		1	16	1 / 0					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10090443	10090443	A	T	het	off-target;low_conf_region	QUAL=48;DP=25;QD=1.92;AF=0.20;MQM=60;SAP=14;ABP=23;SAR=5;SAF=0	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron37/42:c.3777+58A>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-8912T>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]				rs1276937447	0.0006	0.0003,0.0008,0.0007,0.0005,0.0011	0,	49	86991	-0.2200			1.84				0.01		11	53	3 / 30					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10092265	10092265	A	G	het	off-target	QUAL=2563;DP=176;QD=14.56;AF=0.55;MQM=60;SAP=5;ABP=6;SAR=53;SAF=43	FANCD2,FANCD2OS	splice_region&intron,intron	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron38/42:c.3849+13A>G::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron38/43:c.3849+13A>G::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron38/43:c.3849+13A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-10734T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257079 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs9811771	0.2490	0.4860,0.1766,0.0893,0.1626,0.2195	6440,	24925	113999	0.7300			15.61			COSV55047434	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10094466	10094466	C	T	het	off-target	QUAL=346;DP=30;QD=11.53;AF=0.60;MQM=60;SAP=42;ABP=6;SAR=18;SAF=0	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron40/42:c.3963+103C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron40/43:c.3963+103C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron40/43:c.3963+103C>T::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+9732G>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1235228 [benign DISEASE=not provided];			rs7610821	0.2420	0.4642,0.1736,0.0905,0.1623,0.2015	5953,	24840	115106	-0.0590			3.07				0	21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10096385	10096385	T	G	het		QUAL=9105;DP=785;QD=11.60;AF=0.47;MQM=60;SAP=3;ABP=9;SAR=188;SAF=181	FANCD2,FANCD2OS	synonymous,intron	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257081 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2];		rs2272125	0.2417	0.4631,0.1734,0.0896,0.1622,0.2019	5942,	24861	115257	1.9740			7.05			COSV55037985	0	25741868,21766209,16679306	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10096505	10096505	T	C	het	off-target	QUAL=2791;DP=206;QD=13.55;AF=0.52;MQM=60;SAP=4;ABP=4;SAR=57;SAF=51	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron42/42:c.4185+33T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7693A>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257082 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,not provided];			rs2272124	0.2417	0.4633,0.1735,0.0895,0.1623,0.2010	5940,	24844	115214	-0.0720			4.69			COSV55047440	0.03	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10098987	10098987	G	A	het	off-target	QUAL=10311;DP=680;QD=15.16;AF=0.54;MQM=60;SAP=3;ABP=15;SAR=183;SAF=187	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647.7:3_prime_UTR_variant:MODIFIER:exon43/43:c.*37G>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+5211C>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342381 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not provided];			rs7626117	0.3372	0.7479,0.2206,0.0898,0.1826,0.2284	13612,	24011	100701	-0.0220			3.53			COSV55047455	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10099012	10099012	A	G	het	off-target	QUAL=7694;DP=566;QD=13.59;AF=0.53;MQM=60;SAP=3;ABP=9;SAR=148;SAF=154	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647.7:3_prime_UTR_variant:MODIFIER:exon43/43:c.*62A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4281+197A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4281+197A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+5186T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342383 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not provided];			rs7647987	0.2420	0.4634,0.1738,0.0899,0.1625,0.2013	5944,	24849	115091	-0.4240			0.70			COSV55047463	0	21766209,29156695	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10101066	10101066	A	-	het	off-target	QUAL=942;DP=90;QD=10.47;AF=0.43;MQM=60;SAP=3;ABP=6;SAR=19;SAF=20	FANCD2,FANCD2OS	intron	FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4282-109del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4282-109del::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+3132del::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1234759 [benign DISEASE=not provided];		AluSx (SINE/Alu)	rs78434344	0.2260	0.3898,0.1651,0.0685,0.1695,0.1833	4304,	24090	112018	-1.0440			0.05			COSV55044503	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	36993455	36993455	G	A	het	off-target	QUAL=500;DP=50;QD=10.00;AF=0.48;MQM=60;SAP=4;ABP=3;SAR=10;SAF=14	MLH1	5'UTR	MLH1:ENST00000536378.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-725G>A::	regulatory_region_variant:promoter	120436_[GENE=MLH1_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	89600 [benign DISEASE=Lynch syndrome,Colorectal cancer, hereditary nonpolyposis, type 2,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];	CR045225 [CLASS=DFP MUT=ALT PHEN="Lung cancer risk association with" GENE=MLH1];		rs1800734	0.2319	0.1722,0.2741,0.5541,0.2154,0.3837	4667,	25944	116852	-0.7370			3.89			COSV99212309	0.09	25741868,24944790,23946381,30038702,28827732,22623965,26724419,30989434,23720673,29399184,23565320,21036793,21738611,24515656,29664240,24205329,29156846,29108386,21093899,20967208,23240038,21980013,25047469,19930554,17870204,18523027,18723338,20473912,20860725,22136435,22174852,22740958,24689082,25986311,26275295,29190978,17230510,17301300,17959715,18712731,21093954,21565826,22294770,22371642,22927776,24325908,25115745,25252909,26911399,26987333,28195176,28293327,28304185,28791697,29181059,29304767,30519050,30952131,31035658,31209889,31273068,31342644,31530880,31953835,19888426,25938433,24073290,23112559,26187503,22935517,18022218,25519377,25252713,31779681,20444249,31742432,25421847,25355167,26512054,18588460,29341452,31031852,22763379,19494183,18615680,27630279,30283143,18851982,24084575,22144422,32641106,32742474,33794988,32161499,34540665,27895767,34540891,32756484,33462484,33567514,26086992,33632709,25804231,25328415,33534415,33931130,30256891,34383893,35055016	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPM2AIP1 (inh=n/a oe_syn=1.18 oe_mis=0.77 oe_lof=0.20), MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37006802	37006802	A	-	het	off-target;low_conf_region	QUAL=128;DP=124;QD=1.03;AF=0.15;MQM=60;SAP=44;ABP=133;SAR=0;SAF=19	MLH1	intron	MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron3/17:c.-343-176del::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron4/14:c.381-176del::,MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron4/18:c.381-176del::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron4/15:c.381-176del::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron5/19:c.-343-176del::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron5/19:c.-343-176del::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron4/18:c.-343-176del::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron4/17:c.-251-176del::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron4/18:c.87-176del::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron4/14:c.-343-176del::		120436_[GENE=MLH1_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]			AluSq2 (SINE/Alu)	rs35239510	0.0208	0.0409,0.0187,0.0003,0.0140,0.0078	16,	1947	93025	-0.2960			0.37				0		0	2	0 / 0					MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37025606	37025606	A	T	het	off-target;low_conf_region	QUAL=1193;DP=247;QD=4.83;AF=0.25;MQM=60;SAP=33;ABP=140;SAR=16;SAF=45	MLH1	intron	MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron8/14:c.678-3178A>T::,MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron11/18:c.1039-31A>T::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron11/15:c.1039-31A>T::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron11/14:c.316-31A>T::	regulatory_region_variant:enhancer	120436_[GENE=MLH1_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	629888 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,not provided];		(TA)n (Simple_repeat)	rs59684491	0.3316	0.3284,0.3002,0.3638,0.3431,0.2991	1748,	14006	35284	-0.4710			1.11			COSV51624244	0.03	29434720	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37025608	37025608	A	T	het	off-target;low_conf_region	QUAL=1193;DP=247;QD=4.83;AF=0.25;MQM=60;SAP=33;ABP=140;SAR=16;SAF=45	MLH1	intron	MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron8/14:c.678-3176A>T::,MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron11/18:c.1039-29A>T::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron11/15:c.1039-29A>T::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron11/18:c.745-29A>T::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron11/14:c.316-29A>T::	regulatory_region_variant:enhancer	120436_[GENE=MLH1_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	629889 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,not provided];		(TA)n (Simple_repeat)	rs6771325	0.4827	0.4818,0.4603,0.4772,0.4943,0.3899	4172,	14524	24510	0.1950			1.14			COSV51617601	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	2	"[2] auto-classification 24.10.2017  "			MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	142449489	142449489	C	T	hom		QUAL=1594;DP=49;QD=32.53;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=22;SAF=27	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:PF02260 [FATC domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:PF02260 [FATC domain]		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93669 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs1802904	0.8866	0.9695,0.8066,0.9289,0.8665,0.9384	60074,	14732	17248	1.2390			6.93			COSV99377126	0	24033266,18414213,23757202,17010193,23844225,32724790	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					XRN1 (inh=n/a oe_syn=0.94 oe_mis=0.80 oe_lof=0.12), ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142459302	142459302	C	T	het		QUAL=1052;DP=77;QD=13.66;AF=0.55;MQM=60;SAP=8;ABP=4;SAR=26;SAF=16	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase],ATR:ENST00000661310.1:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase]		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136470 [benign DISEASE=Seckel syndrome 1,not specified,not provided];	CM1010619 [CLASS=DP MUT=ALT PHEN="Acute rejection in kidney transplantation association with" GENE=ATR];		rs2229032	0.1275	0.0810,0.1098,0.1013,0.1603,0.0982	1340,	16694	132628	0.0370	T(0.23),T(0.23)	B(0.00),B(0.00)	0.70	0.17		COSV63383988	0	24033266,18414213,21085059,17010193,23313170,27905519,32597209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142465321	142465321	-	A	het	off-target	QUAL=35;DP=42;QD=0.83;AF=0.17;MQM=60;SAP=3;ABP=44;SAR=4;SAF=3	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron40/46:c.6898-82dup::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron39/45:c.6706-82dup::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1216707 [likely benign DISEASE=not provided];			rs78538255	0.0053	0.0130,0.0027,0.0043,0.0018,0.0078	8,	735	140343				3.64				0		0	25	0 / 4					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142469495	142469495	A	C	het		QUAL=9936;DP=681;QD=14.59;AF=0.56;MQM=60;SAP=4;ABP=26;SAR=197;SAF=186	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:ENST00000661310.1:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	158000 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];	CM1725174 [CLASS=DP MUT=ALT PHEN="Haematological traits association with" GENE=ATR];		rs28910273	0.0034	0.0015,0.0014,0.0000,0.0061,0.0019	0,	519	151695	2.4040	T(0.06),T(0.07)	B(0.01),B(0.01)	20.90	0.05		COSV63384218	0.03	25741868,18414213,17010193,28787443,30595370,32888494	0	251	0 / 52	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496279	142496279	T	A	het	off-target;low_conf_region	QUAL=97;DP=10;QD=9.70;AF=0.60;MQM=60;SAP=16;ABP=4;SAR=0;SAF=6	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+82A>T::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+82A>T::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1264913 [benign DISEASE=not provided];		(TA)n (Simple_repeat)	rs73864545	0.5788	0.6583,0.5068,0.5418,0.5603,0.5354	1369,	5880	6272	0.4140			2.48			COSV63385549,COSV63393775	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496280	142496280	A	T	het	off-target;low_conf_region	QUAL=97;DP=10;QD=9.70;AF=0.60;MQM=60;SAP=16;ABP=4;SAR=0;SAF=6	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+81T>A::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+81T>A::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1288139 [benign DISEASE=not provided];		(TA)n (Simple_repeat)	rs201323437	0.5628	0.6451,0.4674,0.5204,0.5509,0.5072	1299,	5871	6579	0.3350			1.49			COSV63385552	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496329	142496329	T	C	het	off-target;low_conf_region	QUAL=124;DP=8;QD=15.50;AF=0.75;MQM=60;SAP=16;ABP=7;SAR=6;SAF=0	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157998 [likely benign DISEASE=not specified];		(TA)n (Simple_repeat)	rs11719960	0.0439	0.0093,0.0306,0.0327,0.0690,0.0332	404,	3405	91821	-1.5210			0.12			COSV63384221	0.01		370	3891	75 / 798					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496336	142496336	A	C	het	off-target;low_conf_region	QUAL=124;DP=8;QD=15.50;AF=0.75;MQM=60;SAP=16;ABP=7;SAR=6;SAF=0	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+25T>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+25T>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157997 [benign DISEASE=Seckel syndrome 1,not specified,not provided];		(TA)n (Simple_repeat)	rs7620648	0.6327	0.7942,0.5816,0.5151,0.5902,0.4404	17182,	16191	29351	-0.6440			0.33			COSV63391396	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142498695	142498695	A	G	het		QUAL=3564;DP=350;QD=10.18;AF=0.51;MQM=60;SAP=345;ABP=3;SAR=5;SAF=172	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:PF02259 [FAT domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:PF02259 [FAT domain]	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136471 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227932	0.0787	0.0198,0.0582,0.0031,0.1119,0.1539	669,	10628	140166	1.4980			9.41			COSV100637634	0	18414213,17010193,23844225	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142512220	142512220	-	A	het	off-target;low_conf_region	QUAL=20;DP=21;QD=0.95;AF=0.19;MQM=60;SAP=12;ABP=20;SAR=4;SAF=0	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron27/46:c.4852+39dup::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron26/45:c.4660+39dup::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1269319 [benign DISEASE=not provided];			rs74269486	0.4605	0.5384,0.4218,0.3825,0.4410,0.3335	12436,	32953	67757				0.18				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142536248	142536248	T	C	het	off-target	QUAL=1313;DP=111;QD=11.83;AF=0.46;MQM=60;SAP=6;ABP=5;SAR=30;SAF=21	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron19/46:c.3726-47A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron18/45:c.3534-47A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157979 [benign DISEASE=not specified,not provided];			rs73240314	0.1378	0.1162,0.1161,0.1011,0.1605,0.0991	1474,	17996	131060	-0.2480			10.30			COSV63384224	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142540865	142540865	A	-	het	off-target;low_conf_region	QUAL=9092;DP=875;QD=10.39;AF=0.43;MQM=60;SAP=4;ABP=46;SAR=179;SAF=193	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron18/46:c.3581+39del::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron17/45:c.3389+39del::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1225553 [benign DISEASE=not provided];			rs201551475	0.1607	0.1573,0.1334,0.1103,0.1738,0.1103	1543,	18956	115150	3.0930			8.47				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142553472	142553472	G	A	het	off-target	QUAL=104;DP=12;QD=8.67;AF=0.58;MQM=60;SAP=18;ABP=4;SAR=7;SAF=0	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron12/46:c.2634-74C>T::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron11/45:c.2442-74C>T::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	670440 [benign DISEASE=not provided];			rs9869842	0.6266	0.7931,0.5353,0.4677,0.5871,0.4450	30660,	33609	56569	-1.7890			0.05			COSV63385113	0	17010193	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142555897	142555897	-	T	het	mosaic	QUAL=2;DP=100;QD=0.02;AF=0.10;MQM=60;SAP=3;ABP=142;SAR=5;SAF=5	ATR	frameshift	ATR:ENST00000350721.9:frameshift_variant:HIGH:exon10/47:c.2320dup:p.Ile774AsnfsTer3:,ATR:ENST00000661310.1:frameshift_variant:HIGH:exon9/46:c.2128dup:p.Ile710AsnfsTer3:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	938417 [pathogenic/likely pathogenic DISEASE=not provided];	CI1925995 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=ATR];		rs757500301	0.0000	0.0001,0.0000,0.0000,0.0000,0.0000	0,	6	150360				21.80				0.01	21228398,23144622,19470935	0	0	0 / 0					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558523	142558523	-	AAAT	het	off-target	QUAL=2882;DP=310;QD=9.30;AF=0.45;MQM=60;SAP=303;ABP=11;SAR=0;SAF=138	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron8/46:c.1885+97_1885+100dup::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron7/45:c.1693+97_1693+100dup::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1248576 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs56661838	0.0974	0.0926,0.0830,0.1058,0.1044,0.0882	651,	12695	129687				1.83				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558585	142558585	A	G	het	off-target;low_conf_region	QUAL=6988;DP=587;QD=11.90;AF=0.48;MQM=60;SAP=5;ABP=6;SAR=147;SAF=132	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron8/46:c.1885+39T>C::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron7/45:c.1693+39T>C::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157967 [benign DISEASE=not specified,not provided];		(TAGA)n (Simple_repeat)	rs73240318	0.1056	0.0729,0.0861,0.0936,0.1279,0.0950	832,	13594	129274	-0.5170			0.26			COSV63383992	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558733	142558733	A	T	het		QUAL=3159;DP=274;QD=11.53;AF=0.47;MQM=60;SAP=13;ABP=6;SAR=52;SAF=76	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:ENST00000661310.1:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157965 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227930	0.6263	0.7939,0.5341,0.4650,0.5866,0.4439	30738,	33590	56722	-0.2640			7.02			COSV63383320	0.34	24033266,18414213,17010193,27863252,29403010,32888493	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142562770	142562770	A	G	het		QUAL=6583;DP=530;QD=12.42;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=129;SAF=129	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:ENST00000661310.1:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93668 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227928	0.6255	0.7903,0.5345,0.4644,0.5871,0.4435	30655,	33712	56898	1.4770	T(0.63),T(0.58)	B(0.00),B(0.00)	14.16	0.09		COSV63383325	0	24033266,22938532,18414213,26743341,23757202,18191955,28415781,18551366,26920143,17010193,28238063,23313170,22767148,27905519,32597209,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	156677540	156677540	G	T	het	off-target	QUAL=34;DP=20;QD=1.70;AF=0.25;MQM=60;SAP=14;ABP=14;SAR=0;SAF=5	TIPARP	intron	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::	regulatory_region_variant:promoter					rs345986	0.3592	0.2754,0.3154,0.1099,0.4227,0.4339	10394,	33777	97341	0.3640			8.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156696129	156696129	T	C	hom	off-target	QUAL=17860;DP=577;QD=30.95;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=292;SAF=284	TIPARP	intron	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::						rs344016	0.9551	0.9346,0.9699,0.9642,0.9667,0.9092	69403,	6487	6835	-1.2670			1.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156703736	156703736	G	T	het	off-target	QUAL=6009;DP=474;QD=12.68;AF=0.52;MQM=60;SAP=3;ABP=4;SAR=124;SAF=121	TIPARP	intron	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::	regulatory_region_variant:enhancer				AluYm1 (SINE/Alu)	rs34277251	0.3378	0.0850,0.5005,0.7114,0.4083,0.3829	10993,	29352	100622	-0.1810			1.04				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156705283	156705283	A	T	het	off-target	QUAL=83;DP=8;QD=10.38;AF=0.63;MQM=60;SAP=14;ABP=4;SAR=5;SAF=0	TIPARP	3'UTR	TIPARP:ENST00000295924.12:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::,TIPARP:ENST00000461166.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::,TIPARP:ENST00000542783.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::	regulatory_region_variant:enhancer					rs346003	0.3556	0.2518,0.3149,0.1119,0.4276,0.4234	10102,	33221	96817	0.2400			1.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	179199217	179199217	A	G	het	off-target	QUAL=850;DP=54;QD=15.74;AF=0.63;MQM=60;SAP=3;ABP=11;SAR=16;SAF=18	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron2/20:c.352+40A>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron2/21:c.352+40A>G::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	873175 [benign DISEASE=Squamous cell lung carcinoma,not provided];			rs3729674	0.2566	0.4231,0.2278,0.1036,0.1887,0.2408	5940,	27125	112985	0.6980			7.27			COSV55876899	0.01	26587011,30569174,32368160	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203370	179203370	G	A	het	off-target	QUAL=31;DP=8;QD=3.88;AF=0.38;MQM=60;SAP=10;ABP=4;SAR=0;SAF=3	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron4/20:c.814-174G>A::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron4/21:c.814-174G>A::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1228928 [benign DISEASE=not provided];			rs7623154	0.2407	0.3896,0.2255,0.1003,0.1847,0.1077	5154,	26268	115358	-0.0980			1.61			COSV104380944	0	31709530	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203465	179203465	-	TAAA	het	off-target	QUAL=74;DP=16;QD=4.63;AF=0.31;MQM=60;SAP=7;ABP=8;SAR=4;SAF=1	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron4/20:c.814-77_814-76insAATA::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron4/21:c.814-77_814-76insAATA::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1275985 [benign DISEASE=not provided];			rs17550640	0.2559	0.4217,0.2277,0.1033,0.1884,0.2411	5866,	27127	112981				4.51				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203851	179203851	C	A	hom	off-target	QUAL=2511;DP=75;QD=33.48;AF=1.00;MQM=60;SAP=31;ABP=0;SAR=53;SAF=22	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron5/20:c.1059+62C>A::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron5/21:c.1059+62C>A::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1227071 [benign DISEASE=not provided];			rs2699895	0.5733	0.7607,0.5095,0.2225,0.5263,0.4688	26215,	34645	64815	-0.2870			0.75			COSV55874922	0	30867801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204434	179204434	G	T	het	off-target	QUAL=5347;DP=480;QD=11.14;AF=0.50;MQM=60;SAP=334;ABP=3;SAR=217;SAF=25	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron5/20:c.1060-69G>T::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron5/21:c.1060-69G>T::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1248893 [benign DISEASE=not provided];			rs3729676	0.2565	0.4230,0.2278,0.1039,0.1887,0.2404	5922,	27117	112927	0.9590			6.81			COSV55898889	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204486	179204486	C	A	hom	off-target	QUAL=13699;DP=480;QD=28.54;AF=1.00;MQM=60;SAP=643;ABP=0;SAR=428;SAF=52	PIK3CA	splice_region&intron	PIK3CA:ENST00000263967.4:splice_region_variant&intron_variant:LOW:intron5/20:c.1060-17C>A::,PIK3CA:ENST00000643187.1:splice_region_variant&intron_variant:LOW:intron5/21:c.1060-17C>A::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	259957 [benign DISEASE=Cowden syndrome,not specified,not provided];			rs2699896	0.6368	0.8574,0.5477,0.2592,0.5800,0.5518	32547,	31671	55189	-0.5230			0.61		11.00>10.43	COSV55874930	0.04	25741868,28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204642	179204642	A	G	hom	off-target	QUAL=1931;DP=64;QD=30.17;AF=1.00;MQM=60;SAP=8;ABP=0;SAR=38;SAF=26	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron6/21:c.1145+54A>G::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1236289 [benign DISEASE=not provided];			rs3729679	0.5725	0.7561,0.5105,0.2225,0.5273,0.4683	26093,	34701	64875	-1.2590			0.67			COSV55874940	0	26585822	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179210061	179210061	T	-	hom	off-target	QUAL=2843;DP=137;QD=20.75;AF=0.87;MQM=60;SAP=228;ABP=0;SAR=4;SAF=115	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron7/20:c.1252-114del::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron7/21:c.1252-114del::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1278006 [benign DISEASE=not provided];			rs67871207	0.2452	0.3928,0.2297,0.1013,0.1876,0.1097	5080,	26194	111912	0.3330			4.94				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179218439	179218439	T	G	het	off-target	QUAL=2980;DP=233;QD=12.79;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=58;SAF=59	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron10/20:c.1664+105T>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron10/21:c.1664+105T>G::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1274886 [benign DISEASE=not provided];			rs17849071	0.0797	0.1042,0.0916,0.0991,0.0637,0.0807	513,	11084	139864	0.3970			1.23			COSV104381265	0	24908061,26453385,23185308,26823876,20416519,33182378,31905960	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179220959	179220959	A	T	het	off-target;low_conf_region	QUAL=4429;DP=375;QD=11.81;AF=0.47;MQM=55;SAP=10;ABP=6;SAR=100;SAF=77	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron13/21:c.2016-27A>T::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1229619 [benign DISEASE=not provided];			rs6443625	0.2563	0.4216,0.2274,0.1033,0.1889,0.2448	5907,	27091	112905	-0.4160			0.12			COSV55887980	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179224643	179224643	C	G	hom	off-target	QUAL=183;DP=7;QD=26.14;AF=1.00;MQM=60;SAP=18;ABP=0;SAR=7;SAF=0	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron15/21:c.2295-57C>G::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1281921 [benign DISEASE=not provided];			rs2699889	0.6684	0.9131,0.5726,0.2834,0.5997,0.6196	36073,	29271	50317	0.2750			5.62			COSV55874955	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr4	185078433	185078433	T	A	het	off-target	QUAL=686;DP=71;QD=9.66;AF=0.46;MQM=60;SAP=75;ABP=4;SAR=0;SAF=33	LINC02436	intron&non_coding_transcript	LINC02436:ENST00000509017.6:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1499+6360T>A::,LINC02436:ENST00000671007.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.490-2665T>A::,LINC02436:ENST00000655383.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1001+6360T>A::,LINC02436:ENST00000658467.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/5:n.1129-2665T>A::,LINC02436:ENST00000653833.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.889+6360T>A::,LINC02436:ENST00000669078.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.638+6360T>A::,LINC02436:ENST00000668759.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/7:n.529+6360T>A::,LINC02436:ENST00000655167.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/11:n.959+6360T>A::	regulatory_region_variant:enhancer					rs6818170	0.6988	0.8299,0.6264,0.4322,0.6705,0.6517	37911,	30376	45786	0.1640			3.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LINC02436 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	58321576	58321576	G	C	het		QUAL=11940;DP=940;QD=12.70;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=233;SAF=233		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:enhancer				MLT1E1A (LTR/ERVL-MaLR)	rs37535	0.5920	0.6434,0.5696,0.4961,0.5930,0.4865	26748,	36369	61939	0.8590			3.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr5	80654689	80654689	C	T	hom	off-target	QUAL=3032;DP=109;QD=27.82;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=50;SAF=59	DHFR,MSH3	5'UTR	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-200G>A::,MSH3:ENST00000265081.7:5_prime_UTR_variant:MODIFIER:exon1/24:c.-39C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1220684 [benign DISEASE=not provided];			rs1105525	0.1338	0.0479,0.1127,0.0677,0.1783,0.2405	1639,	16986	131158	-0.0080			8.40			COSV54143671	0	21629435,30967127,33256598,21317831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80654693	80654693	A	G	hom	off-target	QUAL=3032;DP=109;QD=27.82;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=50;SAF=59	DHFR,MSH3	5'UTR	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-204T>C::,MSH3:ENST00000265081.7:5_prime_UTR_variant:MODIFIER:exon1/24:c.-35A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1237508 [benign DISEASE=not provided];			rs1105524	0.7244	0.9187,0.6310,0.3927,0.6668,0.7514	40944,	27505	41627	-4.8940			3.10			COSV54143681	0	31216018,25966119,32756484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80654962	80654962	A	G	het		QUAL=420;DP=38;QD=11.05;AF=0.47;MQM=60;SAP=27;ABP=3;SAR=2;SAF=16	DHFR,MSH3	5'UTR,missense&splice_region	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::,MSH3:ENST00000265081.7:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,MSH3:ENST00000667069.1:missense_variant&splice_region_variant:MODERATE:exon1/22:c.235A>G:p.Ile79Val:	regulatory_region_variant:promoter	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	402591 [benign DISEASE=Constitutional megaloblastic anemia with severe neurologic disease,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1650697	0.7939	0.9128,0.7642,0.6691,0.7566,0.6960	48045,	24021	31175	-0.2430	 ,T(1.00),T(0.74)	 ,B(0.00),B(0.00)	3.55	0.24	4.07>2.71	COSV54144023	0.43	24033266,26811195,19493349,20472929,22495907,28266606,22103680,24846176,25759212,20737570,18551366,23313170,21629435,22450926,24732178,30583708,31216018,29844566,34354741,25966119,21317831,32756484,34050153,25592580,34881269	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80670359	80670359	G	A	het	off-target;low_conf_region	QUAL=5454;DP=416;QD=13.11;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=105;SAF=101	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron4/23:c.792+50G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron4/21:c.792+50G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron4/23:c.624+50G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1288145 [benign DISEASE=not specified,not provided];			rs6151630	0.0383	0.0121,0.0287,0.0008,0.0546,0.0398	141,	5542	146296	0.0690			11.74			COSV54144136	0		60	1903	12 / 433					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80678827	80678827	T	C	hom	off-target	QUAL=3575;DP=116;QD=30.82;AF=1.00;MQM=60;SAP=46;ABP=0;SAR=82;SAF=34	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron7/23:c.1174-100T>C::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron7/21:c.1174-100T>C::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron7/23:c.1006-100T>C::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1244295 [benign DISEASE=not provided];			rs836807	0.9988	0.9995,0.9996,1.0000,0.9979,0.9990	75940,	181	181	-0.5450			0.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80787812	80787812	G	A	hom	off-target	QUAL=938;DP=36;QD=26.06;AF=1.00;MQM=60;SAP=81;ABP=0;SAR=36;SAF=0	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron18/23:c.2543+140G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron16/21:c.2348+140G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron18/23:c.2375+140G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1251794 [benign DISEASE=not provided];			rs33010	0.8456	0.8389,0.8586,0.9989,0.8332,0.8666	54420,	19812	23490	0.4410			6.35				0	17903301	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80792643	80792644	AG	-	hom	off-target	QUAL=4004;DP=159;QD=25.18;AF=1.00;MQM=60;SAP=348;ABP=0;SAR=0;SAF=159	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron18/23:c.2544-88_2544-87del::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron16/21:c.2349-88_2349-87del::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron18/23:c.2376-88_2376-87del::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1262383 [benign DISEASE=not provided];			rs3830224	0.3302	0.2051,0.3424,0.3643,0.3794,0.4178	8682,	32647	101463	1.7540			4.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80854162	80854162	A	G	hom		QUAL=28040;DP=903;QD=31.05;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=452;SAF=451	MSH3	missense	MSH3:ENST00000265081.7:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:PF00488 [MutS domain V],MSH3:ENST00000667069.1:missense_variant:MODERATE:exon19/22:c.2651A>G:p.Gln884Arg:PF00488 [MutS domain V],MSH3:ENST00000658259.1:missense_variant:MODERATE:exon21/24:c.2678A>G:p.Gln893Arg:PF00488 [MutS domain V]		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	821892 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided];			rs184967	0.8671	0.8920,0.8667,0.9987,0.8429,0.8849	57227,	17320	20204	0.4290	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	4.96	0.28		COSV54143790	0	23946381,25491747,26811195,18701435,21700777,20386703,28415781,19781088,31374908,25023197,23313170,23755158,27630279,32756484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80864778	80864781	AATG	-	het	off-target	QUAL=58;DP=16;QD=3.63;AF=0.38;MQM=60;SAP=16;ABP=5;SAR=0;SAF=6	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron21/23:c.3001-33_3001-30del::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron19/21:c.2806-33_2806-30del::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron21/23:c.2833-33_2833-30del::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1258155 [benign DISEASE=not provided];			rs3991216	0.4485	0.2408,0.4087,0.3746,0.5598,0.5390	16672,	34663	83625	3.5250			6.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80873118	80873118	G	A	hom		QUAL=3771;DP=114;QD=33.08;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=70;SAF=44	MSH3	missense&splice_region	MSH3:ENST00000265081.7:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:PF00488 [MutS domain V],MSH3:ENST00000667069.1:missense_variant&splice_region_variant:MODERATE:exon21/22:c.2938G>A:p.Ala980Thr:PF00488 [MutS domain V],MSH3:ENST00000658259.1:missense_variant&splice_region_variant:MODERATE:exon23/24:c.2965G>A:p.Ala989Thr:PF00488 [MutS domain V]		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	822964 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided];			rs26279	0.7060	0.6683,0.7025,0.7539,0.7162,0.7960	37881,	31524	44682	1.9220	T(0.54),T(0.54),T(0.54)	B(0.04),B(0.00),B(0.05)	6.56	0.11	10.88>10.94	COSV54143807	0.02	21514219,23946381,25491747,26811195,30038702,22454423,31428123,24086368,22623965,18701435,21700777,20386703,19781088,29616133,21974800,31374908,22294770,31035658,31342644,31953835,23313170,18364438,26027715,27335251,18355840,27902597,31114287,30271482,23755158,26617824,31216018,31031852,25586538,27630279,18851982,25966119,32957448,32756484,25592580,31973052	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80873351	80873351	G	A	het	off-target	QUAL=1064;DP=60;QD=17.73;AF=0.67;MQM=60;SAP=3;ABP=17;SAR=20;SAF=20	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron23/23:c.3302+64G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron21/21:c.3107+64G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron23/23:c.3134+64G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1244496 [benign DISEASE=not provided];			rs6151928	0.0238	0.0078,0.0206,0.0000,0.0309,0.0124	67,	3490	148552	0.8450			7.13				0		20	958	2 / 174					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	112781076	112781076	A	G	het	off-target	QUAL=35;DP=7;QD=5.00;AF=0.43;MQM=60;SAP=10;ABP=3;SAR=3;SAF=0	APC	intron	APC:ENST00000257430.9:intron_variant:MODIFIER:intron6/15:c.645+173A>G::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron7/16:c.645+173A>G::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	82939 [benign DISEASE=Familial colorectal cancer,not provided];			rs2289484	0.4234	0.1613,0.5724,0.6686,0.5093,0.5615	15896,	32561	87645	-0.8280			0.15				0	29050326	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10), CBX3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RNU6-482P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	112818847	112818847	-	G	het	off-target;low_conf_region	QUAL=24;DP=7;QD=3.43;AF=0.43;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	APC	intron	APC:ENST00000257430.9:intron_variant:MODIFIER:intron9/15:c.934-111dup::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron10/16:c.934-111dup::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	1292418 [benign DISEASE=not provided];			rs71590728	0.3951	0.1396,0.5443,0.6443,0.4799,0.5328	12040,	26901	78063				0.58				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112827157	112827157	T	C	het		QUAL=1667;DP=183;QD=9.11;AF=0.42;MQM=60;SAP=58;ABP=14;SAR=16;SAF=60	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000508376.6:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42238 [benign DISEASE=Hepatocellular carcinoma,Neoplasm of stomach,Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,Desmoid disease, hereditary,not specified,APC-Associated Polyposis Disorders,not provided];	CS1822474 [CLASS=DFP MUT=ALT PHEN="Adenomatous polyposis coli predisposition to" GENE=APC];		rs2229992	0.4822	0.2064,0.6225,0.6719,0.5859,0.6457	20034,	33194	78662	1.2980			8.94			COSV57321592	0	25741868,20844743,25324626,23757202,17267408,23940558,22532847,27217144,18849522,18708403,26493165,16569251,20333795,20510605,21995949,27028212,27087319,15768050,17221838,21279955,29050326,29434720,17963004,20685668,9487968,20434453,7959691,26092435,22528324,30809121,26511139,28010732,24666523,24403877,25992589,31383941,33352971	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112828864	112828864	G	A	het		QUAL=2531;DP=179;QD=14.14;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=46;SAF=46	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42239 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs351771	0.6014	0.5338,0.6685,0.8194,0.6127,0.7323	27971,	35448	60580	1.6090			11.07			COSV57321606	0	25741868,20844743,23757202,23940558,27217144,18849522,24078348,16569251,20333795,21995949,27028212,27087319,14616385,27081525,33352971,35075162	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112837409	112837409	-	AGAA	het	off-target	QUAL=1238;DP=145;QD=8.54;AF=0.51;MQM=60;SAP=164;ABP=3;SAR=0;SAF=74	APC	intron	APC:ENST00000257430.9:intron_variant:MODIFIER:intron15/15:c.1959-143_1959-140dup::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron16/16:c.1959-143_1959-140dup::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	1265993 [benign DISEASE=not provided];			rs3839284	0.6130	0.5438,0.6861,0.8221,0.6263,0.7354	28865,	35109	58623				9.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840073	112840073	G	A	het		QUAL=5170;DP=423;QD=12.22;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=104;SAF=103	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:PF05923 [APC repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42242 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];	CM2115758 [CLASS=R MUT=ALT PHEN="Adenomatous polyposis coli" GENE=APC];		rs41115	0.6016	0.5343,0.6690,0.8200,0.6126,0.7308	27950,	35424	60486	0.0920			2.72			COSV57321403,COSV57381675	0	25741868,20844743,23757202,23940558,14724163,27217144,16569251,19777185,20333795,20510605,21995949,24861525,27028212,27087319,27898031,26092435,28010732,27081525,28243320,25490678,33790997,27245242,33352971	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840628	112840628	G	A	het		QUAL=233;DP=26;QD=8.96;AF=0.50;MQM=60;SAP=31;ABP=3;SAR=13;SAF=0	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42243 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs42427	0.6047	0.5358,0.6743,0.8199,0.6176,0.7304	28255,	35352	60050	0.4930			6.19			COSV57321627	0	25741868,20844743,25324626,23757202,23940558,14724163,18547414,27217144,23251617,24980784,16569251,20333795,20510605,15768050,17221838,26173102,30809121,28010732,27081525,24403877,16169467,33790997	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840862	112840862	T	G	het		QUAL=3249;DP=261;QD=12.45;AF=0.49;MQM=60;SAP=4;ABP=3;SAR=67;SAF=61	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42245 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs866006	0.6028	0.5349,0.6692,0.8197,0.6147,0.7309	28119,	35354	60348	0.1690			0.45			COSV57321636,COSV57325918	0	25741868,20844743,23757202,23940558,11818965,27217144,16569251,20333795,21995949,27087319,14616385,15122587,21110124,27081525	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112841059	112841059	T	A	het		QUAL=4290;DP=381;QD=11.26;AF=0.45;MQM=60;SAP=8;ABP=11;SAR=76;SAF=96	APC	missense	APC:ENST00000257430.9:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000508376.6:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	21030 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs459552	0.8200	0.9565,0.8122,0.9022,0.7613,0.7935	51821,	21028	27372	2.3600	T(0.50),T(0.50)	B(0.00),B(0.00)	16.08	0.19		COSV57321643	0	25741868,26451011,20357209,20844743,24728327,23946381,21819567,30337837,23757202,25372392,18992263,23940558,14724163,22703879,29458332,20149637,24039736,27217144,29963112,19453261,19619005,28410400,24078348,18708403,31485167,24980784,31723073,16569251,20333795,20510605,21995949,27028212,27087319,17221838,14616385,11221825,17556698,18375958,20301519,23159591,23576677,25941542,26809274,23516639,29273807,30239722,22528324,28010732,27081525,26213617,25243319,18343606,25653542,33240400,33769591,32053874,32708070,31406247	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112841474	112841474	G	A	het		QUAL=9917;DP=812;QD=12.21;AF=0.49;MQM=60;SAP=4;ABP=5;SAR=191;SAF=203	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:PF05923 [APC repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42247 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs465899	0.6028	0.5381,0.6695,0.8211,0.6129,0.7304	28071,	35400	60326	-0.1460			4.85			COSV57321652	0	25741868,20844743,25324626,23757202,27217144,16569251,20333795,27087319,15768050,17221838,14616385,25941542,30809121,28010732,27081525,24403877,33790997,25250560	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	132557287	132557287	G	A	hom	off-target	QUAL=1592;DP=66;QD=24.12;AF=0.98;MQM=60;SAP=144;ABP=0;SAR=0;SAF=65	RAD50	5'UTR	RAD50:ENST00000378823.8:5_prime_UTR_variant:MODIFIER:exon1/25:c.-38G>A::	regulatory_region_variant:promoter	604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]				rs4526098	0.9298	0.7624,0.9719,0.9998,0.9967,0.9882	66576,	8345	10681	2.2570			14.68			COSV99528532	0.13	24743186,29879995,20805886,28541483,19917125	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132579521	132579521	G	A	het	off-target;low_conf_region	QUAL=1499;DP=145;QD=10.34;AF=0.46;MQM=60;SAP=69;ABP=5;SAR=56;SAF=11	RAD50	splice_region&intron	RAD50:ENST00000378823.8:splice_region_variant&intron_variant:LOW:intron4/24:c.551+19G>A::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	259870 [benign DISEASE=Nijmegen breakage syndrome-like disorder,Hereditary cancer-predisposing syndrome,not specified,not provided];	CS139954 [CLASS=DFP MUT=ALT PHEN="Acute lymphoblastic leukaemia decreased risk" GENE=RAD50];		rs17166050	0.1813	0.1157,0.1457,0.1758,0.2147,0.2249	2697,	22158	124428	-0.1920			1.50			COSV99528535	0	25741868,21356067,18614543,16724073,24079363,24093751,19917125,26014697,33969541	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132589791	132589791	G	C	het		QUAL=814;DP=67;QD=12.15;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=16;SAF=17	RAD50	missense	RAD50:ENST00000378823.8:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	216618 [uncertain significance DISEASE=Hereditary cancer-predisposing syndrome];			rs55653181	0.0000	0.0000,0.0000,0.0000,0.0000,0.0000	0,	3	152131	6.4160	T(0.20)	B(0.19)	22.50	0.26			0	28202063	1	2	0 / 1					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132595759	132595759	-	A	het	mosaic	QUAL=0;DP=927;QD=0.00;AF=0.03;MQM=60;SAP=3;ABP=0;SAR=6;SAF=6	RAD50	frameshift	RAD50:ENST00000378823.8:frameshift_variant:HIGH:exon13/25:c.2165dup:p.Glu723GlyfsTer5:		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	141045 [pathogenic DISEASE=Nijmegen breakage syndrome-like disorder,Hereditary cancer-predisposing syndrome,Breast and/or ovarian cancer,not provided];	CI161712 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=RAD50];		rs397507178	0.0001	0.0001,0.0001,0.0002,0.0002,0.0000	0,	21	150305				32.00				0	26824983,25452441,16385572,19409520,29566657,29739316,34070018	0	11	0 / 2					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132595760	132595760	A	-	het	mosaic	QUAL=0;DP=927;QD=0.00;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=16;SAF=16	RAD50	frameshift	RAD50:ENST00000378823.8:frameshift_variant:HIGH:exon13/25:c.2165del:p.Lys722ArgfsTer14:		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	408407 [pathogenic DISEASE=Nijmegen breakage syndrome-like disorder,Hereditary cancer-predisposing syndrome];	CD2036440 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=RAD50];		rs397507178	0.0000	0.0001,0.0001,0.0000,0.0000,0.0000	0,	4	150308	-0.1260			22.30			COSV54758496	0	26824983,25452441,16385572,19409520,29566657,29739316,34070018	0	2	0 / 0					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132604212	132604212	T	G	het	off-target	QUAL=291;DP=43;QD=6.77;AF=0.47;MQM=60;SAP=46;ABP=3;SAR=20;SAF=0	RAD50	intron	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron15/24:c.2524+166T>G::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1224961 [benign DISEASE=not provided];			rs12187537	0.1617	0.0645,0.1393,0.1778,0.2076,0.2140	2314,	19961	127511	0.0490			6.13			COSV54749162	0	18614543,26622944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132608437	132608437	G	A	het	off-target	QUAL=54;DP=4;QD=13.50;AF=0.75;MQM=60;SAP=10;ABP=5;SAR=0;SAF=3	RAD50	intron	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron16/24:c.2719-178G>A::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1291971 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs2522394	0.3263	0.6234,0.2045,0.1764,0.2145,0.2368	10670,	28227	102319	-0.0730			0.62				0	19840389,26622944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132638371	132638371	T	A	het	off-target	QUAL=2451;DP=221;QD=11.09;AF=0.56;MQM=60;SAP=272;ABP=10;SAR=124;SAF=0	RAD50,TH2LCRR	intron,intron&non_coding_transcript	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron23/24:c.3618+148T>A::,TH2LCRR:ENST00000457489.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.29-106A>T::,TH2LCRR:ENST00000435042.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.283-106A>T::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1269272 [benign DISEASE=not provided];			rs7737470	0.2221	0.2536,0.1674,0.1770,0.2157,0.2326	3878,	26005	118259	0.1150			3.89				0	20159242,18846228,18614543,23146381,25935106,23982189	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70), TH2LCRR (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	176906125	176906125	C	T	het	off-target	QUAL=2882;DP=242;QD=11.91;AF=0.51;MQM=60;SAP=223;ABP=3;SAR=118;SAF=6	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron13/14:c.1913-78G>A::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron13/14:c.1913-78G>A::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron13/14:c.1415-78G>A::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron9/10:c.803-78G>A::						rs2292256	0.5770	0.8104,0.4245,0.4913,0.4967,0.5023	27012,	33652	64278	0.8360			11.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176907194	176907194	C	T	het	off-target	QUAL=11593;DP=625;QD=18.55;AF=0.69;MQM=60;SAP=3;ABP=205;SAR=216;SAF=217	UIMC1	splice_region&intron	UIMC1:ENST00000377227.8:splice_region_variant&intron_variant:LOW:intron12/14:c.1849-17G>A::,UIMC1:ENST00000511320.6:splice_region_variant&intron_variant:LOW:intron12/14:c.1849-17G>A::,UIMC1:ENST00000506128.5:splice_region_variant&intron_variant:LOW:intron12/14:c.1351-17G>A::,UIMC1:ENST00000510698.2:splice_region_variant&intron_variant:LOW:intron8/10:c.739-17G>A::						rs2292255	0.5801	0.8217,0.4250,0.4901,0.4967,0.5017	27397,	33313	63787	-3.9000			0.00		12.99>12.00	COSV65894272	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176911170	176911170	G	A	het	off-target;low_conf_region	QUAL=804;DP=45;QD=17.87;AF=0.87;MQM=60;SAP=88;ABP=56;SAR=0;SAF=39	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron11/14:c.1676+141C>T::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron11/14:c.1676+141C>T::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron11/14:c.1178+141C>T::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron7/10:c.566+141C>T::	regulatory_region_variant:enhancer				(AAGAA)n (Simple_repeat)	rs868843585						-0.0240			0.72				0		0	0	0 / 0					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176911287	176911287	C	T	het	off-target	QUAL=3694;DP=318;QD=11.62;AF=0.49;MQM=60;SAP=111;ABP=3;SAR=122;SAF=34	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron11/14:c.1178+24G>A::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron7/10:c.566+24G>A::	regulatory_region_variant:enhancer					rs17078630	0.0235	0.0067,0.0170,0.0000,0.0373,0.0046	57,	3464	148470	-2.9070			0.02				0.02	26848770	27	1008	3 / 226					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176968373	176968373	A	-	het	off-target	QUAL=17;DP=14;QD=1.21;AF=0.29;MQM=60;SAP=12;ABP=9;SAR=0;SAF=4	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron6/14:c.1200+182del::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron6/14:c.1200+182del::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron6/14:c.702+680del::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron2/10:c.90+1228del::					AluSg (SINE/Alu)	rs752467394	0.0026	0.0065,0.0010,0.0002,0.0008,0.0002	0,	355	136747	-0.0150			0.33				0.01		0	1	0 / 0					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr6	35452851	35452851	A	C	het	off-target	QUAL=67;DP=8;QD=8.38;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=2;SAF=2	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron1/9:c.248+58A>C::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron1/7:c.248+58A>C::	regulatory_region_variant:promoter	613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	929571 [benign DISEASE=not provided];			rs9470029	0.6186	0.5807,0.6627,0.5340,0.6386,0.6393	29198,	35685	58013	-2.3380			2.41			COSV57691516	0.01	33863951	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MKRN6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35455712	35455712	A	G	het	off-target	QUAL=7908;DP=635;QD=12.45;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=155;SAF=154	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron1/9:c.249-35A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron1/7:c.249-35A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261434 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided];			rs7757405	0.7413	0.8654,0.7645,0.6844,0.6738,0.7440	42316,	27959	39303	1.6900			8.49			COSV57690099	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35455885	35455885	A	C	het		QUAL=871;DP=98;QD=8.89;AF=0.40;MQM=60;SAP=3;ABP=12;SAR=19;SAF=20	FANCE	synonymous	FANCE:ENST00000229769.3:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:,FANCE:ENST00000696264.1:synonymous_variant:LOW:exon2/8:c.387A>C:p.Pro129=:		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261435 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided];			rs4713867	0.7429	0.8706,0.7665,0.6854,0.6737,0.7442	42567,	27786	39088	-1.1030			1.46			COSV57690669	0	25741868,14695169,32708070	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456411	35456411	A	G	het	off-target	QUAL=1441;DP=106;QD=13.59;AF=0.53;MQM=60;SAP=7;ABP=4;SAR=23;SAF=33	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+58A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron2/7:c.855+58A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	929575 [benign DISEASE=not provided];			rs3800377	0.7150	0.8638,0.7355,0.5493,0.6500,0.6750	39600,	29429	43293	-1.5070			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456491	35456491	A	G	het	off-target	QUAL=513;DP=24;QD=21.38;AF=0.83;MQM=60;SAP=3;ABP=26;SAR=10;SAF=10	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+138A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron2/7:c.855+138A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	1279735 [benign DISEASE=not provided];			rs4713868	0.7416	0.8652,0.7646,0.6854,0.6741,0.7426	42204,	27931	39149	-0.0720			1.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456520	35456520	T	-	het	off-target	QUAL=20;DP=12;QD=1.67;AF=0.25;MQM=60;SAP=10;ABP=10;SAR=3;SAF=0	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+178del::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron2/7:c.855+178del::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]			AluSp (SINE/Alu)	rs373252078	0.0007	0.0004,0.0008,0.0004,0.0007,0.0000	0,	106	144686	-0.3510			0.18				0.02		0	4	0 / 0					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35457639	35457639	A	G	het	off-target	QUAL=10898;DP=830;QD=13.13;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=208;SAF=205	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron3/9:c.900+39A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron3/7:c.900+39A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261436 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided];			rs13214239	0.4253	0.1383,0.5206,0.3538,0.5591,0.4273	16449,	31714	87326	-0.6330			0.59			COSV57690016	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	130827597	130827597	G	A	het	off-target	QUAL=562;DP=41;QD=13.71;AF=0.66;MQM=60;SAP=62;ABP=12;SAR=0;SAF=27	SMLR1	missense	SMLR1:ENST00000541421.2:missense_variant:MODERATE:exon1/2:c.184G>A:p.Val62Met:	regulatory_region_variant:TF_binding_site					rs1044303	0.3713	0.4317,0.4356,0.6498,0.2923,0.4890	11119,	34068	95342	4.5270	D(0.00)	P(0.54)	25.60			COSV73407205	0	25025429	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827723	130827723	A	T	het		QUAL=4396;DP=373;QD=11.79;AF=0.52;MQM=60;SAP=222;ABP=4;SAR=27;SAF=167	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+72A>T::	regulatory_region_variant:TF_binding_site					rs9388856	0.3714	0.4319,0.4362,0.6473,0.2923,0.4892	11121,	34131	95419	0.2310			2.92				0	20189245,26045716	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827751	130827751	-	AT	het	off-target	QUAL=6746;DP=703;QD=9.60;AF=0.41;MQM=60;SAP=6;ABP=53;SAR=154;SAF=134	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::	regulatory_region_variant:TF_binding_site					rs113795427	0.3941	0.5194,0.4395,0.6331,0.2919,0.4860	12529,	34350	91342				3.79				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827886	130827886	C	T	het	off-target	QUAL=2470;DP=331;QD=7.46;AF=0.50;MQM=60;SAP=366;ABP=3;SAR=167;SAF=0	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+235C>T::	regulatory_region_variant:TF_binding_site,TF_binding_site_variant					rs72998266	0.1338	0.1998,0.1715,0.0828,0.0974,0.1201	1655,	17029	131671	-0.4330			1.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr7	5987144	5987144	T	C	hom		QUAL=524;DP=21;QD=24.95;AF=1.00;MQM=60;SAP=49;ABP=0;SAR=21;SAF=0	PMS2	missense,intron	PMS2:ENST00000265849.12:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699811.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699752.1:missense_variant:MODERATE:exon10/14:c.1465A>G:p.Lys489Glu:,PMS2:ENST00000699818.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699754.1:missense_variant:MODERATE:exon9/13:c.1423A>G:p.Lys475Glu:,PMS2:ENST00000699760.1:missense_variant:MODERATE:exon9/13:c.1303A>G:p.Lys435Glu:,PMS2:ENST00000699761.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699762.1:missense_variant:MODERATE:exon10/14:c.1048A>G:p.Lys350Glu:,PMS2:ENST00000699821.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699766.1:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699768.1:missense_variant:MODERATE:exon11/14:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699839.1:missense_variant:MODERATE:exon12/16:c.1807A>G:p.Lys603Glu:,PMS2:ENST00000699823.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699837.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699825.1:missense_variant:MODERATE:exon10/14:c.1060A>G:p.Lys354Glu:,PMS2:ENST00000699827.1:missense_variant:MODERATE:exon10/14:c.1453A>G:p.Lys485Glu:,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron7/7:c.803+10182A>G::,PMS2:ENST00000642292.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000642456.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron7/10:c.804-4153A>G::		600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	135065 [benign DISEASE=Colorectal cancer, hereditary nonpolyposis, type 4,Mismatch repair cancer syndrome 4,Hereditary nonpolyposis colorectal neoplasms,not specified];			rs2228006	0.8654	0.9250,0.7719,0.9146,0.8454,0.8950	57124,	17289	20461	1.5020	T(1.00),T(1.00),T(1.00),T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00),T(1.00), , ,T(1.00),T(1.00),T(1.00), , ,T(1.00),T(1.00), 	B(0.00),B(0.00),B(0.00),B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), , ,B(0.00),B(0.00),B(0.00), , ,B(0.00),B(0.00), 	5.90	0.16		COSV56223170	0.1	25741868,24033266,24728327,26811195,22523087,22594646,16619239,21487324,26900293,22703879,29458332,29963112,27900359,18723338,24689082,15256438,29434720,16472587,24027009,14756672,20186689,24072394,28122645,28926134,31160353,33863951,33240400,32756484,32708070,34247610	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5997349	5997349	G	C	hom		QUAL=748;DP=24;QD=31.17;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=11;SAF=13	PMS2	synonymous,intron	PMS2:ENST00000265849.12:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000699811.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699752.1:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:ENST00000699818.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+1759C>G::,PMS2:ENST00000699760.1:synonymous_variant:LOW:exon5/13:c.462C>G:p.Ser154=:,PMS2:ENST00000699761.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699762.1:synonymous_variant:LOW:exon6/14:c.207C>G:p.Ser69=:,PMS2:ENST00000699821.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699766.1:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000699768.1:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:ENST00000699839.1:synonymous_variant:LOW:exon8/16:c.966C>G:p.Ser322=:,PMS2:ENST00000699823.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699837.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699825.1:synonymous_variant:LOW:exon7/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699827.1:synonymous_variant:LOW:exon6/14:c.612C>G:p.Ser204=:,PMS2:ENST00000699952.1:synonymous_variant:LOW:exon7/8:c.780C>G:p.Ser260=:,PMS2:ENST00000642292.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000642456.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000382321.5:synonymous_variant:LOW:exon7/11:c.780C>G:p.Ser260=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	36693 [benign DISEASE=Endometrial carcinoma,Lynch syndrome,Colorectal cancer, hereditary nonpolyposis, type 4,Hereditary cancer-predisposing syndrome,Mismatch repair cancer syndrome 4,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs1805319	0.8169	0.8432,0.7370,0.9148,0.8122,0.8123	50590,	22315	27681	-2.2610			0.03			COSV56223185	0.01	25741868,23757202,16619239,26900293,19692168,15256438,8993976,16472587,20205264,182681,19132747,34247610	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5997426	5997426	-	A	het	low_conf_region	QUAL=230;DP=27;QD=8.52;AF=0.44;MQM=60;SAP=6;ABP=4;SAR=8;SAF=4	PMS2	splice_region&intron,intron	PMS2:ENST00000265849.12:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000699811.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699752.1:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:ENST00000699818.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+1681dup::,PMS2:ENST00000699760.1:splice_region_variant&intron_variant:LOW:intron4/12:c.388-4dup::,PMS2:ENST00000699761.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699762.1:splice_region_variant&intron_variant:LOW:intron5/13:c.133-4dup::,PMS2:ENST00000699821.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699766.1:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000699768.1:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:ENST00000699839.1:splice_region_variant&intron_variant:LOW:intron7/15:c.892-4dup::,PMS2:ENST00000699823.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000699837.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000699825.1:splice_region_variant&intron_variant:LOW:intron6/13:c.301-4dup::,PMS2:ENST00000699827.1:splice_region_variant&intron_variant:LOW:intron5/13:c.538-4dup::,PMS2:ENST00000699952.1:splice_region_variant&intron_variant:LOW:intron6/7:c.706-4dup::,PMS2:ENST00000642292.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000642456.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000382321.5:splice_region_variant&intron_variant:LOW:intron6/10:c.706-4dup::	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	198429 [benign(replaced by megSAP based on classifications:6x1,2x2,1x3) DISEASE=Lynch syndrome,Lynch syndrome 1,Colorectal cancer, hereditary nonpolyposis, type 4,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs60794673	0.1014	0.1049,0.1147,0.0284,0.1106,0.0386	655,	12188	119628				3.73				0	25741868,24033266,33240400	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5998990	5998990	A	-	het	off-target	QUAL=718;DP=44;QD=16.32;AF=0.57;MQM=60;SAP=57;ABP=5;SAR=0;SAF=25	PMS2	intron	PMS2:ENST00000265849.12:intron_variant:MODIFIER:intron6/14:c.705+118del::,PMS2:ENST00000699811.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699752.1:intron_variant:MODIFIER:intron6/13:c.705+118del::,PMS2:ENST00000699818.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+118del::,PMS2:ENST00000699760.1:intron_variant:MODIFIER:intron4/12:c.387+118del::,PMS2:ENST00000699761.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699762.1:intron_variant:MODIFIER:intron5/13:c.133-1567del::,PMS2:ENST00000699821.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699766.1:intron_variant:MODIFIER:intron6/14:c.705+118del::,PMS2:ENST00000699768.1:intron_variant:MODIFIER:intron6/13:c.705+118del::,PMS2:ENST00000699839.1:intron_variant:MODIFIER:intron7/15:c.891+118del::,PMS2:ENST00000699823.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000699837.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000699825.1:intron_variant:MODIFIER:intron6/13:c.300+118del::,PMS2:ENST00000699827.1:intron_variant:MODIFIER:intron5/13:c.538-1567del::,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron6/7:c.705+118del::,PMS2:ENST00000642292.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000642456.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron6/10:c.705+118del::		600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]			AluSx3 (SINE/Alu)	rs11289444	0.7356	0.7431,0.6958,0.8102,0.7369,0.7185	36440,	29023	36635	0.5950			0.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5998990	5998991	AA	-	het	off-target	QUAL=718;DP=44;QD=16.32;AF=0.25;MQM=60;SAP=27;ABP=27;SAR=0;SAF=11	PMS2	intron	PMS2:ENST00000265849.12:intron_variant:MODIFIER:intron6/14:c.705+117_705+118del::,PMS2:ENST00000699811.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000699752.1:intron_variant:MODIFIER:intron6/13:c.705+117_705+118del::,PMS2:ENST00000699818.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+117_705+118del::,PMS2:ENST00000699760.1:intron_variant:MODIFIER:intron4/12:c.387+117_387+118del::,PMS2:ENST00000699761.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000699762.1:intron_variant:MODIFIER:intron5/13:c.133-1568_133-1567del::,PMS2:ENST00000699821.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000699766.1:intron_variant:MODIFIER:intron6/14:c.705+117_705+118del::,PMS2:ENST00000699768.1:intron_variant:MODIFIER:intron6/13:c.705+117_705+118del::,PMS2:ENST00000699839.1:intron_variant:MODIFIER:intron7/15:c.891+117_891+118del::,PMS2:ENST00000699823.1:intron_variant:MODIFIER:intron5/13:c.300+117_300+118del::,PMS2:ENST00000699837.1:intron_variant:MODIFIER:intron5/13:c.300+117_300+118del::,PMS2:ENST00000699825.1:intron_variant:MODIFIER:intron6/13:c.300+117_300+118del::,PMS2:ENST00000699827.1:intron_variant:MODIFIER:intron5/13:c.538-1568_538-1567del::,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron6/7:c.705+117_705+118del::,PMS2:ENST00000642292.1:intron_variant:MODIFIER:intron5/13:c.300+117_300+118del::,PMS2:ENST00000642456.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron6/10:c.705+117_705+118del::		600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]			AluSx3 (SINE/Alu)	rs11289444	0.0033	0.0052,0.0027,0.0011,0.0019,0.0005	0,	463	137995	0.5950			1.29				0		0	62	0 / 8					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	6008925	6008925	G	A	het	off-target	QUAL=680;DP=48;QD=14.17;AF=0.56;MQM=60;SAP=3;ABP=5;SAR=14;SAF=13	PMS2	intron,5'UTR	PMS2:ENST00000265849.12:intron_variant:MODIFIER:intron1/14:c.23+72C>T::,PMS2:ENST00000699811.1:intron_variant:MODIFIER:intron1/14:c.-553+72C>T::,PMS2:ENST00000699752.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699818.1:5_prime_UTR_variant:MODIFIER:exon1/15:c.-501C>T::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron1/12:c.23+72C>T::,PMS2:ENST00000699760.1:intron_variant:MODIFIER:intron1/12:c.-53+72C>T::,PMS2:ENST00000699761.1:intron_variant:MODIFIER:intron1/14:c.-325+72C>T::,PMS2:ENST00000699762.1:intron_variant:MODIFIER:intron1/13:c.-378+72C>T::,PMS2:ENST00000699766.1:intron_variant:MODIFIER:intron1/14:c.23+72C>T::,PMS2:ENST00000699768.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699839.1:intron_variant:MODIFIER:intron1/15:c.23+72C>T::,PMS2:ENST00000699823.1:intron_variant:MODIFIER:intron1/13:c.-190+72C>T::,PMS2:ENST00000699837.1:intron_variant:MODIFIER:intron1/13:c.-275+72C>T::,PMS2:ENST00000699825.1:intron_variant:MODIFIER:intron1/13:c.-378+72C>T::,PMS2:ENST00000699827.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron1/7:c.23+72C>T::,PMS2:ENST00000642292.1:intron_variant:MODIFIER:intron1/13:c.-243+72C>T::,PMS2:ENST00000642456.1:intron_variant:MODIFIER:intron1/14:c.-378+72C>T::,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron1/10:c.23+72C>T::	regulatory_region_variant:promoter	600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]&600859_[GENE=AIMP2_PHENOS=Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive]	1169336 [benign DISEASE=Hereditary nonpolyposis colorectal neoplasms,not provided];	CS1714329 [CLASS=R MUT=ALT PHEN="Lynch syndrome" GENE=PMS2];		rs3735295	0.2262	0.3171,0.1511,0.1606,0.1881,0.2329	4252,	25892	117640	1.0220			12.01				0	28499365,23424144	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98), AIMP2 (inh=AR oe_syn=1.21 oe_mis=1.17 oe_lof=0.46)
chr7	6009173	6009173	G	C	het	off-target	QUAL=58;DP=10;QD=5.80;AF=0.40;MQM=60;SAP=3;ABP=4;SAR=2;SAF=2	PMS2,Y_RNA,AIMP2	upstream_gene	PMS2:ENST00000265849.12:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699811.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699752.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699818.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699754.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699760.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699761.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699762.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699821.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699766.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699768.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699839.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699823.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699837.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699825.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699827.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699952.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000642292.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000642456.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000382321.5:upstream_gene_variant:MODIFIER::::,Y_RNA:ENST00000365120.1:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000400479.6:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000223029.8:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000395236.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]&600859_[GENE=AIMP2_PHENOS=Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive]	91280 [benign DISEASE=Lynch syndrome];			rs3735296	0.1623	0.2294,0.1076,0.0662,0.1380,0.1452	2212,	20247	127315	0.1400			8.88					24689082	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98), AIMP2 (inh=AR oe_syn=1.21 oe_mis=1.17 oe_lof=0.46)
chr7	129203328	129203328	C	T	hom	off-target	QUAL=315;DP=12;QD=26.25;AF=1.00;MQM=60;SAP=29;ABP=0;SAR=0;SAF=12	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron1/11:c.332-56C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1244213 [benign DISEASE=not provided];			rs2566871	0.4919	0.4741,0.4723,0.4063,0.5235,0.4379	18493,	37778	77240	-1.2520			0.59			COSV50824292	0	31209431	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205177	129205177	C	T	hom	off-target	QUAL=6757;DP=205;QD=32.96;AF=1.00;MQM=60;SAP=24;ABP=0;SAR=80;SAF=125	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron2/11:c.538-26C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1275728 [benign DISEASE=Hamartoma of hypothalamus,not provided];			rs2703091	0.7849	0.6869,0.7438,0.7431,0.8437,0.7649	47256,	24715	32681	0.0620			4.15			COSV99976307	0	28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205436	129205436	G	C	hom	off-target	QUAL=1590;DP=55;QD=28.91;AF=1.00;MQM=60;SAP=83;ABP=0;SAR=5;SAF=50	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron3/11:c.747+24G>C::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1268093 [benign DISEASE=Hamartoma of hypothalamus,not provided];			rs2075777	0.7847	0.6868,0.7435,0.7434,0.8435,0.7633	47291,	24739	32745	-0.0750			1.81				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205484	129205484	G	A	hom	off-target	QUAL=1843;DP=63;QD=29.25;AF=1.00;MQM=60;SAP=28;ABP=0;SAR=18;SAF=45	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron3/11:c.747+72G>A::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1290719 [benign DISEASE=not provided];			rs2566872	0.7847	0.6865,0.7430,0.7422,0.8436,0.7658	47267,	24725	32715	-0.1160			0.88			COSV50827858	0.09		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205861	129205861	C	T	hom	off-target	QUAL=1256;DP=42;QD=29.90;AF=1.00;MQM=60;SAP=8;ABP=0;SAR=26;SAF=16	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron4/11:c.920+79C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1221870 [benign DISEASE=not provided];			rs2075778	0.7859	0.6908,0.7438,0.7417,0.8437,0.7647	47389,	24676	32550	0.1800			2.65			COSV99976190	0.2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206066	129206066	T	C	hom	off-target	QUAL=113;DP=4;QD=28.25;AF=1.00;MQM=60;SAP=12;ABP=0;SAR=4;SAF=0	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron4/11:c.921-84T>C::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1259833 [benign DISEASE=not provided];			rs2075779	0.7859	0.6911,0.7439,0.7419,0.8436,0.7644	47409,	24678	32552	-0.2590			3.77			COSV50841276	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206487	129206487	G	C	hom		QUAL=28443;DP=908;QD=31.32;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=449;SAF=459	SMO	synonymous	SMO:ENST00000249373.8:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:PF01534 [Frizzled/Smoothened family membrane region]		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	403462 [benign DISEASE=Hamartoma of hypothalamus,not specified,not provided];			rs2228617	0.7867	0.6912,0.7451,0.7546,0.8439,0.7663	47468,	24621	32421	1.1650			10.22			COSV50829466	0	24033266,27236920,30334169,23826113,25189937,28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206628	129206628	A	G	hom	off-target	QUAL=27683;DP=857;QD=32.30;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=428;SAF=429	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron6/11:c.1264+41A>G::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1281387 [benign DISEASE=Hamartoma of hypothalamus,not provided];			rs2735842	0.7860	0.6913,0.7437,0.7420,0.8436,0.7649	47388,	24665	32525	0.2220			6.39			COSV50829472	0	27236920	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206716	129206716	-	AG	hom	off-target	QUAL=25501;DP=827;QD=30.84;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=414;SAF=407	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron6/11:c.1264+130_1264+131dup::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1277300 [benign DISEASE=not provided];			rs10622446	0.7854	0.6900,0.7437,0.7417,0.8434,0.7642	47288,	24676	32576				8.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129211961	129211961	G	A	het	off-target	QUAL=699;DP=58;QD=12.05;AF=0.60;MQM=60;SAP=63;ABP=8;SAR=2;SAF=33	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron11/11:c.1937-63G>A::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]				rs73230586	0.0002	0.0001,0.0000,0.0000,0.0003,0.0000	0,	28	152098	0.8380			4.78				0.05		0	10	0 / 4					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	142749281	142749281	A	C	hom	off-target	QUAL=1604;DP=76;QD=21.11;AF=1.00;MQM=59;SAP=168;ABP=0;SAR=0;SAF=76	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1169050 [benign DISEASE=Hereditary pancreatitis];			rs4726576	0.5552	0.5600,0.5876,0.2282,0.5783,0.3166	21898,	37062	64794	-3.0540			0.04					26820620,26784911,30832275,30467200,31506327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749335	142749335	A	G	het	off-target	QUAL=559;DP=111;QD=5.04;AF=0.33;MQM=57;SAP=83;ABP=30;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1302270496	0.3712	0.4372,0.3770,0.1204,0.3633,0.1931	0,	41485	70275	-0.5770			0.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749336	142749336	G	A	het	off-target	QUAL=559;DP=111;QD=5.04;AF=0.33;MQM=57;SAP=83;ABP=30;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1466629343	0.3732	0.4391,0.3792,0.1238,0.3650,0.1974	0,	41797	70209	-0.2050			0.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749349	142749349	C	A	het	off-target	QUAL=578;DP=111;QD=5.21;AF=0.33;MQM=57;SAP=83;ABP=30;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1194150362	0.3881	0.4509,0.3930,0.1447,0.3806,0.2200	0,	46751	73699	-1.4380			0.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749351	142749351	C	A	het	off-target	QUAL=578;DP=111;QD=5.21;AF=0.33;MQM=57;SAP=83;ABP=30;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796363879	0.3889	0.4517,0.3939,0.1463,0.3812,0.2203	0,	47061	73961	-0.0630			1.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749359	142749359	A	C	het	off-target	QUAL=551;DP=111;QD=4.96;AF=0.33;MQM=57;SAP=83;ABP=30;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796221450	0.3915	0.4535,0.3964,0.1525,0.3843,0.2260	0,	48377	75185	0.2990			5.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749360	142749360	G	A	het	off-target	QUAL=551;DP=111;QD=4.96;AF=0.33;MQM=57;SAP=83;ABP=30;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs576859120	0.3920	0.4540,0.3969,0.1528,0.3847,0.2262	0,	48553	75301	0.6120			5.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749392	142749392	G	A	het	off-target	QUAL=1384;DP=257;QD=5.39;AF=0.29;MQM=51;SAP=3;ABP=103;SAR=37;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1329539668	0.3958	0.4536,0.4005,0.1643,0.3901,0.2356	0,	51467	78553	0.1980			4.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749413	142749413	T	A	het	off-target	QUAL=1285;DP=267;QD=4.81;AF=0.27;MQM=51;SAP=3;ABP=122;SAR=36;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796163171	0.3988	0.4556,0.4031,0.1698,0.3930,0.2412	0,	52544	79222	-1.4940			0.92						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749434	142749434	G	C	het	off-target;low_conf_region	QUAL=185;DP=191;QD=0.97;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs764706324	0.3949	0.4523,0.3989,0.1602,0.3894,0.2339	0,	50253	77019	-0.4660			1.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749435	142749435	T	A	het	off-target;low_conf_region	QUAL=185;DP=191;QD=0.97;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs780768878	0.3942	0.4521,0.3988,0.1586,0.3887,0.2313	0,	49988	76822	-0.6810			0.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749439	142749439	G	C	het	off-target;low_conf_region	QUAL=185;DP=191;QD=0.97;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs372312254	0.3931	0.4502,0.3980,0.1574,0.3880,0.2317	0,	49700	76744	0.0310			1.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749450	142749450	A	G	het	off-target;low_conf_region	QUAL=201;DP=191;QD=1.05;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs972712999	0.3860	0.4437,0.3915,0.1485,0.3815,0.2197	0,	46757	74377	-0.3940			0.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749452	142749452	T	C	het	off-target;low_conf_region	QUAL=201;DP=191;QD=1.05;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1387019363	0.3857	0.4446,0.3909,0.1469,0.3809,0.2189	0,	46387	73867	-0.6900			0.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749454	142749454	C	T	het	off-target;low_conf_region	QUAL=201;DP=191;QD=1.05;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1431962420	0.3835	0.4421,0.3883,0.1447,0.3790,0.2148	0,	45903	73793	-0.1290			1.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749466	142749466	T	A	het	off-target;low_conf_region	QUAL=109;DP=214;QD=0.51;AF=0.18;MQM=44;SAP=79;ABP=191;SAR=38;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1170526371	0.3791	0.4381,0.3839,0.1367,0.3747,0.2085	0,	44301	72549	-2.0710			0.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749472	142749472	A	G	het	off-target;low_conf_region	QUAL=111;DP=214;QD=0.52;AF=0.18;MQM=44;SAP=79;ABP=191;SAR=38;SAF=1	PRSS1	5'UTR	PRSS1:ENST00000486171.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-13A>G::,PRSS1:ENST00000311737.12:5_prime_UTR_variant:MODIFIER:exon1/5:c.-13A>G::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs748424130	0.3681	0.4225,0.3746,0.1271,0.3663,0.1964	0,	41827	71803	1.0320			6.54						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749506	142749506	A	G	het	low_conf_region	QUAL=233;DP=187;QD=1.25;AF=0.20;MQM=44;SAP=77;ABP=146;SAR=37;SAF=1	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon1/6:c.22A>G:p.Thr8Ala:,PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon1/5:c.22A>G:p.Thr8Ala:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs749856663	0.3297	0.3922,0.3354,0.0916,0.3252,0.1619	0,	34677	70505	1.2940	T(1.00),T(1.00)	B(0.00),B(0.00)	0.03	0.24		COSV100298375	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749516	142749516	C	G	het	low_conf_region	QUAL=204;DP=192;QD=1.06;AF=0.20;MQM=44;SAP=77;ABP=155;SAR=37;SAF=1	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon1/6:c.32C>G:p.Ala11Gly:,PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon1/5:c.32C>G:p.Ala11Gly:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs748442280	0.3390	0.4017,0.3486,0.0992,0.3335,0.1618	0,	35790	69796	2.7440	T(1.00),T(1.00)	B(0.00),B(0.00)	7.26	0.26					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749524	142749524	C	G	het	low_conf_region	QUAL=230;DP=165;QD=1.39;AF=0.22;MQM=44;SAP=83;ABP=112;SAR=37;SAF=0	PRSS1	missense&splice_region	PRSS1:ENST00000486171.5:missense_variant&splice_region_variant:MODERATE:exon1/6:c.40C>G:p.Leu14Val:,PRSS1:ENST00000311737.12:missense_variant&splice_region_variant:MODERATE:exon1/5:c.40C>G:p.Leu14Val:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	939930 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Hereditary pancreatitis];			rs747228052	0.3493	0.4129,0.3562,0.1064,0.3440,0.1690	0,	37367	69601	2.0030	T(1.00),T(1.00)	B(0.00),B(0.00)	6.17	0.22	8.41>10.10		0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749531	142749531	A	T	het	low_conf_region	QUAL=215;DP=166;QD=1.30;AF=0.22;MQM=44;SAP=83;ABP=114;SAR=37;SAF=0	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron1/5:c.40+7A>T::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron1/4:c.40+7A>T::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796173487	0.3543	0.4181,0.3603,0.1123,0.3489,0.1725	0,	38339	69885	-1.9840			0.04				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751804	142751804	C	T	het	mosaic;low_conf_region	QUAL=0;DP=1073;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=24	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.273C>T:p.Asn91=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.231C>T:p.Asn77=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs555535168	0.0044	0.0055,0.0042,0.0015,0.0041,0.0027	0,	541	121591	5.9520			11.99			COSV105883384,COSV61196330	0.02		0	7846	0 / 1279					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751878	142751878	A	T	het	mosaic	QUAL=0;DP=998;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon4/6:c.347A>T:p.Lys116Met:PF00089 [Trypsin],PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon3/5:c.305A>T:p.Lys102Met:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs778568523	0.0086	0.0149,0.0072,0.0014,0.0064,0.0023	0,	898	103668	-1.2550	T(0.24),T(0.20)	B(0.02),B(0.02)	0.21	0.39			0.04		0	607	0 / 539					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751879	142751879	G	T	het	mosaic	QUAL=0;DP=998;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon4/6:c.348G>T:p.Lys116Asn:PF00089 [Trypsin],PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon3/5:c.306G>T:p.Lys102Asn:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1373631104	0.0084	0.0146,0.0069,0.0011,0.0063,0.0023	0,	878	103718	0.1220	T(0.71),T(0.55)	B(0.00),B(0.00)	5.32	0.25			0.09		0	607	0 / 539					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751901	142751901	T	C	het	mosaic	QUAL=0;DP=1009;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.370T>C:p.Leu124=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.328T>C:p.Leu110=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs747546710	0.0023	0.0047,0.0017,0.0004,0.0012,0.0014	0,	284	121438	2.6340			7.74			COSV61190485	0.16		0	535	0 / 518					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751903	142751903	A	G	het	mosaic	QUAL=0;DP=1009;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.372A>G:p.Leu124=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.330A>G:p.Leu110=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs771259654	0.0017	0.0036,0.0012,0.0004,0.0008,0.0009	0,	210	124424	0.6840			5.07			COSV61190491	0.29		0	534	0 / 518					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752462	142752462	T	C	het		QUAL=4335;DP=189;QD=22.94;AF=0.87;MQM=60;SAP=13;ABP=225;SAR=68;SAF=96	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.528T>C:p.Asp176=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	239391 [benign/likely benign DISEASE=Hereditary pancreatitis,Inborn genetic diseases,not specified];			rs6666	0.4273	0.5172,0.4216,0.1975,0.4096,0.2593	1829,	59587	84783	-3.8310			0.17			COSV61190814	0	25741868,33202925,31506327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752561	142752561	A	C	het		QUAL=101;DP=326;QD=0.31;AF=0.15;MQM=50;SAP=3;ABP=343;SAR=25;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.627A>C:p.Ser209=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.585A>C:p.Ser195=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	826012 [benign DISEASE=Inborn genetic diseases];			rs758274784	0.3985	0.4432,0.4093,0.1742,0.3977,0.2491	0,	52007	78505	0.0750			10.23			COSV61192546	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752564	142752564	T	C	het		QUAL=101;DP=326;QD=0.31;AF=0.15;MQM=50;SAP=3;ABP=343;SAR=25;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.630T>C:p.Cys210=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.588T>C:p.Cys196=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	826034 [benign DISEASE=Hereditary pancreatitis,Inborn genetic diseases];			rs751264273	0.3993	0.4468,0.4090,0.1732,0.3978,0.2487	0,	52113	78385	2.0850			12.49			COSV61192554	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752574	142752574	T	A	het		QUAL=90;DP=324;QD=0.28;AF=0.15;MQM=50;SAP=3;ABP=345;SAR=24;SAF=25	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.633+7T>A::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.591+7T>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1437923103	0.4016	0.4552,0.4095,0.1706,0.3976,0.2467	0,	52489	78215	-2.2470			0.22				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752596	142752596	G	T	het	off-target	QUAL=801;DP=189;QD=4.24;AF=0.26;MQM=50;SAP=3;ABP=94;SAR=25;SAF=25	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+29G>T::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+29G>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1194632115	0.4030	0.4636,0.4092,0.1670,0.3958,0.2432	0,	52477	77749	-2.3330			0.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752598	142752598	C	T	het	off-target	QUAL=801;DP=189;QD=4.24;AF=0.26;MQM=50;SAP=3;ABP=94;SAR=25;SAF=25	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+31C>T::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+31C>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1287891250	0.4030	0.4644,0.4089,0.1657,0.3957,0.2416	0,	52455	77697	0.0720			0.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752612	142752612	T	C	het	off-target	QUAL=395;DP=45;QD=8.78;AF=0.56;MQM=40;SAP=57;ABP=4;SAR=25;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+45T>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+45T>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs751484562	0.4027	0.4663,0.4069,0.1594,0.3942,0.2387	0,	52112	77312	-1.0110			6.36			COSV61192569	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752616	142752616	C	A	het	off-target	QUAL=395;DP=45;QD=8.78;AF=0.56;MQM=40;SAP=57;ABP=4;SAR=25;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+49C>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+49C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1277061180	0.4025	0.4667,0.4075,0.1583,0.3937,0.2359	0,	52040	77258	-0.6130			0.97			COSV100298220			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752631	142752631	G	A	het	off-target	QUAL=413;DP=51;QD=8.10;AF=0.49;MQM=40;SAP=57;ABP=3;SAR=25;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+64G>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+64G>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796982044	0.4023	0.4674,0.4063,0.1572,0.3928,0.2362	0,	52152	77500	-0.0710			3.31			COSV61192304			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752643	142752643	A	C	het	off-target	QUAL=376;DP=50;QD=7.52;AF=0.48;MQM=40;SAP=55;ABP=3;SAR=24;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+76A>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+76A>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs564920652	0.4008	0.4673,0.4037,0.1510,0.3905,0.2338	0,	51278	76676	-0.1840			3.63			COSV61193671			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752644	142752644	A	C	het	off-target	QUAL=376;DP=50;QD=7.52;AF=0.48;MQM=40;SAP=55;ABP=3;SAR=24;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+77A>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+77A>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs879215460	0.4010	0.4678,0.4038,0.1508,0.3907,0.2326	0,	51272	76594	-0.0120			5.77			COSV61193677	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752652	142752652	T	-	het	off-target	QUAL=357;DP=50;QD=7.14;AF=0.48;MQM=40;SAP=55;ABP=3;SAR=24;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+85del::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+85del::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1316059404	0.4006	0.4676,0.4032,0.1525,0.3901,0.2333	0,	51651	77293	-1.9860			0.00			COSV61191754			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752718	142752718	T	C	het	off-target	QUAL=364;DP=79;QD=4.61;AF=0.38;MQM=60;SAP=68;ABP=13;SAR=0;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-150T>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-150T>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs377684105	0.4127	0.4739,0.4164,0.1871,0.4025,0.2567	0,	57765	82195	-0.6350			2.57			COSV61191941	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752752	142752752	A	G	het	off-target	QUAL=1373;DP=148;QD=9.28;AF=0.41;MQM=60;SAP=3;ABP=15;SAR=30;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-116A>G::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-116A>G::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs370565903	0.4165	0.4753,0.4214,0.1960,0.4063,0.2680	0,	60215	84369	-4.3710			0.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752760	142752760	G	A	het	off-target	QUAL=1359;DP=148;QD=9.18;AF=0.41;MQM=60;SAP=3;ABP=15;SAR=30;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-108G>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-108G>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1293060442	0.4170	0.4754,0.4218,0.1967,0.4071,0.2698	0,	60644	84776	1.3030			6.88				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752812	142752812	A	C	het	off-target	QUAL=1404;DP=146;QD=9.62;AF=0.41;MQM=60;SAP=3;ABP=13;SAR=30;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-56A>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-56A>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs571822942	0.4186	0.4759,0.4233,0.2031,0.4089,0.2752	0,	61870	85936	-1.0180			0.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752844	142752844	C	A	het	off-target;low_conf_region	QUAL=127;DP=410;QD=0.31;AF=0.15;MQM=60;SAP=3;ABP=448;SAR=30;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-24C>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-24C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs192452846	0.4130	0.4734,0.4176,0.1928,0.4025,0.2630	0,	58804	83566	-0.8660			1.78			COSV104411417	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752861	142752861	C	A	het	low_conf_region	QUAL=108;DP=410;QD=0.26;AF=0.15;MQM=60;SAP=3;ABP=448;SAR=30;SAF=30	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-7C>A::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-7C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1443925968	0.4090	0.4719,0.4129,0.1794,0.3984,0.2517	0,	55266	79870	-1.6010			0.05		11.40>8.71				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752862	142752862	C	T	het	low_conf_region	QUAL=108;DP=410;QD=0.26;AF=0.15;MQM=60;SAP=3;ABP=448;SAR=30;SAF=30	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-6C>T::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-6C>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1345716315	0.4084	0.4716,0.4122,0.1784,0.3979,0.2504	0,	54990	79670	-0.5380			1.24		11.40>9.68				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752863	142752863	C	G	het	low_conf_region	QUAL=108;DP=410;QD=0.26;AF=0.15;MQM=60;SAP=3;ABP=448;SAR=30;SAF=30	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-5C>G::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-5C>G::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1220665540	0.4078	0.4713,0.4121,0.1785,0.3969,0.2491	0,	54665	79389	-0.8100			0.37		11.40>9.70				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142753014	142753014	T	C	hom		QUAL=10156;DP=357;QD=28.45;AF=1.00;MQM=60;SAP=411;ABP=0;SAR=308;SAF=49	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon6/6:c.780T>C:p.Asn260=:,PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	258803 [benign/likely benign DISEASE=Hereditary pancreatitis,Inborn genetic diseases,not specified];			rs6667	0.5271	0.4638,0.5749,0.2253,0.5768,0.3089	21011,	36332	70294	0.2440			2.45			COSV61193305	0	25741868,12011155,9633818,11842279,14526128,31506327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr8	89943130	89943130	C	T	het	off-target	QUAL=1166;DP=112;QD=10.41;AF=0.45;MQM=60;SAP=3;ABP=6;SAR=25;SAF=25	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron15/16:c.1938+123G>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron16/17:c.1938+123G>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron13/14:c.1938+123G>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron12/13:c.1872+123G>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron12/13:c.1959+123G>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron13/14:c.2115+123G>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron14/15:c.2184+123G>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron15/16:c.1938+123G>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron14/15:c.1938+123G>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron14/14:c.2184+123G>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1177037 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,not provided];			rs7840099	0.3333	0.3153,0.3517,0.4524,0.3221,0.4366	8315,	33373	100013	0.1550			1.93			COSV55372468	0	20734064,21987080,20004634,26045716,24396275,26622944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89943396	89943396	T	A	het	off-target	QUAL=411;DP=31;QD=13.26;AF=0.55;MQM=60;SAP=18;ABP=4;SAR=14;SAF=3	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron15/17:c.1825-30A>T::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron12/14:c.1825-30A>T::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron11/13:c.1759-30A>T::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-30A>T::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron12/14:c.2002-30A>T::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron13/15:c.2071-30A>T::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron13/15:c.1825-30A>T::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron13/14:c.2071-30A>T::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	258769 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,not specified,not provided];			rs3736639	0.3337	0.3170,0.3523,0.4519,0.3221,0.4359	8507,	33648	101164	-0.7230			0.74			COSV55378350	0	25741868,20734064,20004634,19523210,19917125,24396275,27936167	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89946194	89946194	T	C	het		QUAL=584;DP=47;QD=12.43;AF=0.55;MQM=60;SAP=11;ABP=4;SAR=18;SAF=8	NBN	synonymous,intron	NBN:ENST00000697292.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:,NBN:ENST00000697293.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:,NBN:ENST00000517337.2:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:ENST00000697298.1:synonymous_variant:LOW:exon15/18:c.1770A>G:p.Pro590=:,NBN:ENST00000697299.1:synonymous_variant:LOW:exon12/15:c.1770A>G:p.Pro590=:,NBN:ENST00000697304.1:synonymous_variant:LOW:exon11/14:c.1704A>G:p.Pro568=:,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-2828A>G::,NBN:ENST00000697308.1:synonymous_variant:LOW:exon12/15:c.1947A>G:p.Pro649=:,NBN:ENST00000265433.8:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:,NBN:ENST00000523444.2:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:ENST00000409330.5:synonymous_variant:LOW:exon13/16:c.1770A>G:p.Pro590=:,NBN:ENST00000697309.1:synonymous_variant:LOW:exon13/15:c.2016A>G:p.Pro672=:,NBN:ENST00000697310.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:	regulatory_region_variant:CTCF_binding_site	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183696 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1061302	0.3082	0.2305,0.3412,0.4529,0.3216,0.4358	7452,	31884	105022	-2.5830			0.68			COSV55371426	0.04	25741868,24033266,20386703,20004634,30799775,19523210,20478923,20571895,29416357,19393077,24166361,26402912,30272267,28647780,28402931,19917125,24396275,28288557,22864661,21908578,27936167,33403820	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89946302	89946302	T	C	het		QUAL=380;DP=35;QD=10.86;AF=0.46;MQM=60;SAP=12;ABP=4;SAR=12;SAF=4	NBN	splice_region&intron,intron	NBN:ENST00000697292.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::,NBN:ENST00000697293.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::,NBN:ENST00000517337.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:ENST00000697298.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1669-7A>G::,NBN:ENST00000697299.1:splice_region_variant&intron_variant:LOW:intron11/14:c.1669-7A>G::,NBN:ENST00000697304.1:splice_region_variant&intron_variant:LOW:intron10/13:c.1603-7A>G::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-2936A>G::,NBN:ENST00000697308.1:splice_region_variant&intron_variant:LOW:intron11/14:c.1846-7A>G::,NBN:ENST00000265433.8:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::,NBN:ENST00000523444.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:ENST00000409330.5:splice_region_variant&intron_variant:LOW:intron12/15:c.1669-7A>G::,NBN:ENST00000697309.1:splice_region_variant&intron_variant:LOW:intron12/14:c.1915-7A>G::,NBN:ENST00000697310.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::	regulatory_region_variant:CTCF_binding_site	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	258768 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs2308962	0.3326	0.3140,0.3516,0.4531,0.3220,0.4363	8448,	33567	101267	-1.9330			0.03		3.91>3.28	COSV55371846	0.03	25741868,24033266,20004634,19523210,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89955483	89955483	A	G	het		QUAL=349;DP=37;QD=9.43;AF=0.43;MQM=60;SAP=4;ABP=4;SAR=7;SAF=9	NBN	synonymous	NBN:ENST00000697292.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:,NBN:ENST00000697293.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:,NBN:ENST00000517337.2:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:ENST00000697298.1:synonymous_variant:LOW:exon12/18:c.951T>C:p.Asp317=:,NBN:ENST00000697299.1:synonymous_variant:LOW:exon9/15:c.951T>C:p.Asp317=:,NBN:ENST00000697304.1:synonymous_variant:LOW:exon8/14:c.885T>C:p.Asp295=:,NBN:ENST00000697307.1:synonymous_variant:LOW:exon10/14:c.1197T>C:p.Asp399=:,NBN:ENST00000697308.1:synonymous_variant:LOW:exon10/15:c.1197T>C:p.Asp399=:,NBN:ENST00000265433.8:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:,NBN:ENST00000523444.2:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:ENST00000409330.5:synonymous_variant:LOW:exon10/16:c.951T>C:p.Asp317=:,NBN:ENST00000697309.1:synonymous_variant:LOW:exon10/15:c.1197T>C:p.Asp399=:,NBN:ENST00000697310.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183701 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs709816	0.5089	0.7678,0.5217,0.6499,0.3610,0.5218	21973,	33250	74502	-0.0610			1.13			COSV55371961	0.01	25741868,24033266,20003265,20386703,19276285,21987080,22933979,28610420,25542228,30799775,16091150,16620382,19523210,20478923,20571895,29416357,24166361,28356832,30272267,28647780,26101473,26045716,19917125,24396275,28288557,26064273,25755792,22864661,32461785,25176580,27936167	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89955634	89955634	G	T	het	off-target	QUAL=747;DP=51;QD=14.65;AF=0.55;MQM=60;SAP=6;ABP=4;SAR=17;SAF=11	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron10/16:c.879-79C>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron11/17:c.879-79C>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron8/14:c.879-79C>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron7/13:c.813-79C>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron9/13:c.1125-79C>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron9/14:c.1125-79C>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron9/15:c.1125-79C>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron10/16:c.879-79C>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron9/15:c.879-79C>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron9/14:c.1125-79C>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1239473 [benign DISEASE=not provided];			rs1805786	0.3308	0.3073,0.3503,0.4531,0.3221,0.4358	8364,	33471	101551	0.6450			3.55			COSV55376816	0	19276285,19523210	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89958634	89958634	G	T	het	off-target	QUAL=163;DP=31;QD=5.26;AF=0.35;MQM=60;SAP=27;ABP=9;SAR=0;SAF=11	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron10/16:c.878+91C>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron11/17:c.878+91C>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron8/14:c.878+91C>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron7/13:c.812+91C>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron9/13:c.1124+91C>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron9/14:c.1124+91C>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron9/15:c.1124+91C>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron10/16:c.878+91C>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron9/15:c.878+91C>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron9/14:c.1124+91C>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1177038 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,not provided];			rs1805818	0.3305	0.3071,0.3502,0.4528,0.3220,0.4352	8366,	33469	101673	0.1280			2.00			COSV55373610	0	20004634,19523210,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89958707	89958707	G	A	het	off-target	QUAL=463;DP=48;QD=9.65;AF=0.42;MQM=60;SAP=19;ABP=6;SAR=4;SAF=16	NBN	splice_region&intron	NBN:ENST00000697292.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::,NBN:ENST00000697293.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::,NBN:ENST00000517337.2:splice_region_variant&intron_variant:LOW:intron10/16:c.878+18C>T::,NBN:ENST00000697298.1:splice_region_variant&intron_variant:LOW:intron11/17:c.878+18C>T::,NBN:ENST00000697299.1:splice_region_variant&intron_variant:LOW:intron8/14:c.878+18C>T::,NBN:ENST00000697304.1:splice_region_variant&intron_variant:LOW:intron7/13:c.812+18C>T::,NBN:ENST00000697307.1:splice_region_variant&intron_variant:LOW:intron9/13:c.1124+18C>T::,NBN:ENST00000697308.1:splice_region_variant&intron_variant:LOW:intron9/14:c.1124+18C>T::,NBN:ENST00000265433.8:splice_region_variant&intron_variant:LOW:intron9/15:c.1124+18C>T::,NBN:ENST00000523444.2:splice_region_variant&intron_variant:LOW:intron10/16:c.878+18C>T::,NBN:ENST00000409330.5:splice_region_variant&intron_variant:LOW:intron9/15:c.878+18C>T::,NBN:ENST00000697309.1:splice_region_variant&intron_variant:LOW:intron9/14:c.1124+18C>T::,NBN:ENST00000697310.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	199080 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs2234744	0.3083	0.2306,0.3409,0.4526,0.3216,0.4357	7468,	31902	105090	-0.3950			0.75			COSV55373621	0	25741868,19276285,20004634,19523210,19917125,24396275,27936167	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89978251	89978251	C	G	het		QUAL=10738;DP=828;QD=12.97;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=211;SAF=205	NBN	missense	NBN:ENST00000697292.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:,NBN:ENST00000697293.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:,NBN:ENST00000517337.2:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:ENST00000697298.1:missense_variant:MODERATE:exon7/18:c.307G>C:p.Glu103Gln:,NBN:ENST00000697299.1:missense_variant:MODERATE:exon4/15:c.307G>C:p.Glu103Gln:,NBN:ENST00000697304.1:missense_variant:MODERATE:exon5/14:c.553G>C:p.Glu185Gln:,NBN:ENST00000697307.1:missense_variant:MODERATE:exon5/14:c.553G>C:p.Glu185Gln:,NBN:ENST00000697308.1:missense_variant:MODERATE:exon5/15:c.553G>C:p.Glu185Gln:,NBN:ENST00000265433.8:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:,NBN:ENST00000523444.2:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:ENST00000409330.5:missense_variant:MODERATE:exon5/16:c.307G>C:p.Glu103Gln:,NBN:ENST00000697309.1:missense_variant:MODERATE:exon5/15:c.553G>C:p.Glu185Gln:,NBN:ENST00000697310.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:	regulatory_region_variant:promoter	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	134876 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN];		rs1805794	0.3104	0.2375,0.3417,0.4531,0.3219,0.4354	7536,	32076	104730	2.2150	T(1.00), ,T(1.00),T(1.00),T(1.00), , , ,T(1.00),T(1.00),T(1.00), ,T(1.00)	B(0.00), ,B(0.00),B(0.00),B(0.00), , , ,B(0.00),B(0.00),B(0.00), ,B(0.00)	14.16	0.10		COSV55371261,COSV55372457,COSV55375647	0	25741868,24033266,20734064,24728327,28827732,23284679,18191955,26514363,16465622,16857995,18701435,19109789,19124499,20150366,21129811,21700777,23720673,31584889,20386703,18830263,29458332,19276285,29963112,18579371,22430443,24062231,25178586,23719583,18768505,31374908,22300735,29732392,32014908,21927616,20805886,19706757,18638378,19584272,21647442,22933979,28610420,20004634,25542228,19367277,30799775,19523210,20478923,20571895,29416357,19393077,24166361,24113799,26998278,12917199,21166880,21656575,22413803,23283743,23381647,23979977,25073514,26493193,27845421,28356832,28476809,29433451,24382701,24093751,28345844,28402931,22070649,26622786,24594932,26101473,19917125,30197789,24396275,26064273,20975951,18394656,22313875,17991492,22245109,15921821,19022265,32778093,22864661,32728337,33800431,21908578,32957448,34295994,21864546,22631660,26974709,26622944,32234891,25176580,21215087,27936167,34926254	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89982791	89982791	C	T	het		QUAL=99;DP=19;QD=5.21;AF=0.37;MQM=60;SAP=18;ABP=6;SAR=7;SAF=0	NBN	synonymous,5'UTR,intron	NBN:ENST00000697292.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697293.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000517337.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:ENST00000697298.1:5_prime_UTR_variant:MODIFIER:exon3/18:c.-195G>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron1/14:c.-75-1268G>A::,NBN:ENST00000697304.1:synonymous_variant:LOW:exon2/14:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697307.1:synonymous_variant:LOW:exon2/14:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697308.1:synonymous_variant:LOW:exon2/15:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000265433.8:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000523444.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:ENST00000409330.5:5_prime_UTR_variant:MODIFIER:exon2/16:c.-145G>A::,NBN:ENST00000697309.1:synonymous_variant:LOW:exon2/15:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697310.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain]	regulatory_region_variant:promoter	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183697 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1063045	0.3327	0.3139,0.3516,0.4526,0.3220,0.4358	8469,	33597	101345	-0.1370			5.51			COSV55371979	0	25741868,24033266,20386703,19276285,21987080,20004634,30799775,17496786,19523210,20478923,19393077,26402912,22841127,19917125,24396275,15921821,22864661,18612309,17001621,18023021,24645271,27936167	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	106223973	106223973	A	C	hom	off-target	QUAL=413;DP=15;QD=27.53;AF=0.93;MQM=60;SAP=5;ABP=0;SAR=5;SAF=9		intergenic	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393979	0.6227	0.3309,0.6533,0.8411,0.7329,0.8449	32098,	30418	57338	-0.9390			4.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr8	106224052	106224052	G	T	hom		QUAL=20602;DP=650;QD=31.70;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=333;SAF=317		intergenic	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393978	0.5621	0.2757,0.6158,0.8374,0.6594,0.8222	26584,	32176	66492	-0.5960			0.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	5919543	5919543	-	AC	het	off-target	QUAL=427;DP=71;QD=6.01;AF=0.31;MQM=60;SAP=9;ABP=25;SAR=7;SAF=15	KIAA2026	3'UTR	KIAA2026:ENST00000381461.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*139_*140dup::,KIAA2026:ENST00000399933.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*139_*140dup::						rs375745414	0.0865	0.0645,0.0910,0.0121,0.0967,0.0788	495,	10067	116761				5.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIAA2026 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	5921881	5921881	G	A	het		QUAL=15248;DP=1060;QD=14.38;AF=0.54;MQM=60;SAP=5;ABP=15;SAR=296;SAF=273	KIAA2026	missense	KIAA2026:ENST00000381461.6:missense_variant:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile:,KIAA2026:ENST00000399933.8:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:						rs72697396	0.0000	0.0000,0.0000,0.0000,0.0001,0.0000	0,	4	152178	2.5130	D(0.02),D(0.02)	B(0.08),B(0.08)	14.15	0.03			0		0	14	0 / 3					KIAA2026 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	17235645	17235645	T	-	het	off-target	QUAL=537;DP=40;QD=13.43;AF=0.60;MQM=60;SAP=16;ABP=6;SAR=6;SAF=18	CNTLN	splice_region&intron	CNTLN:ENST00000380641.4:splice_region_variant&intron_variant:LOW:intron3/6:c.535-7del::,CNTLN:ENST00000380647.8:splice_region_variant&intron_variant:LOW:intron3/25:c.535-7del::						rs67017076	0.8172	0.9533,0.8609,0.9987,0.7334,0.9333	51837,	20506	27774	1.4780			7.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273880	17273880	A	G	het		QUAL=1161;DP=64;QD=18.14;AF=0.72;MQM=60;SAP=4;ABP=30;SAR=21;SAF=25	CNTLN	splice_region&intron	CNTLN:ENST00000380641.4:splice_region_variant&intron_variant:LOW:intron6/6:c.983+14A>G::,CNTLN:ENST00000380647.8:splice_region_variant&intron_variant:LOW:intron6/25:c.983+14A>G::						rs12376938	0.2354	0.1734,0.2393,0.0838,0.2665,0.3637	4464,	26823	116139	-1.4110			0.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273928	17273928	C	G	het	off-target	QUAL=189;DP=16;QD=11.81;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=4;SAF=4	CNTLN	intron	CNTLN:ENST00000380641.4:intron_variant:MODIFIER:intron6/6:c.983+62C>G::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron6/25:c.983+62C>G::						rs12379655	0.2936	0.3213,0.2773,0.3325,0.2717,0.4161	6598,	31328	107122	-2.0210			0.13			COSV52090650,COSV52097738	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17298549	17298549	C	G	het	off-target	QUAL=78;DP=7;QD=11.14;AF=0.57;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	CNTLN	3'UTR,intron	CNTLN:ENST00000380641.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*167C>G::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron7/25:c.1146+197C>G::						rs3739490	0.2504	0.2309,0.2418,0.0833,0.2641,0.3625	4888,	28224	113766	-1.2110			0.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17308971	17308972	TG	-	hom	off-target	QUAL=8824;DP=357;QD=24.72;AF=0.98;MQM=60;SAP=765;ABP=0;SAR=0;SAF=351	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron7/25:c.1147-86_1147-85del::					L2d2 (LINE/L2)	rs66758062	0.7923	0.6455,0.8155,0.8141,0.8609,0.7162	48062,	23505	31369	0.2650			1.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17330560	17330560	T	A	het	off-target	QUAL=338;DP=22;QD=15.36;AF=0.64;MQM=60;SAP=3;ABP=7;SAR=7;SAF=7	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron8/25:c.1342-72T>A::						rs3765040	0.5935	0.5658,0.5983,0.7283,0.6123,0.3481	26998,	36047	61673	-0.0680			0.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17332487	17332487	T	-	het	off-target	QUAL=393;DP=26;QD=15.12;AF=0.54;MQM=60;SAP=33;ABP=3;SAR=0;SAF=14	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron9/25:c.1519-105del::	regulatory_region_variant:enhancer					rs3084508	0.2379	0.1974,0.2343,0.0860,0.2587,0.3700	4340,	26947	114145	0.7440			9.82			COSV52096250	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17332487	17332488	TT	-	het	off-target	QUAL=393;DP=26;QD=15.12;AF=0.27;MQM=60;SAP=18;ABP=15;SAR=0;SAF=7	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron9/25:c.1519-106_1519-105del::	regulatory_region_variant:enhancer					rs3084508	0.5914	0.5632,0.5982,0.7265,0.6109,0.3469	26277,	36047	61217	1.0530			10.59				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17342385	17342385	C	T	hom		QUAL=983;DP=30;QD=32.77;AF=1.00;MQM=60;SAP=13;ABP=0;SAR=21;SAF=9	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:						rs1442527	0.9566	0.8487,0.9841,1.0000,0.9994,0.9983	69900,	5664	6604	2.1420			4.88				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394538	17394538	C	T	hom		QUAL=1783;DP=56;QD=31.84;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=28;SAF=28	CNTLN	missense	CNTLN:ENST00000380647.8:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:	regulatory_region_variant:enhancer					rs7035276	0.8178	0.7048,0.8291,0.8182,0.8743,0.7385	51286,	21714	27682	0.3660	T(0.27)	B(0.00)	14.49	0.06		COSV52066811	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394998	17394998	T	C	hom		QUAL=3143;DP=98;QD=32.07;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=49;SAF=49	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:	regulatory_region_variant:enhancer					rs3739489	0.8705	0.7827,0.8649,0.8209,0.9165,0.8697	57902,	16554	19690	0.5350			6.62				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17395110	17395110	C	T	hom	off-target;low_conf_region	QUAL=6825;DP=215;QD=31.74;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=107;SAF=108	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::	regulatory_region_variant:enhancer					rs3739488	0.8181	0.7052,0.8296,0.8179,0.8743,0.7406	51336,	21677	27653	3.8150			16.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409193	17409193	A	G	het	off-target	QUAL=69;DP=9;QD=7.67;AF=0.44;MQM=60;SAP=12;ABP=3;SAR=0;SAF=4	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron15/25:c.2616-100A>G::						rs62559023	0.0029	0.0007,0.0037,0.0002,0.0042,0.0044	1,	434	151774	0.0590			2.94				0		1	67	0 / 15					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409368	17409368	G	A	hom		QUAL=12154;DP=384;QD=31.65;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=192;SAF=192	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:						rs2780211	0.8679	0.7833,0.8595,0.8206,0.9145,0.8459	57514,	16871	20085	0.6420			5.75			COSV52096895	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457515	17457515	A	-	hom	low_conf_region	QUAL=104;DP=4;QD=26.00;AF=1.00;MQM=60;SAP=12;ABP=0;SAR=4;SAF=0	CNTLN	splice_acceptor&inframe_deletion	CNTLN:ENST00000380647.8:splice_acceptor_variant&inframe_deletion:HIGH:intron18/25:c.3115-2del:p.?:					(TATATT)n (Simple_repeat)	rs35399020	0.7958	0.5903,0.7968,0.6726,0.9045,0.7729	49329,	21394	30810	0.1530			0.54			COSV52086669	0.1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457856	17457856	A	G	hom	off-target	QUAL=6003;DP=233;QD=25.76;AF=1.00;MQM=60;SAP=509;ABP=0;SAR=233;SAF=0	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron19/25:c.3306+141A>G::						rs2197152	0.6928	0.5685,0.6479,0.9279,0.7463,0.6934	37174,	30730	46586	-0.7660			0.19				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17464404	17464404	G	C	hom	off-target	QUAL=9088;DP=317;QD=28.67;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=157;SAF=160	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron20/25:c.3405-93G>C::						rs1442532	0.9668	0.9049,0.9773,0.9204,0.9992,0.9563	70663,	4532	5002	0.0040			0.91				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494735	17494735	C	T	het	off-target	QUAL=715;DP=58;QD=12.33;AF=0.62;MQM=60;SAP=81;ABP=10;SAR=0;SAF=36	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4119+7669C>T::					Tigger3b (DNA/TcMar-Tigger)	rs7861498	0.3596	0.3021,0.4555,0.5255,0.3632,0.3147	10119,	34362	97224	-0.6620			1.13			COSV52071433	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494877	17494877	T	-	het	off-target;low_conf_region	QUAL=239;DP=30;QD=7.97;AF=0.20;MQM=60;SAP=9;ABP=26;SAR=1;SAF=5	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4120-7653del::					Tigger3b (DNA/TcMar-Tigger), AluSx (SINE/Alu)	rs35224903	0.6010	0.5923,0.6840,0.7114,0.5819,0.6826	8271,	20939	24887	0.1770			0.52				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494877	17494879	TTT	-	het	off-target;low_conf_region	QUAL=239;DP=30;QD=7.97;AF=0.17;MQM=60;SAP=14;ABP=32;SAR=0;SAF=5	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4120-7655_4120-7653del::					Tigger3b (DNA/TcMar-Tigger), AluSx (SINE/Alu)	rs35224903	0.0005	0.0003,0.0009,0.0000,0.0006,0.0000	0,	31	62267	0.1770			0.61				0.04		13	760	0 / 132	2	"[2] auto-classification 15.09.2017  "			CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	21971138	21971138	T	G	het		QUAL=280;DP=53;QD=5.28;AF=0.45;MQM=60;SAP=55;ABP=4;SAR=0;SAF=24	CDKN2A	missense,synonymous	CDKN2A:ENST00000304494.10:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000579755.2:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:ENST00000579122.1:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000578845.2:missense_variant:MODERATE:exon1/2:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000530628.2:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:ENST00000498124.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000498628.6:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000494262.5:missense_variant:MODERATE:exon3/4:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000479692.2:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000497750.1:missense_variant:MODERATE:exon2/2:c.68A>C:p.Asp23Ala:		600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]	802463 [uncertain significance DISEASE=Melanoma-pancreatic cancer syndrome];	CM165602 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=CDKN2A];		rs200429615	0.0000	0.0000,0.0000,0.0004,0.0000,0.0000	0,	4	150578	7.4100	D(0.00), ,D(0.00),D(0.00), ,D(0.00),D(0.00),D(0.00),D(0.00),D(0.00)	D(1.00), ,P(0.87),D(1.00), ,D(1.00),D(1.00),D(1.00),D(1.00),D(1.00)	32.00	0.88		COSV104609655,COSV58684939,COSV58689077	0.01	25353071	10	280	10 / 279	1	"[1] old entry - no details available"			CDKN2A-DT (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=n/a), CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21974672	21974672	A	C	het		QUAL=122;DP=20;QD=6.10;AF=0.70;MQM=60;SAP=33;ABP=10;SAR=14;SAF=0	CDKN2A	splice_region&intron,intron	CDKN2A:ENST00000304494.10:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::,CDKN2A:ENST00000579122.1:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::,CDKN2A:ENST00000498124.1:splice_region_variant&intron_variant:LOW:intron1/3:c.150+6T>G::,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3464T>G::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3464T>G::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]										0.6550			10.22		8.56>6.92	COSV105166956	0.11		29	349	29 / 349	2	"[2] auto-classification 15.09.2017  [3] ahsepai1 2016-07-13  "			CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21974676	21974676	A	C	het		QUAL=122;DP=20;QD=6.10;AF=0.70;MQM=60;SAP=33;ABP=10;SAR=14;SAF=0	CDKN2A	splice_donor,intron	CDKN2A:ENST00000304494.10:splice_donor_variant:HIGH:intron1/2:c.150+2T>G:p.?:,CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::,CDKN2A:ENST00000579122.1:splice_donor_variant:HIGH:intron1/2:c.150+2T>G:p.?:,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::,CDKN2A:ENST00000498124.1:splice_donor_variant:HIGH:intron1/3:c.150+2T>G:p.?:,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3468T>G::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3468T>G::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]										5.5950			32.00		8.56>0.92	COSV58686447,COSV58697953	0.99		29	352	29 / 351	4	"[4] ahsepai1 2016-07-13 TEST TEST3124"		"testing"	CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21975018	21975018	C	T	hom	off-target	QUAL=803;DP=31;QD=25.90;AF=1.00;MQM=60;SAP=70;ABP=0;SAR=31;SAF=0	CDKN2A	intron	CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3810G>A::,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3810G>A::,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3810G>A::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3810G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]	873184 [benign DISEASE=Squamous cell lung carcinoma,Melanoma, cutaneous malignant, susceptibility to, 2,not provided];			rs3814960	0.5035	0.2329,0.4756,0.6482,0.6259,0.6171	21594,	33334	75448	-0.1700			6.17			COSV58720858	0	27414035,27055116,21355081,18761660,20386740,25280564,20381282	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	35074920	35074920	T	C	hom		QUAL=3127;DP=99;QD=31.59;AF=1.00;MQM=60;SAP=6;ABP=0;SAR=55;SAF=44	FANCG	splice_region&intron	FANCG:ENST00000378643.8:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::,FANCG:ENST00000448890.2:splice_region_variant&intron_variant:LOW:intron13/14:c.1636+7A>G::,FANCG:ENST00000696710.1:splice_region_variant&intron_variant:LOW:intron12/13:c.1630+7A>G::,FANCG:ENST00000696715.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1636+7A>G::		601023_[GENE=VCP_PHENOS=Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant]&602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	259477 [benign DISEASE=Fanconi anemia complementation group G,Fanconi anemia,not specified,Amyotrophic Lateral Sclerosis, Dominant,Inclusion Body Myopathy, Dominant,not provided];	CS2129783 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCG];		rs587118	0.3526	0.0912,0.4572,0.0052,0.4965,0.2357	12180,	29241	98409	0.4790			11.30			COSV62719986	0.07	25741868,17618707,32888493	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AD oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	35077444	35077444	T	C	hom	off-target	QUAL=6869;DP=207;QD=33.18;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=104;SAF=103	FANCG	intron	FANCG:ENST00000378643.8:intron_variant:MODIFIER:intron4/13:c.511-45A>G::,FANCG:ENST00000448890.2:intron_variant:MODIFIER:intron5/14:c.511-45A>G::,FANCG:ENST00000696710.1:intron_variant:MODIFIER:intron4/13:c.511-45A>G::,FANCG:ENST00000696715.1:intron_variant:MODIFIER:intron4/12:c.511-45A>G::		601023_[GENE=VCP_PHENOS=Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant]&602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	259478 [benign DISEASE=Fanconi anemia complementation group G,not specified,not provided];			rs554098	0.7527	0.7407,0.7944,0.4601,0.7797,0.7070	43310,	27607	37527	-1.4080			0.43			COSV62719498	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AD oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	35079364	35079364	G	T	hom	off-target	QUAL=5329;DP=171;QD=31.16;AF=1.00;MQM=60;SAP=22;ABP=0;SAR=66;SAF=105	FANCG	intron	FANCG:ENST00000378643.8:intron_variant:MODIFIER:intron1/13:c.84+77C>A::,FANCG:ENST00000448890.2:intron_variant:MODIFIER:intron2/14:c.84+77C>A::,FANCG:ENST00000696710.1:intron_variant:MODIFIER:intron1/13:c.84+77C>A::,FANCG:ENST00000696715.1:intron_variant:MODIFIER:intron1/12:c.84+77C>A::	regulatory_region_variant:promoter	602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	1177024 [benign DISEASE=Fanconi anemia complementation group G,not provided];			rs504082	0.5453	0.2739,0.6571,0.0833,0.7067,0.4762	25873,	31134	69110	-0.0480			6.76			COSV66213684	0.04	17618707,32888493,32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCG (inh=AD oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	87447908	87447908	A	G	hom		QUAL=14935;DP=527;QD=28.34;AF=1.00;MQM=60;SAP=740;ABP=0;SAR=52;SAF=475		intergenic	::intergenic_variant:MODIFIER::::						rs12682834	0.5963	0.4842,0.6418,0.7053,0.6293,0.7461	27499,	35595	61333	-0.5610			0.49					19956101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	95107236	95107236	C	T	het	mosaic	QUAL=0;DP=232;QD=0.00;AF=0.02;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	FANCC	missense	FANCC:ENST00000289081.8:missense_variant:MODERATE:exon14/15:c.1363G>A:p.Ala455Thr:PF02106 [Fanconi anaemia group C protein],FANCC:ENST00000375305.6:missense_variant:MODERATE:exon14/15:c.1363G>A:p.Ala455Thr:PF02106 [Fanconi anaemia group C protein]	regulatory_region_variant:enhancer	613899_[GENE=FANCC_PHENOS=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive]				rs730881724						0.4150	T(0.58),T(0.58)	B(0.00),B(0.00)	0.91	0.01		COSV100001818	0		0	0	0 / 0					FANCC (inh=AR oe_syn=1.09 oe_mis=1.03 oe_lof=0.74)
chr9	95247331	95247331	-	A	het	off-target	QUAL=56;DP=52;QD=1.08;AF=0.15;MQM=60;SAP=3;ABP=57;SAR=4;SAF=4	FANCC	intron	FANCC:ENST00000289081.8:intron_variant:MODIFIER:intron3/14:c.250+100dup::,FANCC:ENST00000375305.6:intron_variant:MODIFIER:intron3/14:c.250+100dup::,FANCC:ENST00000490972.7:intron_variant:MODIFIER:intron3/13:c.250+100dup::,FANCC:ENST00000649872.1:intron_variant:MODIFIER:intron2/3:c.250+100dup::,FANCC:ENST00000696262.1:intron_variant:MODIFIER:intron3/3:c.250+100dup::		613899_[GENE=FANCC_PHENOS=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive]	1214388 [likely benign DISEASE=not provided];			rs529124256	0.0026	0.0008,0.0027,0.0010,0.0027,0.0004	1,	369	142563				0.69				0		0	17	0 / 6					FANCC (inh=AR oe_syn=1.09 oe_mis=1.03 oe_lof=0.74)
chr9	95447312	95447312	G	A	het		QUAL=1196;DP=71;QD=16.85;AF=0.66;MQM=60;SAP=4;ABP=19;SAR=21;SAF=26	PTCH1	missense	PTCH1:ENST00000331920.11:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:ENST00000437951.6:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:,PTCH1:ENST00000430669.6:missense_variant:MODERATE:exon23/23:c.3746C>T:p.Pro1249Leu:,PTCH1:ENST00000692981.1:missense_variant:MODERATE:exon22/23:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000429896.6:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:	regulatory_region_variant:enhancer	601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	41663 [benign DISEASE=Gorlin syndrome,Holoprosencephaly 7,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs357564	0.3300	0.2324,0.3870,0.5636,0.3366,0.4722	8752,	32643	101807	9.5400	D(0.01),D(0.01),D(0.01),D(0.01),D(0.01)	B(0.44),P(0.71),P(0.65),B(0.44),B(0.44)	24.70	0.44		COSV59463357	0	25741868,24033266,24728327,23757202,19937600,22703879,26893459,21811255,20583170,30214282,22677152,24073265,20346027,22221699,27825128,30334169,31209431,31204176,24260604,27081528,23826113,18059179,27591082,31669095,33298892,34021172,29498494,35047024,34944636	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95468642	95468642	-	T	het	off-target	QUAL=84;DP=106;QD=0.79;AF=0.14;MQM=60;SAP=4;ABP=121;SAR=6;SAF=9	PTCH1	intron	PTCH1:ENST00000331920.11:intron_variant:MODIFIER:intron14/23:c.2250+108dup::,PTCH1:ENST00000437951.6:intron_variant:MODIFIER:intron14/23:c.2247+108dup::,PTCH1:ENST00000430669.6:intron_variant:MODIFIER:intron14/22:c.2052+108dup::,PTCH1:ENST00000692981.1:intron_variant:MODIFIER:intron13/22:c.1797+108dup::,PTCH1:ENST00000429896.6:intron_variant:MODIFIER:intron14/23:c.1797+108dup::		601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]				rs35352942	0.0051	0.0018,0.0102,0.0004,0.0058,0.0085	6,	745	149093				3.39				0		0	94	0 / 12					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95469942	95469942	A	-	het		QUAL=562;DP=59;QD=9.53;AF=0.54;MQM=60;SAP=72;ABP=4;SAR=32;SAF=0	PTCH1	splice_region&intron	PTCH1:ENST00000331920.11:splice_region_variant&intron_variant:LOW:intron12/23:c.1729-11del::,PTCH1:ENST00000437951.6:splice_region_variant&intron_variant:LOW:intron12/23:c.1726-11del::,PTCH1:ENST00000430669.6:splice_region_variant&intron_variant:LOW:intron12/22:c.1531-11del::,PTCH1:ENST00000692981.1:splice_region_variant&intron_variant:LOW:intron11/22:c.1276-11del::,PTCH1:ENST00000429896.6:splice_region_variant&intron_variant:LOW:intron12/23:c.1276-11del::		601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	1290901 [benign/likely benign DISEASE=Gorlin syndrome,Hereditary cancer-predisposing syndrome,not provided];			rs779000277	0.0008	0.0002,0.0006,0.0000,0.0015,0.0000	0,	120	151876	0.9180			0.96			COSV59495096	0.01		0	51	0 / 13					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95476908	95476908	G	C	hom	off-target	QUAL=1285;DP=42;QD=30.60;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=13;SAF=29	PTCH1	intron	PTCH1:ENST00000331920.11:intron_variant:MODIFIER:intron10/23:c.1504-51C>G::,PTCH1:ENST00000437951.6:intron_variant:MODIFIER:intron10/23:c.1501-51C>G::,PTCH1:ENST00000430669.6:intron_variant:MODIFIER:intron10/22:c.1306-51C>G::,PTCH1:ENST00000692981.1:intron_variant:MODIFIER:intron9/22:c.1051-51C>G::,PTCH1:ENST00000429896.6:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::		601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	1280181 [benign DISEASE=not provided];			rs574688	0.1957	0.0529,0.2439,0.0863,0.2642,0.2814	3674,	22414	122306	0.2170			3.49			COSV100107392	0.01	34021172,29498494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95508311	95508313	GCC	-	het	mosaic	QUAL=0;DP=392;QD=0.00;AF=0.02;MQM=60;SAP=3;ABP=0;SAR=3;SAF=3	PTCH1	inframe_deletion,intron	PTCH1:ENST00000331920.11:inframe_deletion:MODERATE:exon1/24:c.49_51del:p.Gly17del:,PTCH1:ENST00000437951.6:intron_variant:MODIFIER:intron1/23:c.199-1714_199-1712del::,PTCH1:ENST00000430669.6:intron_variant:MODIFIER:intron1/22:c.4-1714_4-1712del::,PTCH1:ENST00000468211.6:intron_variant:MODIFIER:intron1/4:c.4-1714_4-1712del::	regulatory_region_variant:promoter	601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	802503 [uncertain significance DISEASE=Gorlin syndrome];		(CCG)n (Simple_repeat)	rs756897237	0.0000	0.0000,0.0001,0.0000,0.0000,0.0000	0,	1	150737	2.2670			15.97				0		0	0	0 / 0					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr10	43077302	43077304	TGC	-	het	mosaic	QUAL=0;DP=281;QD=0.00;AF=0.03;MQM=60;SAP=3;ABP=0;SAR=4;SAF=4	RET	inframe_deletion	RET:ENST00000340058.6:inframe_deletion:MODERATE:exon1/19:c.56_58del:p.Leu19del:,RET:ENST00000355710.8:inframe_deletion:MODERATE:exon1/20:c.56_58del:p.Leu19del:,RET:ENST00000615310.5:inframe_deletion:MODERATE:exon1/17:c.56_58del:p.Leu19del:	regulatory_region_variant:promoter	164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	543749 [uncertain significance(replaced by megSAP based on classifications:1x2,1x3) DISEASE=Multiple endocrine neoplasia, type 2a,Multiple endocrine neoplasia, type 2];		(GCT)n (Simple_repeat)	rs768132465	0.0000	0.0000,0.0000,0.0000,0.0000,0.0000	0,	1	151727	2.5770			18.50				0		0	0	0 / 0					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43100333	43100333	G	T	hom	off-target	QUAL=309;DP=12;QD=25.75;AF=1.00;MQM=60;SAP=29;ABP=0;SAR=12;SAF=0	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron1/18:c.74-126G>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron1/19:c.74-126G>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron1/16:c.74-126G>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	677050 [benign DISEASE=Multiple endocrine neoplasia, type 2,not provided];	CS045982 [CLASS=DP MUT=ALT PHEN="Thyroid cancer association with" GENE=RET];		rs2565206	0.3812	0.5894,0.3209,0.1115,0.3299,0.1965	12369,	33039	93783	-0.0150			0.82				0	23820649,22312249,23059849,20860806,21995290,22584707,16816022,28930629,32411094,32228166,34950210	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43100389	43100389	T	-	het	off-target	QUAL=716;DP=67;QD=10.69;AF=0.49;MQM=60;SAP=22;ABP=3;SAR=8;SAF=25	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron1/18:c.74-57del::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron1/19:c.74-57del::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron1/16:c.74-57del::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1258537 [benign DISEASE=not provided];			rs57003029	0.2516	0.2570,0.2396,0.1168,0.2748,0.1195	4408,	28219	110145	-0.5180			0.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43100520	43100520	A	G	hom		QUAL=16186;DP=520;QD=31.13;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=268;SAF=252	RET	synonymous	RET:ENST00000340058.6:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000355710.8:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000615310.5:synonymous_variant:LOW:exon2/17:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1]		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	167589 [benign DISEASE=Pheochromocytoma,Multiple endocrine neoplasia, type 2b,Multiple endocrine neoplasia, type 2a,Multiple endocrine neoplasia, type 2,not specified,not provided];			rs1800858	0.7850	0.9491,0.7560,0.5479,0.7423,0.7074	47871,	23561	32671	-2.1930			0.35			COSV60686024	0	30409984,17267408,10090908,19138047,8001158,26102504,18091754,20532249,15759212,22312249,24897126,29131865,10521317,10528857,10922382,11950855,16091499,18284634,20123584,20454948,21349203,23059849,23084198,23527089,31644668,22648184,22584707,23840513,26191299,30072953,27174043,16443855,28930629,18436345,23441071,24651702,33827484,32411094,32364585,32708070,34950210,34981673,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43106301	43106301	T	C	hom	off-target	QUAL=1737;DP=56;QD=31.02;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=28;SAF=28	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron4/18:c.868-75T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron4/19:c.868-75T>C::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron4/16:c.867+1108T>C::	regulatory_region_variant:CTCF_binding_site	164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1222122 [benign DISEASE=not provided];			rs2742243	0.7635	0.8736,0.7495,0.5427,0.7421,0.7075	44937,	26188	35950	-1.7550			0.39			COSV60698036	0	24144365,32913965	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43108942	43108942	A	T	hom	off-target	QUAL=3924;DP=136;QD=28.85;AF=1.00;MQM=60;SAP=121;ABP=0;SAR=25;SAF=111	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron5/18:c.1064-89A>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron5/19:c.1064-89A>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron4/16:c.868-2265A>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1277152 [benign DISEASE=not provided];			rs1864404	0.7843	0.9460,0.7583,0.5435,0.7423,0.7068	47800,	23657	32795	-0.0510			1.25				0.01	22584707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43114918	43114918	G	A	hom	off-target	QUAL=1996;DP=77;QD=25.92;AF=1.00;MQM=60;SAP=170;ABP=0;SAR=77;SAF=0	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron11/18:c.2136+182G>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron11/19:c.2136+182G>A::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron9/16:c.1740+182G>A::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1226080 [benign DISEASE=not provided];			rs1864400	0.8242	0.9079,0.8019,0.4971,0.8147,0.7076	52134,	20931	26711	-2.8890			0.05			COSV60687565	0	25310821,32851260	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43116417	43116417	T	C	hom	off-target	QUAL=806;DP=27;QD=29.85;AF=1.00;MQM=60;SAP=62;ABP=0;SAR=0;SAF=27	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron11/18:c.2137-167T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron11/19:c.2137-167T>C::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron9/16:c.1741-167T>C::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	677053 [benign DISEASE=not provided];			rs2256550	0.5573	0.6635,0.4906,0.2931,0.5574,0.3094	24337,	36032	67284	-1.4090			7.43			COSV60688429	0	24144365	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43116741	43116741	A	G	het	mosaic	QUAL=0;DP=563;QD=0.00;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=3;SAF=3	RET	splice_region&intron	RET:ENST00000340058.6:splice_region_variant&intron_variant:LOW:intron12/18:c.2284+10A>G::,RET:ENST00000355710.8:splice_region_variant&intron_variant:LOW:intron12/19:c.2284+10A>G::,RET:ENST00000615310.5:splice_region_variant&intron_variant:LOW:intron10/16:c.1888+10A>G::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]										0.1330			9.73			COSV60697473	0		0	0	0 / 0					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43116778	43116778	C	T	het	off-target;low_conf_region	QUAL=2397;DP=316;QD=7.59;AF=0.46;MQM=60;SAP=213;ABP=8;SAR=131;SAF=13	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron12/18:c.2284+47C>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron12/19:c.2284+47C>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron10/16:c.1888+47C>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	261396 [benign DISEASE=not specified,not provided];			rs760466	0.1924	0.0576,0.2003,0.0556,0.2818,0.1294	3405,	21937	120683	-0.9730			0.51			COSV60689537	0	25741868,32411094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43118395	43118395	G	T	hom		QUAL=37763;DP=1156;QD=32.67;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=582;SAF=574	RET	synonymous	RET:ENST00000340058.6:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000355710.8:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000615310.5:synonymous_variant:LOW:exon11/17:c.1911G>T:p.Leu637=:PF07714 [Protein tyrosine and serine/threonine kinase]		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	167590 [benign DISEASE=Pheochromocytoma,Multiple endocrine neoplasia, type 2b,Multiple endocrine neoplasia, type 2a,Multiple endocrine neoplasia, type 2,not specified,not provided];			rs1800861	0.7846	0.8833,0.7658,0.4950,0.7671,0.6204	47391,	24515	32745	1.2810			7.08			COSV60687116	0.01	24033266,30089490,19379518,20565774,22024213,26829565,19138047,20532249,8084609,22312249,24897126,25330015,25736215,28946813,16091499,21349203,23059849,23084198,23527089,16118333,22648184,15531548,22584707,23840513,31263477,27174043,28930629,18976163,24651702,33342844,33827484,32411094,32228166,32913965,34769224,34950210	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43120057	43120057	G	A	het	off-target	QUAL=9252;DP=734;QD=12.60;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=189;SAF=183	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron14/18:c.2608-24G>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron14/19:c.2608-24G>A::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron12/16:c.2212-24G>A::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	24956 [benign DISEASE=Multiple endocrine neoplasia, type 2,not specified,not provided];	CS116395 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2472737	0.2024	0.1500,0.1927,0.2310,0.2275,0.1576	3272,	24236	121270	-0.3050			4.67			COSV60686346	0	25741868,23757202,22312249,24897126,18284634,12872262,11302967,16118333,24144365,34769224	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43126769	43126769	T	C	hom	off-target	QUAL=1163;DP=42;QD=27.69;AF=1.00;MQM=60;SAP=86;ABP=0;SAR=1;SAF=41	RET	3'UTR,intron	RET:ENST00000340058.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*15T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron19/19:c.3187+47T>C::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*15T>C::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	165056 [benign DISEASE=Pheochromocytoma,Multiple endocrine neoplasia, type 2b,Multiple endocrine neoplasia, type 2a,Multiple endocrine neoplasia, type 2,not specified];	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2075912	0.8307	0.9148,0.8052,0.4994,0.8230,0.7101	53013,	20295	25741	1.4280			13.49			COSV60689472	0.03	25741868,24033266,27798940,29131865,20454948,22648184,31247956,32411094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43126920	43126920	T	A	hom	off-target	QUAL=1115;DP=43;QD=25.93;AF=1.00;MQM=60;SAP=96;ABP=0;SAR=43;SAF=0	RET	3'UTR,intron	RET:ENST00000340058.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*166T>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron19/19:c.3187+198T>A::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*166T>A::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1230253 [benign DISEASE=not provided];			rs2075913	0.7574	0.8157,0.7587,0.4034,0.7656,0.5503	44217,	26726	36892	3.1000			21.60			COSV60699882	0	32139661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43128364	43128364	C	T	het	off-target	QUAL=7101;DP=499;QD=14.23;AF=0.54;MQM=60;SAP=9;ABP=10;SAR=148;SAF=121	RET	3'UTR	RET:ENST00000355710.8:3_prime_UTR_variant:MODIFIER:exon20/20:c.*95C>T::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*1610C>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	299903 [benign DISEASE=Pheochromocytoma,Hirschsprung disease, susceptibility to, 1,Multiple endocrine neoplasia,Renal hypodysplasia/aplasia 1];			rs17028	0.1680	0.0415,0.1744,0.2314,0.2197,0.1444	2699,	20141	126453	0.3030			10.38			COSV60689480	0	22369086,20532249,21841314,32139661,29131865	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	86876022	86876022	C	A	het		QUAL=851;DP=70;QD=12.16;AF=0.56;MQM=53;SAP=4;ABP=5;SAR=21;SAF=18	BMPR1A	missense	BMPR1A:ENST00000372037.8:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	41782 [benign DISEASE=Generalized juvenile polyposis/juvenile polyposis coli,Hereditary cancer-predisposing syndrome,Juvenile polyposis syndrome,not specified,not provided];			rs11528010	0.4040	0.6597,0.3492,0.7029,0.2520,0.3146	14968,	31439	90529	3.2000	T(1.00)	B(0.00)	11.73	0.21		COSV64406247,COSV64409048	0.02	25741868,24728327,26293461,26900293,22703879,29458332,16436638,19502417,22886282,28473326,33032550	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86890006	86890006	C	T	het	off-target;low_conf_region	QUAL=672;DP=53;QD=12.68;AF=0.49;MQM=60;SAP=15;ABP=3;SAR=7;SAF=19	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron3/12:c.68-56C>T::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	1292350 [benign DISEASE=not provided];			rs7087358	0.4477	0.6837,0.3717,0.7085,0.3087,0.3928	17435,	33166	83924	-0.1980			2.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17), RNU1-19P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr10	86918991	86918991	A	T	hom	off-target	QUAL=159;DP=6;QD=26.50;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=0;SAF=6	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron9/12:c.869-181A>T::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	1292661 [benign DISEASE=not provided];			rs1240188	0.9580	0.9792,0.9497,0.9658,0.9461,0.9799	69863,	6085	6399	-0.4140			2.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923240	86923240	-	GAT	het	off-target	QUAL=4998;DP=558;QD=8.96;AF=0.46;MQM=60;SAP=559;ABP=11;SAR=0;SAF=256	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron11/12:c.1343-135_1343-134insATG::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]				rs544039657													0.03		158	1686	29 / 238					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923242	86923242	-	ATATA	het	off-target	QUAL=4998;DP=558;QD=8.96;AF=0.46;MQM=60;SAP=559;ABP=11;SAR=0;SAF=256	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron11/12:c.1343-134_1343-133insATATA::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]				rs1554891541													0.07		153	1597	26 / 232					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923365	86923365	T	C	het	off-target	QUAL=5533;DP=615;QD=9.00;AF=0.44;MQM=60;SAP=431;ABP=22;SAR=251;SAF=20	BMPR1A	splice_region&intron	BMPR1A:ENST00000372037.8:splice_region_variant&intron_variant:LOW:intron11/12:c.1343-11T>C::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	259286 [benign DISEASE=Generalized juvenile polyposis/juvenile polyposis coli,Hereditary cancer-predisposing syndrome,Juvenile polyposis syndrome,not specified,not provided];			rs7074064	0.4020	0.6616,0.3342,0.6980,0.2509,0.3151	14879,	31288	90812	-0.2270			1.82		10.64>9.92		0	25741868,26293461,16385451,23555554,35037836	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	87893929	87893929	A	G	hom	off-target	QUAL=115;DP=4;QD=28.75;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	PTEN	intron	PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron2/9:c.80-96A>G::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron2/9:c.599-96A>G::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron1/8:c.80-96A>G::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron1/7:c.80-96A>G::,PTEN:ENST00000472832.3:intron_variant:MODIFIER:intron1/7:c.80-96A>G::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3); {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	440219 [benign DISEASE=not provided];			rs1903858	0.3875	0.4718,0.4450,0.5075,0.3281,0.2988	11868,	33752	90870	-0.7510			0.54			COSV64292778	0	18805939,22562547,27187382,24959314,21633361,19625176,26082156,24132918,26220040,23930209,19421400,25881591,16574322,32547095,32537792,25419146,32583210,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	87931195	87931195	-	TTATC	het	off-target	QUAL=915;DP=55;QD=16.64;AF=0.64;MQM=60;SAP=6;ABP=12;SAR=21;SAF=14	PTEN	intron	PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron5/9:c.253+109_253+110insTCTTA::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron5/9:c.772+109_772+110insTCTTA::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron4/8:c.253+109_253+110insTCTTA::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron3/7:c.208+109_208+110insTCTTA::,PTEN:ENST00000472832.3:intron_variant:MODIFIER:intron4/7:c.253+109_253+110insTCTTA::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3); {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	1292390 [benign DISEASE=not provided];			rs1799734	0.3932	0.4831,0.4477,0.5043,0.3345,0.2990	12063,	35241	91609				10.40				0	31704287,17033968,26885116,24901890,26417029	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	87961150	87961150	T	G	het	off-target	QUAL=251;DP=29;QD=8.66;AF=0.52;MQM=60;SAP=36;ABP=3;SAR=0;SAF=15	PTEN	intron,3'UTR	PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron9/9:c.1026+32T>G::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron9/9:c.1545+32T>G::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron8/8:c.1026+32T>G::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron7/7:c.981+32T>G::,PTEN:ENST00000472832.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*23T>G::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3); {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	92810 [benign DISEASE=Cowden syndrome 1,Macrocephaly-autism syndrome,Hereditary cancer-predisposing syndrome,PTEN hamartoma tumor syndrome,not specified,not provided];	CS1815672 [CLASS=R MUT=ALT PHEN="Cowden disease" GENE=PTEN];		rs555895	0.3994	0.5015,0.4515,0.5058,0.3357,0.3005	12632,	35397	91207	-0.8500			0.60			COSV64292683	0	25741868,23757202,18805939,17033968,23068025,26541596,25361012,26220040,19421400,21869887,16574322	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	102504350	102504350	C	T	hom		QUAL=9982;DP=411;QD=24.29;AF=1.00;MQM=60;SAP=895;ABP=0;SAR=411;SAF=0	SUFU	splice_region&intron	SUFU:ENST00000369902.8:splice_region_variant&intron_variant:LOW:intron1/11:c.182+16C>T::,SUFU:ENST00000369899.6:splice_region_variant&intron_variant:LOW:intron1/10:c.182+16C>T::,SUFU:ENST00000423559.2:splice_region_variant&intron_variant:LOW:intron1/9:c.182+16C>T::	regulatory_region_variant:promoter	607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	260689 [benign DISEASE=Medulloblastoma,Gorlin syndrome,Joubert syndrome 32,not specified,not provided];			rs2274351	0.4613	0.3177,0.4119,0.3211,0.5470,0.4876	17115,	35786	81758	-0.1750			16.27			COSV64013811	0.03	25741868,26192919,22508808	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTR1A (inh=n/a oe_syn=0.79 oe_mis=0.44 oe_lof=0.13), SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102509460	102509460	G	A	hom	off-target	QUAL=160;DP=6;QD=26.67;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=6;SAF=0	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron2/11:c.317+157G>A::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron2/10:c.317+157G>A::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron2/9:c.317+157G>A::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	677130 [benign DISEASE=not provided];			rs2281880	0.4620	0.3176,0.4117,0.3233,0.5476,0.4880	17171,	35773	81657	-0.3310			1.20			COSV64014869	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102597065	102597065	A	G	hom	off-target	QUAL=2286;DP=74;QD=30.89;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=35;SAF=39	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron6/11:c.757-75A>G::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron6/10:c.757-75A>G::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron6/9:c.757-75A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	1246567 [benign DISEASE=not provided];			rs10786690	0.9927	0.9756,0.9979,0.9992,0.9998,0.9996	74890,	1086	1106	-0.0720			4.54			COSV100882930	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102618932	102618935	GTGT	-	het	off-target;low_conf_region	QUAL=367;DP=37;QD=9.92;AF=0.30;MQM=60;SAP=3;ABP=16;SAR=5;SAF=6	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron10/11:c.1296+1548_1296+1551del::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron10/10:c.1297-90_1297-87del::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]			(GT)n (Simple_repeat)	rs59259635	0.1283	0.0852,0.1092,0.0983,0.1466,0.1593	974,	13656	105990	0.2690			0.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102618932	102618937	GTGTGT	-	het	off-target;low_conf_region	QUAL=367;DP=37;QD=9.92;AF=0.30;MQM=60;SAP=8;ABP=16;SAR=3;SAF=8	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron10/11:c.1296+1546_1296+1551del::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron10/10:c.1297-92_1297-87del::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]			(GT)n (Simple_repeat)	rs59259635	0.0556	0.0794,0.0405,0.0634,0.0485,0.0298	165,	6439	114907	0.2690			0.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102627262	102627262	T	C	het		QUAL=14824;DP=1197;QD=12.38;AF=0.49;MQM=60;SAP=4;ABP=5;SAR=300;SAF=283	SUFU	splice_region&intron	SUFU:ENST00000369902.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1365+19T>C::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	260688 [benign DISEASE=Medulloblastoma,Gorlin syndrome,Joubert syndrome 32,not specified,not provided];			rs12414407	0.6828	0.7524,0.6336,0.7477,0.6557,0.7115	35723,	32407	48249	0.4520			7.22			COSV64017850	0	25741868,26627480,23538333,24067507,27617143	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102630175	102630175	T	G	hom		QUAL=59563;DP=1886;QD=31.58;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=925;SAF=960	SUFU	3'UTR	SUFU:ENST00000369902.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	1175161 [benign DISEASE=Gorlin syndrome,Joubert syndrome 32,not specified];			rs4917980	0.9983	0.9944,0.9995,1.0000,0.9999,1.0000	75835,	251	253	1.4220			16.48			COSV100883278	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr11	13081343	13081343	C	A	het	off-target	QUAL=22540;DP=1762;QD=12.79;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=444;SAF=435		intergenic	::intergenic_variant:MODIFIER::::						rs2727397	0.5859	0.6443,0.6439,0.1510,0.5913,0.4545	26759,	35422	62860	0.0480			6.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	13081377	13081377	G	A	het		QUAL=297;DP=26;QD=11.42;AF=0.54;MQM=60;SAP=19;ABP=3;SAR=12;SAF=2		intergenic	::intergenic_variant:MODIFIER::::						rs2583136	0.5858	0.6441,0.6438,0.1508,0.5913,0.4540	26761,	35429	62903	-0.7750			0.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	22624479	22624479	G	A	hom	off-target	QUAL=925;DP=37;QD=25.00;AF=1.00;MQM=60;SAP=83;ABP=0;SAR=0;SAF=37	FANCF	3'UTR	FANCF:ENST00000327470.6:3_prime_UTR_variant:MODIFIER:exon1/1:c.*207C>T::	regulatory_region_variant:promoter	613897_[GENE=FANCF_PHENOS=Fanconi anemia, complementation group F, 603467 (3), Autosomal recessive]	304197 [benign DISEASE=Fanconi anemia complementation group F,not provided];			rs4447177	0.7129	0.4167,0.7314,0.8904,0.8348,0.8206	41376,	25602	43636	-0.3340			1.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCF (inh=AR oe_syn=1.43 oe_mis=1.38 oe_lof=0.00)
chr11	64804546	64804546	T	C	hom		QUAL=8197;DP=256;QD=32.02;AF=1.00;MQM=60;SAP=23;ABP=0;SAR=152;SAF=104	MEN1	missense	MEN1:ENST00000377316.6:missense_variant:MODERATE:exon8/8:c.1456A>G:p.Thr486Ala:,MEN1:ENST00000377313.6:missense_variant:MODERATE:exon9/9:c.1636A>G:p.Thr546Ala:,MEN1:ENST00000315422.9:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000450708.7:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000377321.5:missense_variant:MODERATE:exon10/10:c.1516A>G:p.Thr506Ala:,MEN1:ENST00000377326.7:missense_variant:MODERATE:exon9/9:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000312049.11:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000672304.1:missense_variant:MODERATE:exon11/11:c.1747A>G:p.Thr583Ala:,MEN1:ENST00000440873.6:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:	regulatory_region_variant:CTCF_binding_site	613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	134640 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified,not provided];			rs2959656	0.8975	0.7134,0.9033,0.7008,0.9960,0.9857	62559,	11399	15587	0.1390	T(0.76),T(0.76),T(0.77),T(0.77),T(0.75),T(0.77),T(0.77),T(0.77),T(0.77)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.02),B(0.00)	5.02	0.30		COSV53639974	0	25741868,24033266,24728327,23757202,22703879,26307114,564891,9215689,18775714,27185868,28969599,28899949,33240400,30214228,32708070	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64804931	64804931	C	G	het	off-target	QUAL=458;DP=42;QD=10.90;AF=0.48;MQM=60;SAP=3;ABP=3;SAR=10;SAF=10	MEN1	intron	MEN1:ENST00000377316.6:intron_variant:MODIFIER:intron7/7:c.1186-115G>C::,MEN1:ENST00000377313.6:intron_variant:MODIFIER:intron8/8:c.1365+103G>C::,MEN1:ENST00000315422.9:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000450708.7:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000377321.5:intron_variant:MODIFIER:intron9/9:c.1245+103G>C::,MEN1:ENST00000377326.7:intron_variant:MODIFIER:intron8/8:c.1350+103G>C::,MEN1:ENST00000312049.11:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000672304.1:intron_variant:MODIFIER:intron10/10:c.1476+103G>C::,MEN1:ENST00000440873.6:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::		613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	1245707 [benign DISEASE=not provided];			rs654440	0.3202	0.0869,0.2810,0.0096,0.4724,0.2540	10216,	28261	103385	1.6130			8.90				0	27366707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64805085	64805085	A	G	hom		QUAL=6551;DP=203;QD=32.27;AF=1.00;MQM=60;SAP=38;ABP=0;SAR=73;SAF=130	MEN1	intron,synonymous	MEN1:ENST00000377316.6:intron_variant:MODIFIER:intron7/7:c.1186-269T>C::,MEN1:ENST00000377313.6:synonymous_variant:LOW:exon8/9:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000315422.9:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000450708.7:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000377321.5:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:PF05053 [Menin],MEN1:ENST00000377326.7:synonymous_variant:LOW:exon8/9:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000312049.11:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000672304.1:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:PF05053 [Menin],MEN1:ENST00000440873.6:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin]	regulatory_region_variant:CTCF_binding_site	613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	167288 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified];			rs540012	0.9780	0.9230,0.9927,1.0000,0.9998,0.9998	72884,	3096	3350	-0.3010			1.30				0.07	26307114,28969599,28899949,32708070	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64810148	64810148	G	C	het	off-target	QUAL=195;DP=33;QD=5.91;AF=0.45;MQM=60;SAP=36;ABP=4;SAR=0;SAF=15	MEN1	5'UTR,splice_region&intron	MEN1:ENST00000377316.6:5_prime_UTR_variant:MODIFIER:exon1/8:c.-39C>G::,MEN1:ENST00000315422.9:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000450708.7:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000377321.5:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000377326.7:5_prime_UTR_variant:MODIFIER:exon1/9:c.-39C>G::,MEN1:ENST00000312049.11:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000672304.1:splice_region_variant&intron_variant:LOW:intron1/10:c.-23-16C>G::,MEN1:ENST00000440873.6:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::	regulatory_region_variant:promoter	613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	439889 [benign DISEASE=not provided];			rs509606	0.1273	0.1004,0.2420,0.2797,0.1016,0.1943	1531,	16233	132299	0.0940			5.60		11.39>10.32		0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	94479765	94479765	A	-	het	mosaic	QUAL=338;DP=507;QD=0.67;AF=0.12;MQM=60;SAP=3;ABP=937;SAR=10;SAF=10	MRE11	splice_region&intron	MRE11:ENST00000323929.8:splice_region_variant&intron_variant:LOW:intron4/19:c.315-4del::,MRE11:ENST00000407439.7:splice_region_variant&intron_variant:LOW:intron4/19:c.324-4del::,MRE11:ENST00000323977.7:splice_region_variant&intron_variant:LOW:intron4/18:c.315-4del::,MRE11:ENST00000393241.8:splice_region_variant&intron_variant:LOW:intron4/19:c.315-4del::,MRE11:ENST00000540013.5:splice_region_variant&intron_variant:LOW:intron4/7:c.315-4del::		600814_[GENE=MRE11_PHENOS=Ataxia-telangiectasia-like disorder 1, 604391 (3), Autosomal recessive]	140809 [benign/likely benign DISEASE=Ataxia-telangiectasia-like disorder,Hereditary cancer-predisposing syndrome,Ataxia-telangiectasia-like disorder 1,not provided];			rs35062043	0.0001	0.0000,0.0001,0.0000,0.0001,0.0000	0,	8	147024	0.6600			2.67				0.11	19383352	0	48	0 / 12	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			MRE11 (inh=AR oe_syn=1.11 oe_mis=0.98 oe_lof=0.60)
chr11	108229378	108229378	-	T	het	off-target;low_conf_region	QUAL=408;DP=47;QD=8.68;AF=0.45;MQM=60;SAP=6;ABP=4;SAR=8;SAF=13	ATM	intron,3'UTR	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:ENST00000530958.5:intron_variant:MODIFIER:intron3/3:c.331+69dup::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron5/63:c.331+69dup::,ATM:ENST00000682465.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*61dup::,ATM:ENST00000684029.1:intron_variant:MODIFIER:intron4/4:c.331+69dup::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1225892 [benign DISEASE=not specified,not provided];			rs11390378	0.5008	0.3748,0.5937,0.4444,0.5301,0.6352	18361,	35604	72094				0.98				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108229378	108229378	-	TT	het	off-target;low_conf_region	QUAL=408;DP=47;QD=8.68;AF=0.19;MQM=60;SAP=9;ABP=42;SAR=2;SAF=7	ATM	intron,3'UTR	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron4/62:c.331+68_331+69dup::,ATM:ENST00000530958.5:intron_variant:MODIFIER:intron3/3:c.331+68_331+69dup::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron5/63:c.331+68_331+69dup::,ATM:ENST00000682465.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*60_*61dup::,ATM:ENST00000684029.1:intron_variant:MODIFIER:intron4/4:c.331+68_331+69dup::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1175536 [benign DISEASE=not provided];			rs11390378	0.0298	0.0090,0.0249,0.0026,0.0445,0.0172	90,	4124	140184				0.96				0.04		2	24	0 / 4					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108243935	108243935	T	-	het	off-target;low_conf_region	QUAL=63;DP=137;QD=0.46;AF=0.15;MQM=60;SAP=19;ABP=152;SAR=4;SAF=16	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron5/62:c.497-4del::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron6/63:c.497-4del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	183775 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs768748099	0.0021	0.0021,0.0015,0.0004,0.0017,0.0000	0,	300	143820	-0.2470			0.25				0.06		1	92	1 / 14					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108244634	108244634	T	-	hom	off-target	QUAL=6784;DP=314;QD=21.61;AF=0.91;MQM=60;SAP=622;ABP=0;SAR=0;SAF=285	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron6/62:c.663-144del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron7/63:c.663-144del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1257474 [benign DISEASE=not provided];			rs11298747	0.9792	0.9933,0.9635,0.9954,0.9718,0.9820	72252,	3048	3140	-0.8530			0.08				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108248889	108248889	A	-	het	off-target;low_conf_region	QUAL=11;DP=32;QD=0.34;AF=0.16;MQM=60;SAP=3;ABP=36;SAR=3;SAF=2	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron8/62:c.1066-31del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron9/63:c.1066-31del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1235015 [benign DISEASE=not specified,not provided];		AluSp (SINE/Alu)	rs35813860	0.0039	0.0039,0.0038,0.0014,0.0033,0.0006	2,	388	100016	1.8490			1.86				0.03		1	110	1 / 25					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108258930	108258930	A	G	het	off-target	QUAL=38;DP=16;QD=2.38;AF=0.25;MQM=60;SAP=3;ABP=12;SAR=2;SAF=2	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177614 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not specified,not provided];			rs672655	0.4945	0.2760,0.6070,0.4203,0.5673,0.6024	20105,	34927	76803	2.1810			17.13			COSV53757995	0	25010664,18433505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108271229	108271230	TT	-	het	off-target;low_conf_region	QUAL=340;DP=164;QD=2.07;AF=0.17;MQM=60;SAP=3;ABP=157;SAR=14;SAF=14	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron19/62:c.2922-9_2922-8del::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron20/63:c.2922-9_2922-8del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]				rs373881770	0.0003	0.0001,0.0001,0.0000,0.0002,0.0000	0,	41	142199	0.1370			1.58				0.02		0	49	0 / 4					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108279481	108279481	T	-	het		QUAL=889;DP=98;QD=9.07;AF=0.39;MQM=60;SAP=3;ABP=14;SAR=19;SAF=19	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron22/62:c.3285-9del::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron23/63:c.3285-9del::	regulatory_region_variant:enhancer	607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	181857 [benign/likely benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];		(TTTG)n (Simple_repeat)	rs1799757	0.1064	0.0239,0.0918,0.0079,0.1445,0.0753	1202,	13768	135858	0.5080			3.27				0	25741868,24033266,30781715,18433505,19347964,33240400	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108280980	108280980	-	A	het	off-target;low_conf_region	QUAL=1037;DP=76;QD=13.64;AF=0.53;MQM=60;SAP=29;ABP=3;SAR=31;SAF=9	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron23/62:c.3403-13dup::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron24/63:c.3403-13dup::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	181858 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,Breast and/or ovarian cancer,not provided];			rs3218681	0.5515	0.4607,0.6274,0.3956,0.5746,0.6427	23475,	36676	68010				6.87				0.05	25741868,24033266,29879995,19222838,18433505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108284670	108284670	G	A	het	off-target	QUAL=113;DP=15;QD=7.53;AF=0.40;MQM=60;SAP=16;ABP=4;SAR=6;SAF=0	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron26/62:c.3993+197G>A::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron27/63:c.3993+197G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1226443 [benign DISEASE=not provided];			rs654005	0.5370	0.4226,0.6200,0.3862,0.5683,0.6487	22445,	36645	70293	-0.8670			0.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108299544	108299544	G	A	het	off-target	QUAL=199;DP=18;QD=11.06;AF=0.67;MQM=60;SAP=29;ABP=7;SAR=0;SAF=12	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron33/62:c.5006-170G>A::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron34/63:c.5006-170G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1261675 [benign DISEASE=not provided];		AluSx (SINE/Alu)	rs1150203	0.5021	0.3088,0.6070,0.3712,0.5677,0.6025	20389,	35442	75580	-1.5540			0.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108304667	108304667	T	C	het		QUAL=161;DP=14;QD=11.50;AF=0.57;MQM=60;SAP=13;ABP=4;SAR=1;SAF=7	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	132706 [benign/likely benign DISEASE=Hereditary breast ovarian cancer syndrome,Triple-negative breast carcinoma,Malignant tumor of breast,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs3092829	0.0215	0.0053,0.0232,0.0012,0.0329,0.0062	36,	3200	148922	1.2810			7.67		10.05>8.69	COSV53727999	0	25741868,30781715,22529920,18433505,18701470	41	1748	10 / 393	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108304735	108304735	G	A	het		QUAL=388;DP=30;QD=12.93;AF=0.53;MQM=60;SAP=3;ABP=3;SAR=8;SAF=8	ATM	missense	ATM:ENST00000675843.1:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000452508.6:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	128458 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM];		rs1801516	0.1064	0.0240,0.0907,0.0079,0.1447,0.0749	1205,	13764	135846	5.9270	T(0.08),T(0.08)	B(0.34),B(0.34)	22.90	0.12		COSV53728020	0.12	25741868,24033266,24728327,21504893,28499365,30089490,30781715,29178884,26648445,19536092,24756757,18559551,24531918,23238918,26870349,16465622,31584889,22792358,27608007,25077817,28844157,29458332,28206966,28324443,31095341,24218030,24642353,19276285,29963112,18579371,24062231,25591549,32039725,23697595,18768505,21877955,27258253,19094228,31914346,22927776,24980573,29433565,24599715,23313170,19286843,17132159,22276117,30194396,22537351,17582598,23154078,29691986,21983787,18433505,17623063,18701470,19348699,21332318,15756685,16496408,18264724,20799949,21327466,24105688,25849217,26627042,27057881,30384829,31756226,25837821,26857527,29753029,29788924,9711876,10425038,25530832,22438227,19347964,29888979,24392023,27993549,28212542,27443449,30231410,27527855,25380778,22842228,23642098,29657992,25879635,29507678,29890168,27764772,25355167,22952040,26384276,20531418,25861265,23537197,24177593,24324286,24790730,17331670,18374504,17889263,20170971,19162519,19022265,32341527,17351744,10397742,24416720,12473594,31658756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108312687	108312688	CT	-	het	off-target	QUAL=150;DP=23;QD=6.52;AF=0.43;MQM=60;SAP=25;ABP=4;SAR=10;SAF=0	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron40/62:c.6006+191_6006+192del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron41/63:c.6006+191_6006+192del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-3617_641-3616del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1253719 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs10588462	0.5231	0.3687,0.6164,0.4344,0.5678,0.6485	21620,	36105	72349	0.0960			1.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108325250	108325250	T	-	het	off-target;low_conf_region	QUAL=108;DP=9;QD=12.00;AF=0.67;MQM=60;SAP=4;ABP=5;SAR=2;SAF=4	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron45/62:c.6573-42del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron46/63:c.6573-42del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-16179del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1252304 [benign DISEASE=not specified,not provided];		(T)n (Simple_repeat)	rs11366542	0.6492	0.4656,0.7686,0.7867,0.6971,0.8106	20268,	30666	38478	1.3490			2.34				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108325986	108325988	ATT	-	het	off-target;low_conf_region	QUAL=211;DP=23;QD=9.17;AF=0.52;MQM=60;SAP=15;ABP=3;SAR=2;SAF=10	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron46/62:c.6808-60_6808-58del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron47/63:c.6808-60_6808-58del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-16917_641-16915del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	633055 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not specified,not provided];			rs3212322	0.5009	0.3004,0.6085,0.4137,0.5671,0.6016	20272,	35339	75603	3.0460			6.09				0	18433505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108347469	108347469	T	C	het	off-target	QUAL=103;DP=8;QD=12.88;AF=0.75;MQM=60;SAP=16;ABP=7;SAR=6;SAF=0	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron59/62:c.8671+104T>C::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron60/63:c.8671+104T>C::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-38398A>G::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+7446A>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177615 [benign DISEASE=Ataxia-telangiectasia syndrome,not provided];			rs227075	0.6207	0.6852,0.6621,0.4476,0.5775,0.6521	29548,	35157	57593	0.0580			3.45				0	32408300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108353970	108353970	G	A	hom	off-target	QUAL=82;DP=3;QD=27.33;AF=1.00;MQM=60;SAP=10;ABP=0;SAR=3;SAF=0	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8786+90G>A::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron61/63:c.8786+90G>A::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31950C>T::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+945C>T::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1192463 [benign DISEASE=Ataxia-telangiectasia syndrome,not provided];		FLAM_A (SINE/Alu)	rs179108	0.9998	0.9996,0.9999,1.0000,1.0000,1.0000	75890,	33	33	-0.4880			1.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354070	108354070	A	C	het	off-target	QUAL=35;DP=6;QD=5.83;AF=0.50;MQM=60;SAP=10;ABP=3;SAR=3;SAF=0	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8786+190A>C::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron61/63:c.8786+190A>C::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31850T>G::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+845T>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]			(AC)n (Simple_repeat)	rs678526	0.1122	0.0605,0.1393,0.0792,0.1364,0.1682	840,	11257	102365	-2.4860			1.07			COSV53731754	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354756	108354756	C	T	het	off-target	QUAL=1990;DP=159;QD=12.52;AF=0.48;MQM=60;SAP=6;ABP=4;SAR=43;SAF=33	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+159G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177616 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not specified,not provided];			rs664982	0.5375	0.4161,0.6238,0.4355,0.5687,0.6487	22528,	36600	70268	-1.7010			0.07			COSV53733871	0	31548641,12466288,19193393,25010664,19584272,20004998,16622469,28756982,28825373,34522244,21058196	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354934	108354934	A	G	het	off-target	QUAL=4410;DP=275;QD=16.04;AF=0.58;MQM=60;SAP=3;ABP=19;SAR=80;SAF=80	ATM,C11orf65	intron,3'UTR	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::,C11orf65:ENST00000615746.4:3_prime_UTR_variant:MODIFIER:exon11/13:c.*1177T>C::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1169174 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not specified,not provided];			rs664143	0.6180	0.6765,0.6617,0.4455,0.5774,0.6516	29289,	35333	58047	-0.6960			0.44			COSV53746535	0.05	22665904,19536092,19115993,24218030,12466288,29879995,23318652,19193393,19584272,17151932,17132159,25196645,29246212,17431766,28756982,22203481,26094126,30514381,22767148,27905519,28642860,24177593,20171797,17222938,32329754,34540891,32408300,33918597,21058196,33507988,34650388	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	117226142	117226142	T	-	het	off-target	QUAL=337;DP=51;QD=6.61;AF=0.35;MQM=60;SAP=3;ABP=13;SAR=9;SAF=9	PCSK7	intron	PCSK7:ENST00000320934.8:intron_variant:MODIFIER:intron5/16:c.770-121del::,PCSK7:ENST00000524507.6:intron_variant:MODIFIER:intron5/16:c.770-121del::,PCSK7:ENST00000676339.1:intron_variant:MODIFIER:intron4/15:c.770-121del::					AluSz (SINE/Alu)	rs11419279	0.0044	0.0080,0.0027,0.0012,0.0027,0.0004	2,	620	141586	0.0730			1.16				0.02		0	47	0 / 1					PCSK7 (inh=n/a oe_syn=0.96 oe_mis=0.81 oe_lof=0.31)
chr11	125627571	125627571	G	T	het	off-target;low_conf_region	QUAL=1071;DP=108;QD=9.92;AF=0.49;MQM=60;SAP=118;ABP=3;SAR=0;SAF=53	CHEK1	intron	CHEK1:ENST00000438015.7:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000427383.6:intron_variant:MODIFIER:intron2/11:c.337+738G>T::,CHEK1:ENST00000428830.6:intron_variant:MODIFIER:intron2/13:c.66-36G>T::,CHEK1:ENST00000278916.8:intron_variant:MODIFIER:intron2/11:c.66-36G>T::,CHEK1:ENST00000544373.5:intron_variant:MODIFIER:intron2/11:c.7+738G>T::,CHEK1:ENST00000532449.6:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000534070.5:intron_variant:MODIFIER:intron2/12:c.66-36G>T::	regulatory_region_variant:promoter	601134_[GENE=STT3A_PHENOS=Congenital disorder of glycosylation, type Iw, autosomal dominant, 619714 (3), Autosomal dominant; Congenital disorder of glycosylation, type Iw, autosomal recessive, 615596 (3), Autosomal recessive]				rs491528	0.3151	0.3716,0.2417,0.4219,0.2945,0.3491	7802,	32258	104040	-0.6450			2.27			COSV54022242	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STT3A (inh=AR oe_syn=0.85 oe_mis=0.50 oe_lof=0.31), CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125635482	125635482	-	A	het	mosaic	QUAL=0;DP=900;QD=0.00;AF=0.02;MQM=60;SAP=4;ABP=0;SAR=9;SAF=12	CHEK1	frameshift	CHEK1:ENST00000438015.7:frameshift_variant:HIGH:exon7/13:c.676dup:p.Thr226AsnfsTer19:PF00069 [Protein kinase domain],CHEK1:ENST00000427383.6:frameshift_variant:HIGH:exon6/12:c.724dup:p.Thr242AsnfsTer19:PF00069 [Protein kinase domain],CHEK1:ENST00000428830.6:frameshift_variant:HIGH:exon7/14:c.676dup:p.Thr226AsnfsTer19:PF00069 [Protein kinase domain],CHEK1:ENST00000278916.8:frameshift_variant:HIGH:exon7/12:c.676dup:p.Thr226AsnfsTer19:PF00069 [Protein kinase domain],CHEK1:ENST00000544373.5:frameshift_variant:HIGH:exon6/12:c.394dup:p.Thr132AsnfsTer19:PF00069 [Protein kinase domain],CHEK1:ENST00000532449.6:frameshift_variant:HIGH:exon7/13:c.676dup:p.Thr226AsnfsTer19:PF00069 [Protein kinase domain],CHEK1:ENST00000534070.5:frameshift_variant:HIGH:exon7/13:c.676dup:p.Thr226AsnfsTer19:PF00069 [Protein kinase domain]						rs757716680	0.0000	0.0000,0.0000,0.0000,0.0000,0.0000	0,	3	149665				32.00				0		0	4	0 / 3					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125644678	125644678	G	A	het	off-target	QUAL=843;DP=107;QD=7.88;AF=0.42;MQM=60;SAP=56;ABP=9;SAR=39;SAF=6	CHEK1	intron	CHEK1:ENST00000438015.7:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000427383.6:intron_variant:MODIFIER:intron10/11:c.1281+35G>A::,CHEK1:ENST00000428830.6:intron_variant:MODIFIER:intron11/13:c.1233+35G>A::,CHEK1:ENST00000278916.8:intron_variant:MODIFIER:intron11/11:c.1233+35G>A::,CHEK1:ENST00000544373.5:intron_variant:MODIFIER:intron10/11:c.951+35G>A::,CHEK1:ENST00000532449.6:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000534070.5:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::						rs521102	0.4544	0.2824,0.5670,0.4011,0.5222,0.5476	16574,	35842	82838	0.6180			8.77				0	22665904,29928473,27905519	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125655300	125655300	A	G	hom		QUAL=1971;DP=59;QD=33.41;AF=1.00;MQM=60;SAP=11;ABP=0;SAR=22;SAF=37	CHEK1	missense	CHEK1:ENST00000438015.7:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000427383.6:missense_variant:MODERATE:exon12/12:c.1459A>G:p.Ile487Val:,CHEK1:ENST00000428830.6:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000278916.8:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:,CHEK1:ENST00000544373.5:missense_variant:MODERATE:exon12/12:c.1129A>G:p.Ile377Val:,CHEK1:ENST00000532449.6:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000534070.5:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:			496139 [benign DISEASE=not provided];			rs506504	0.9747	0.9931,0.9740,0.9998,0.9640,0.9779	72309,	3726	3850	1.2110	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	14.31	0.05			0	18805967,29458332	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr12	57748709	57748709	T	-	het	off-target;low_conf_region	QUAL=43;DP=83;QD=0.52;AF=0.14;MQM=60;SAP=6;ABP=94;SAR=8;SAF=4	TSPAN31,CDK4	3'UTR,intron	TSPAN31:ENST00000547992.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1433del::,TSPAN31:ENST00000257910.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1433del::,CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron7/7:c.820-92del::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron6/6:c.*132-92del::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron3/3:c.31-92del::		123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs545773931	0.0023	0.0022,0.0027,0.0002,0.0017,0.0011	0,	323	141203	-2.6220			0.13				0		0	19	0 / 4					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	57749071	57749071	C	A	het	off-target	QUAL=1485;DP=107;QD=13.88;AF=0.53;MQM=60;SAP=3;ABP=4;SAR=28;SAF=29	TSPAN31,CDK4	3'UTR,intron	TSPAN31:ENST00000547992.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1781C>A::,TSPAN31:ENST00000257910.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1781C>A::,CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron7/7:c.819+111G>T::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron6/6:c.*131+111G>T::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron3/3:c.30+111G>T::		123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1182049 [benign DISEASE=not provided];			rs2069506	0.2650	0.0820,0.2559,0.6555,0.3145,0.4907	6734,	26823	111775	0.2050			5.63				0	18174243,19258477,18281541	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	57750882	57750882	C	T	het	off-target	QUAL=1964;DP=162;QD=12.12;AF=0.49;MQM=60;SAP=9;ABP=3;SAR=32;SAF=47	CDK4	intron	CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron4/7:c.522+41G>A::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron3/6:c.265-211G>A::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron1/3:c.-158+1293G>A::	regulatory_region_variant:promoter	123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1292556 [benign DISEASE=not provided];			rs2069502	0.2659	0.0823,0.2554,0.6520,0.3157,0.4936	6780,	26863	111621	0.5710			9.49			COSV56983640	0	19258477,23761422,24743186,28806841,23160276,23406874,23150009,23567489,34641739	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr12	57751373	57751373	C	T	het	off-target	QUAL=5480;DP=416;QD=13.17;AF=0.58;MQM=60;SAP=223;ABP=24;SAR=198;SAF=42	CDK4	intron	CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron2/7:c.219-31G>A::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron2/6:c.219-31G>A::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron1/3:c.-158+802G>A::	regulatory_region_variant:promoter	123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1249096 [benign DISEASE=not provided];			rs2270777	0.3334	0.1683,0.3344,0.1569,0.4388,0.2382	9617,	31408	101260	-1.0380			6.46			COSV56985436	0.07	18174243,19258477,18507837,23567489	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr13	32316435	32316435	G	A	het	off-target	QUAL=1359;DP=118;QD=11.52;AF=0.45;MQM=60;SAP=6;ABP=6;SAR=22;SAF=31	BRCA2	5'UTR	BRCA2:ENST00000544455.6:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000380152.8:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::	regulatory_region_variant:promoter	600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	125965 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2];		rs1799943	0.2135	0.1058,0.1895,0.3874,0.2663,0.2814	3894,	24674	119570	0.5460			9.46			COSV61525225	0.04	25741868,19276285,21161372,23663450,12466288,19644020,22513257,26979245,16760289,24337145,21702907,21356067,18724707,21939546,23767878,18694767,28944232,17945002,19012493,23755158,29460995,32284662,28076423,33643918,34287479,22809218,33499154,34295994,24938600	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZAR1L (inh=AD oe_syn=0.79 oe_mis=0.65 oe_lof=0.30), BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32326796	32326796	T	A	het	off-target	QUAL=52;DP=4;QD=13.00;AF=0.75;MQM=60;SAP=10;ABP=5;SAR=3;SAF=0	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron7/26:c.631+183T>A::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron7/26:c.631+183T>A::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	209652 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,not specified,not provided];			rs3752451	0.3340	0.2840,0.3249,0.4998,0.3496,0.4107	8620,	33398	100968	0.0330			2.64				0	25741868,19276285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32329548	32329548	C	T	het	off-target	QUAL=606;DP=44;QD=13.77;AF=0.55;MQM=60;SAP=6;ABP=4;SAR=15;SAF=9	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron8/26:c.681+56C>T::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron8/26:c.681+56C>T::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126192 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,not specified];			rs2126042	0.2051	0.2493,0.2042,0.0824,0.1884,0.1262	3378,	24367	120637	-0.2650			7.64			COSV66457755	0	25741868,19276285,21161372,17428325,19644020,10923033,21356067,18694767,28944232,30323354,28076423,33643918	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32331082	32331082	-	T	het	off-target	QUAL=119;DP=106;QD=1.12;AF=0.17;MQM=60;SAP=3;ABP=103;SAR=9;SAF=9	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron9/26:c.793+64dup::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron9/26:c.793+64dup::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]			AluSx (SINE/Alu)	rs751977993	0.0035	0.0102,0.0011,0.0004,0.0009,0.0011	3,	504	145386				0.19				0		0	3	0 / 0					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32331128	32331128	G	A	hom	off-target	QUAL=4213;DP=131;QD=32.16;AF=1.00;MQM=60;SAP=13;ABP=0;SAR=78;SAF=53	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron9/26:c.793+98G>A::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron9/26:c.793+98G>A::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	209936 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,not provided];		AluSx (SINE/Alu)	rs206073	0.9787	0.9260,0.9925,0.9998,0.9997,0.9996	72563,	2993	3225	-0.1220			0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32333284	32333284	A	-	het	mosaic	QUAL=0;DP=185;QD=0.00;AF=0.03;MQM=60;SAP=3;ABP=0;SAR=3;SAF=2	BRCA2	frameshift	BRCA2:ENST00000544455.6:frameshift_variant:HIGH:exon10/27:c.1813del:p.Ile605TyrfsTer9:,BRCA2:ENST00000380152.8:frameshift_variant:HIGH:exon10/27:c.1813del:p.Ile605TyrfsTer9:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	37763 [pathogenic DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not provided];	CD011988 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=BRCA2];		rs80359306	0.0000	0.0000,0.0000,0.0002,0.0000,0.0000	0,	1	151587	0.5120							0	25741868,26467025,8665505,20104584,21232165,18824701,11389159,10699917,21952622,19016756,9585613,21324516,23199084,26295337,15689453,23683081,22729890,11802209,18489799,15131399,23035815,15070707,18042939,21318380,15024741,24549055,25085752,9667259,9150150,22535016,26026974,17851763,12203997,23704984,32438681,31454914,25072261,12442265,26834852,28724667,29348823,21548014,29433453,28324225,27062684,32365798,32856869,32606146	0	1	0 / 1	5	"[5] Ilnaz Sepahi 12-12-2016 batch import"			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32336191	32336191	T	C	het	off-target	QUAL=804;DP=79;QD=10.18;AF=0.44;MQM=60;SAP=13;ABP=5;SAR=11;SAF=24	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron10/26:c.1910-74T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron10/26:c.1910-74T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	209687 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,not specified,not provided];			rs2320236	0.1943	0.2127,0.1985,0.0825,0.1883,0.1255	3023,	23498	122514	1.7040			14.19				0	21161372	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32337751	32337751	A	G	het		QUAL=835;DP=75;QD=11.13;AF=0.49;MQM=60;SAP=8;ABP=3;SAR=23;SAF=14	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126010 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM2110542 [CLASS=DM? MUT=ALT PHEN="Breast cancer" GENE=BRCA2];		rs1801406	0.2844	0.2305,0.2243,0.3987,0.3165,0.2954	6331,	30542	108704	0.2330			6.39			COSV66448451	0	25741868,16857995,18830263,19692168,19902366,28415781,19276285,21161372,19644020,27478808,20807450,12474142,18431501,21346221,21987080,23767878,28944232,26840129,29884136,27273131,25304112,32284662,28076423,33643918,33814932,34295994,33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32338918	32338918	A	G	hom		QUAL=32017;DP=989;QD=32.37;AF=1.00;MQM=60;SAP=9;ABP=0;SAR=520;SAF=468	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	132779 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs206075	0.9787	0.9260,0.9925,0.9998,0.9997,0.9996	72964,	3007	3245	0.0760			4.48			COSV101203861	0	25741868,24033266,18414213,27478808,1517275,1684755,9971877,12552570,15744044,16847550,19941162,20104584,22034289,28944232,29997359,28076423,33643918,32327675,32708070,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32340868	32340868	G	C	hom		QUAL=857;DP=26;QD=32.96;AF=1.00;MQM=60;SAP=15;ABP=0;SAR=7;SAF=19	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	132780 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs206076	0.9786	0.9255,0.9925,0.9998,0.9997,0.9996	72963,	3025	3265	-0.8640			0.07			COSV66458663	0	25741868,18414213,27478808,9971877,15744044,16847550,20127978,21156238,28439188,29997359,32284662,30254663,28076423,33643918,32327675,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32346707	32346707	T	C	hom	off-target	QUAL=122;DP=4;QD=30.50;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron12/26:c.6938-120T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron12/26:c.6938-120T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	209939 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,not specified,not provided];			rs206080	0.9786	0.9258,0.9924,0.9998,0.9997,0.9983	72868,	3016	3256	-2.1790			0.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32355095	32355095	A	G	het		QUAL=437;DP=38;QD=11.50;AF=0.50;MQM=60;SAP=4;ABP=3;SAR=8;SAF=11	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126133 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs1799955	0.2215	0.2160,0.1828,0.3963,0.2191,0.2210	3840,	25989	118353	0.0960			6.91			COSV66447569	0	25741868,16857995,18830263,21161372,17428325,19644020,22430443,27478808,22034289,20807450,18431501,19471317,12955716,17018160,17686308,21042765,22713736,21356067,21987080,23767878,28944232,29884136,28334899,25304112,28076423,33643918,33004033,34295994	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32355250	32355250	T	C	hom		QUAL=19385;DP=598;QD=32.42;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=311;SAF=287	BRCA2	missense	BRCA2:ENST00000544455.6:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000380152.8:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	133738 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 2,Ductal breast carcinoma,not specified,not provided];			rs169547	0.9806	0.9328,0.9930,0.9998,0.9998,0.9996	73240,	2761	2951	2.4910	T(1.00),T(1.00)	B(0.00),B(0.00)	8.75	0.09		COSV66451785	0	25741868,24033266,24728327,29458332,23961350,27478808,8665505,27698805,27900359,31203256,25802882,26092435,28944232,26358132,29997359,25923920,28076423,33643918,34203389,33240400,32327675,32708070,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32362509	32362509	T	C	hom	off-target	QUAL=2098;DP=63;QD=33.30;AF=1.00;MQM=60;SAP=9;ABP=0;SAR=38;SAF=25	BRCA2	splice_region&intron	BRCA2:ENST00000544455.6:splice_region_variant&intron_variant:LOW:intron16/26:c.7806-14T>C::,BRCA2:ENST00000380152.8:splice_region_variant&intron_variant:LOW:intron16/26:c.7806-14T>C::	regulatory_region_variant:enhancer	600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126158 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,Breast and/or ovarian cancer,not provided];	CS147979 [CLASS=FP MUT=ALT PHEN="Alternative splicing" GENE=BRCA2];		rs9534262	0.5370	0.5667,0.5357,0.5718,0.5210,0.4805	22016,	37515	70303	-1.4060			6.79		8.33>7.94	COSV66447577	0.02	25741868,24033266,21161372,19644020,22382497,21702907,24123850,18694767,29884136,26852130,28076423,33643918	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32376521	32376521	-	A	het	off-target	QUAL=139;DP=36;QD=3.86;AF=0.25;MQM=60;SAP=23;ABP=23;SAR=0;SAF=9	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron20/26:c.8633-135dup::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron20/26:c.8633-135dup::	regulatory_region_variant:enhancer	600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	1273323 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs200156944	0.2513	0.2359,0.2206,0.4211,0.2511,0.2569	3358,	24329	92495				1.28				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32379251	32379251	T	C	hom	off-target	QUAL=7189;DP=254;QD=28.30;AF=1.00;MQM=60;SAP=312;ABP=0;SAR=32;SAF=222	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron21/26:c.8755-66T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron21/26:c.8755-66T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126190 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 2,not specified];			rs4942486	0.5174	0.5003,0.5293,0.5711,0.5195,0.4790	20418,	37752	73316	-1.1820			1.32			COSV66457232	0	25741868,24097068,21161372,22382497,26637267,18694767,28250428,30926973,29507422,28334899,32284662,28076423,33643918,32040442,34290314,33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	79192053	79192053	A	G	het		QUAL=10963;DP=825;QD=13.29;AF=0.52;MQM=60;SAP=4;ABP=5;SAR=206;SAF=221		intergenic	::intergenic_variant:MODIFIER::::						rs2988039	0.4059	0.7002,0.3863,0.6750,0.2526,0.3584	15626,	30380	90218	-0.9400			5.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr14	45137184	45137184	A	G	het		QUAL=593;DP=53;QD=11.19;AF=0.47;MQM=60;SAP=5;ABP=3;SAR=15;SAF=10	FANCM	missense,3'UTR	FANCM:ENST00000267430.10:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000556250.6:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000556036.6:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000542564.6:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696676.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*38A>G::,FANCM:ENST00000554030.2:missense_variant:MODERATE:exon2/2:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696662.1:missense_variant:MODERATE:exon2/10:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696649.1:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000696643.1:missense_variant:MODERATE:exon2/9:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000696682.1:missense_variant:MODERATE:exon2/10:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit]	regulatory_region_variant:promoter	609644_[GENE=FANCM_PHENOS=?Premature ovarian failure 15, 618096 (3), Autosomal recessive; Spermatogenic failure 28, 618086 (3), Autosomal recessive]	241326 [benign/likely benign DISEASE=Fanconi anemia,not specified,not provided];			rs45547534	0.0105	0.0030,0.0134,0.0000,0.0165,0.0085	11,	1579	150581	0.0190	D(0.00),D(0.00),D(0.00),D(0.00), ,D(0.00),D(0.00),D(0.00),D(0.00),D(0.00)	D(0.94),P(0.88),P(0.78),D(0.97), ,B(0.30),D(0.94),D(0.98),P(0.76),P(0.85)	24.10	0.12		COSV53531926	0.13	29351780	9	615	2 / 105	2	"[2] Ilnaz Sepahi 12-10-2016 batch import"			FKBP3 (inh=n/a oe_syn=1.05 oe_mis=1.00 oe_lof=0.54), FANCM (inh=AR oe_syn=1.00 oe_mis=1.01 oe_lof=0.46)
chr14	45183908	45183908	-	T	het	mosaic	QUAL=0;DP=621;QD=0.00;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=4;SAF=3	FANCM	splice_region&intron	FANCM:ENST00000267430.10:splice_region_variant&intron_variant:LOW:intron17/22:c.4515+14dup::,FANCM:ENST00000556250.6:splice_region_variant&intron_variant:LOW:intron16/21:c.4308+14dup::,FANCM:ENST00000542564.6:splice_region_variant&intron_variant:LOW:intron16/21:c.4437+14dup::,FANCM:ENST00000696649.1:splice_region_variant&intron_variant:LOW:intron16/21:c.4359+14dup::		609644_[GENE=FANCM_PHENOS=?Premature ovarian failure 15, 618096 (3), Autosomal recessive; Spermatogenic failure 28, 618086 (3), Autosomal recessive]				rs747887646													0		0	0	0 / 0					FANCM (inh=AR oe_syn=1.00 oe_mis=1.01 oe_lof=0.46)
chr14	67823655	67823655	T	G	het	off-target	QUAL=6800;DP=523;QD=13.00;AF=0.50;MQM=60;SAP=4;ABP=3;SAR=126;SAF=135	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+28T>G::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+28T>G::			1264893 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs17783124	0.3236	0.3429,0.2531,0.0744,0.3540,0.2386	8298,	32572	102782	0.1820			5.16				0.01	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823709	67823709	T	C	het	off-target	QUAL=126;DP=26;QD=4.85;AF=0.35;MQM=60;SAP=23;ABP=8;SAR=0;SAF=9	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+82T>C::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+82T>C::			1270487 [benign DISEASE=not provided];			rs28604984	0.3237	0.3430,0.2532,0.0744,0.3540,0.2384	8305,	32579	102781	0.2040			3.11				0	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823747	67823747	G	A	het	off-target	QUAL=212;DP=35;QD=6.06;AF=0.34;MQM=60;SAP=10;ABP=11;SAR=9;SAF=3	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+120G>A::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+120G>A::			1271766 [benign DISEASE=not provided];			rs28623567	0.3239	0.3434,0.2533,0.0750,0.3542,0.2387	8317,	32582	102714	0.9070			16.54				0	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823803	67823803	T	G	het	off-target	QUAL=149;DP=24;QD=6.21;AF=0.38;MQM=60;SAP=23;ABP=6;SAR=9;SAF=0	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+176T>G::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+176T>G::			1259949 [benign DISEASE=not provided];			rs8006089	0.3633	0.4663,0.2739,0.1483,0.3556,0.2439	10629,	33955	96765	0.0840			7.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67835050	67835050	-	A	het	off-target	QUAL=2995;DP=252;QD=11.88;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=62;SAF=62	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron3/6:c.199-22dup::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron3/11:c.199-22dup::			1270868 [benign DISEASE=not provided];			rs34564590	0.3725	0.4961,0.2788,0.1474,0.3564,0.2433	11256,	33961	95123				7.56				0.01	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67864958	67864958	A	T	hom	off-target;low_conf_region	QUAL=13443;DP=507;QD=26.51;AF=0.97;MQM=60;SAP=915;ABP=0;SAR=19;SAF=474	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron4/6:c.316-45A>T::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron4/11:c.316-45A>T::	regulatory_region_variant:CTCF_binding_site		1264510 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs1474939	0.9504	0.9358,0.9637,0.9521,0.9536,0.9470	45517,	5012	5018	-0.7160			0.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67865242	67865242	T	-	het	off-target	QUAL=217;DP=45;QD=4.82;AF=0.31;MQM=60;SAP=3;ABP=17;SAR=7;SAF=7	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron5/10:c.452+116del::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron5/10:c.452+116del::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron5/10:c.452+116del::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron5/6:c.452+116del::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron5/11:c.452+116del::					AluSz (SINE/Alu)	rs1269999800	0.0011	0.0013,0.0009,0.0000,0.0007,0.0007	0,	145	138323	0.7530			2.04				0		0	9	0 / 2					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68477457	68477457	C	T	het	off-target	QUAL=173;DP=19;QD=9.11;AF=0.53;MQM=60;SAP=25;ABP=3;SAR=0;SAF=10	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron10/10:c.1037-191C>T::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron10/10:c.1036+9207C>T::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron10/10:c.1036+9207C>T::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron10/11:c.1036+9207C>T::						rs36094690	0.0081	0.0028,0.0061,0.0002,0.0135,0.0066	7,	1216	150876	-0.4100			0.72				0		0	160	0 / 31					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68477627	68477627	T	-	het	off-target;low_conf_region	QUAL=780;DP=387;QD=2.02;AF=0.18;MQM=60;SAP=103;ABP=357;SAR=6;SAF=62	RAD51B	splice_region&intron,intron	RAD51B:ENST00000471583.6:splice_region_variant&intron_variant:LOW:intron10/10:c.1037-8del::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron10/11:c.1036+9390del::					(T)n (Simple_repeat)	rs528099287	0.0107	0.0316,0.0033,0.0012,0.0022,0.0018	19,	1452	138076	-0.6900			0.04				0.04		0	172	0 / 35					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	103699416	103699416	G	A	het		QUAL=12821;DP=959;QD=13.37;AF=0.52;MQM=60;SAP=3;ABP=5;SAR=247;SAF=248	KLC1,XRCC3	intron,missense	KLC1:ENST00000348520.10:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::,KLC1:ENST00000334553.11:intron_variant:MODIFIER:intron15/16:c.1849-1239G>A::,KLC1:ENST00000555836.5:intron_variant:MODIFIER:intron15/16:c.1822-1239G>A::,KLC1:ENST00000557450.5:intron_variant:MODIFIER:intron13/14:c.1624-1239G>A::,KLC1:ENST00000452929.6:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,KLC1:ENST00000554280.5:intron_variant:MODIFIER:intron14/15:c.1755-1239G>A::,XRCC3:ENST00000554913.5:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000555055.6:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000352127.11:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000553264.5:missense_variant:MODERATE:exon6/8:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000554974.5:missense_variant:MODERATE:exon2/4:c.107C>T:p.Thr36Met:PF08423 [Rad51]	regulatory_region_variant:enhancer	600675_[GENE=XRCC3_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Melanoma, cutaneous malignant, 6}, 613972 (3)]	8944 [risk factor DISEASE=Melanoma, cutaneous malignant, susceptibility to, 6];	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3];		rs861539	0.2978	0.2091,0.2593,0.0653,0.3755,0.2332	7375,	30461	106605	0.7970	 , , , , , ,T(0.17),T(0.17),T(0.17),T(0.17),T(0.13)	 , , , , , ,B(0.19),B(0.19),B(0.19),B(0.19),B(0.19)	7.75	0.03		COSV57974380	0.01	30409984,26451011,21708280,21514219,25928231,28827732,31516756,30781715,29178884,21658613,26029010,18191955,22655231,16465622,16857995,18701435,19109789,19124499,20150366,21700777,23720673,24500421,25231222,27415837,31584889,23565320,26263974,21487324,24701578,18830263,21347786,27608007,31395900,24315498,28717179,20226869,19902366,28415781,29458332,21195504,23443124,26159902,28206966,28324443,23663450,18990748,21561390,26843108,28520216,30588297,18086758,18579371,22430443,25178586,25452763,28342452,23697595,19127255,21974800,18768505,21877955,27258253,31374908,18194558,27053949,29732392,25589620,30235774,24756092,31629678,19815090,21183201,25529925,27460091,27571987,28749454,29035403,29139108,31446980,31914346,30584056,31175773,24325908,19706757,28983784,21047201,24939416,23313170,22525558,27754415,21104022,21647442,21725594,21749698,22272830,22933979,26339569,28965273,30033552,30712190,31905201,20004634,19367277,30022792,31186630,22868256,28453695,21332318,26627042,28356832,18708406,17557904,21617942,1841058	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLC1 (inh=n/a oe_syn=1.01 oe_mis=0.52 oe_lof=0.23), XRCC3 (inh=AD oe_syn=1.06 oe_mis=0.92 oe_lof=1.13)
chr14	104773454	104773454	C	A	het	mosaic	QUAL=0;DP=303;QD=0.00;AF=0.06;MQM=60;SAP=3;ABP=0;SAR=10;SAF=8	AKT1	splice_donor	AKT1:ENST00000554581.5:splice_donor_variant:HIGH:intron8/12:c.828+1G>T:p.?:,AKT1:ENST00000407796.7:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000649815.2:splice_donor_variant:HIGH:intron10/14:c.828+1G>T:p.?:,AKT1:ENST00000349310.7:splice_donor_variant:HIGH:intron10/14:c.828+1G>T:p.?:,AKT1:ENST00000402615.6:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000555528.5:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000683722.1:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000553797.2:splice_donor_variant:HIGH:intron10/14:c.903+1G>T:p.?:,AKT1:ENST00000554848.5:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:	regulatory_region_variant:CTCF_binding_site	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]										5.7320			34.00		9.05>0.54		0.99		0	1	0 / 0					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104776629	104776629	T	C	het	off-target	QUAL=1967;DP=130;QD=15.13;AF=0.61;MQM=60;SAP=13;ABP=16;SAR=49;SAF=30	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron3/12:c.287+30A>G::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron4/13:c.287+30A>G::		164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1272355 [benign DISEASE=not provided];			rs2494735	0.4886	0.7056,0.5196,0.6468,0.3548,0.5780	20042,	34216	77776	-3.6570			0.14			COSV62573175	0	28050343,28822116,19461960	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104792555	104792555	C	T	hom	off-target	QUAL=3635;DP=111;QD=32.75;AF=1.00;MQM=60;SAP=15;ABP=0;SAR=68;SAF=43	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron1/12:c.46+43G>A::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron2/13:c.46+43G>A::	regulatory_region_variant:promoter	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1182199 [benign DISEASE=not provided];			rs2494748	0.4817	0.2587,0.5033,0.2118,0.6093,0.3987	19603,	34004	78768	-0.8470			1.14			COSV62573228	0	22929028,30275531,30595370,32203549,32888494,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104792556	104792556	A	G	hom	off-target	QUAL=3635;DP=111;QD=32.75;AF=1.00;MQM=60;SAP=15;ABP=0;SAR=68;SAF=43	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron1/12:c.46+42T>C::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron2/13:c.46+42T>C::	regulatory_region_variant:promoter	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1238585 [benign DISEASE=not provided];			rs2494749	0.8716	0.8884,0.7945,0.3411,0.9241,0.6546	58789,	14884	19522	-1.6150			0.28			COSV62573234	0	29023587	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr15	40701377	40701378	TT	-	het	off-target;low_conf_region	QUAL=48;DP=19;QD=2.53;AF=0.32;MQM=60;SAP=16;ABP=9;SAR=6;SAF=0	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron3/8:c.225+189_225+190del::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron3/7:c.225+189_225+190del::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron3/9:c.225+189_225+190del::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron3/9:c.225+189_225+190del::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron3/9:c.225+189_225+190del::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron3/9:c.225+189_225+190del::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs57054958	0.0026	0.0013,0.0018,0.0544,0.0007,0.0003	1,	286	109680	0.1210			0.32				0.01		0	2	0 / 0					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40706144	40706144	T	G	het	off-target	QUAL=1309;DP=99;QD=13.22;AF=0.56;MQM=60;SAP=28;ABP=6;SAR=40;SAF=15	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron3/8:c.226-33T>G::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron3/7:c.225+4943T>G::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron3/9:c.226-33T>G::	regulatory_region_variant:open_chromatin_region	179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]	1255257 [benign DISEASE=not provided];			rs45457497	0.2230	0.2412,0.3502,0.6703,0.1549,0.3102	4765,	24377	118125	1.4560			10.92			COSV51111815	0.11	25918678	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40719057	40719057	-	T	het	off-target	QUAL=18;DP=120;QD=0.15;AF=0.17;MQM=60;SAP=46;ABP=119;SAR=20;SAF=0	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron6/8:c.530+172dup::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron4/7:c.239+172dup::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron6/9:c.533+172dup::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron6/9:c.530+172dup::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron6/9:c.533+172dup::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron6/9:c.530+172dup::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]	1202166 [likely benign DISEASE=not provided];		AluSx (SINE/Alu)	rs938761449	0.0023	0.0015,0.0026,0.0014,0.0018,0.0007	0,	332	144340				3.13				0.01		0	12	0 / 0					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40729373	40729373	A	-	het	off-target;low_conf_region	QUAL=368;DP=66;QD=5.58;AF=0.12;MQM=60;SAP=20;ABP=85;SAR=0;SAF=8	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron7/8:c.645-108del::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron5/7:c.354-108del::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron7/9:c.648-108del::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron7/9:c.645-108del::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron7/9:c.648-108del::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron7/9:c.645-108del::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]			AluYm1 (SINE/Alu)	rs60375696	0.2475	0.1654,0.2299,0.1746,0.2869,0.3204	460,	15019	48453	0.9390			0.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40729373	40729374	AA	-	het	off-target;low_conf_region	QUAL=368;DP=66;QD=5.58;AF=0.12;MQM=60;SAP=27;ABP=67;SAR=0;SAF=11	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron7/8:c.645-109_645-108del::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron5/7:c.354-109_354-108del::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron7/9:c.648-109_648-108del::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron7/9:c.645-109_645-108del::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron7/9:c.648-109_648-108del::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron7/9:c.645-109_645-108del::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]			AluYm1 (SINE/Alu)	rs60375696	0.2128	0.2318,0.3023,0.4585,0.1737,0.2510	513,	12436	49814	0.9390			0.89				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	43408229	43408229	G	A	het	off-target	QUAL=2322;DP=377;QD=6.16;AF=0.47;MQM=60;SAP=392;ABP=5;SAR=179;SAF=0	TUBGCP4,TP53BP1	3'UTR,intron	TUBGCP4:ENST00000564079.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3015G>A::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron26/27:c.5601-141C>T::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron26/27:c.5586-141C>T::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron25/26:c.5451-141C>T::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron26/27:c.5595-141C>T::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]			AluJb (SINE/Alu)	rs45585139	0.1751	0.3337,0.1777,0.2708,0.0934,0.1752	3239,	20151	125433	1.4850			6.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43409749	43409749	A	-	het		QUAL=548;DP=58;QD=9.45;AF=0.43;MQM=60;SAP=5;ABP=5;SAR=15;SAF=10	TUBGCP4,TP53BP1	3'UTR,splice_region&intron	TUBGCP4:ENST00000564079.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron23/26:c.5156-8del::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]				rs56813954	0.2286	0.1171,0.2847,0.3452,0.2658,0.2647	4177,	25533	114375	0.7380			0.86				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43413472	43413472	C	T	het	off-target	QUAL=702;DP=63;QD=11.14;AF=0.48;MQM=60;SAP=6;ABP=3;SAR=18;SAF=12	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron23/27:c.5090-138G>A::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron23/27:c.5075-138G>A::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron22/26:c.4940-138G>A::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron23/27:c.5090-144G>A::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]				rs12908460	0.1684	0.1716,0.1437,0.0014,0.1880,0.1893	2340,	20929	126443	0.7620			14.34				0.12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43415610	43415610	A	T	het		QUAL=1611;DP=136;QD=11.85;AF=0.46;MQM=60;SAP=15;ABP=5;SAR=22;SAF=41	TP53BP1	synonymous	TP53BP1:ENST00000382044.9:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:ENST00000263801.7:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:,TP53BP1:ENST00000382039.7:synonymous_variant:LOW:exon22/27:c.4923T>A:p.Ser1641=:,TP53BP1:ENST00000450115.6:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:						rs2230451	0.1684	0.1715,0.1446,0.0013,0.1880,0.1878	2343,	20931	126467	0.1790			9.38			COSV55501344	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43420139	43420139	A	G	het	off-target	QUAL=1739;DP=211;QD=8.24;AF=0.45;MQM=60;SAP=209;ABP=8;SAR=0;SAF=95	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron21/27:c.4681+166T>C::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron21/27:c.4666+166T>C::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron20/26:c.4531+166T>C::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron21/27:c.4681+166T>C::						rs62021180	0.1687	0.1723,0.1448,0.0014,0.1881,0.1884	2342,	20969	126403	0.2160			6.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43427958	43427958	A	-	het	off-target;low_conf_region	QUAL=1011;DP=306;QD=3.30;AF=0.17;MQM=60;SAP=3;ABP=293;SAR=25;SAF=27	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron18/27:c.3828+58del::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron18/27:c.3813+58del::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron18/26:c.3828+58del::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron18/27:c.3828+58del::					AluJb (SINE/Alu)	rs35437737	0.0034	0.0011,0.0048,0.0012,0.0029,0.0003	0,	354	102964	0.3850			1.04				0		15	9649	1 / 2552					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43427999	43427999	C	T	het	off-target	QUAL=4219;DP=347;QD=12.16;AF=0.55;MQM=60;SAP=12;ABP=12;SAR=110;SAF=82	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron18/27:c.3828+17G>A::,TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron18/27:c.3813+17G>A::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron18/26:c.3828+17G>A::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron18/27:c.3828+17G>A::						rs550239	0.2812	0.6497,0.2157,0.3979,0.1068,0.2290	10161,	22239	108801	0.2330			13.83			COSV55496522	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43428335	43428335	G	C	hom	off-target	QUAL=1566;DP=58;QD=27.00;AF=1.00;MQM=60;SAP=129;ABP=0;SAR=58;SAF=0	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron17/27:c.3676-167C>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron17/27:c.3661-167C>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron17/26:c.3676-167C>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron17/27:c.3676-167C>G::						rs2249952	0.4603	0.8541,0.3628,0.3987,0.2951,0.4348	20870,	28152	81966	-0.6650			0.93			COSV55506772	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43432448	43432448	T	G	hom		QUAL=20035;DP=634;QD=31.60;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=315;SAF=318	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:				CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs2602141	0.4596	0.8512,0.3623,0.3990,0.2951,0.4406	20795,	28252	82116	3.6770	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	17.49	0.08		COSV55496532	0.06	21807602,20106900,21212151,26130668,16741161,23349013,21303977,15987456,20686496,24603722,28487205,26693075,24761925,24316395	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43438288	43438288	A	G	het	off-target	QUAL=11474;DP=893;QD=12.85;AF=0.50;MQM=60;SAP=4;ABP=3;SAR=216;SAF=227	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron16/27:c.3176+36T>C::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron16/26:c.3191+36T>C::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::						rs16957730	0.1749	0.1943,0.1462,0.0014,0.1880,0.1875	2510,	21557	125385	1.4740			6.59				0	27462919	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43447488	43447488	-	A	het	low_conf_region	QUAL=27;DP=16;QD=1.69;AF=0.31;MQM=60;SAP=7;ABP=8;SAR=4;SAF=1	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::,TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron12/27:c.2702-4dup::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron12/26:c.2717-4dup::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::						rs749575788	0.0707	0.0337,0.1686,0.0913,0.0685,0.1497	109,	3547	49459				8.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43455721	43455721	A	-	het	off-target	QUAL=151;DP=105;QD=1.44;AF=0.16;MQM=60;SAP=40;ABP=107;SAR=0;SAF=17	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron12/27:c.2716+171del::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron12/27:c.2701+171del::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron12/26:c.2716+171del::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron12/27:c.2716+171del::					AluSz (SINE/Alu)	rs774205426	0.0021	0.0008,0.0016,0.0011,0.0020,0.0005	0,	267	127449	-0.3170			0.15				0		0	42	0 / 8					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43456106	43456106	A	G	hom		QUAL=30192;DP=958;QD=31.52;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=473;SAF=484	TP53BP1	synonymous	TP53BP1:ENST00000382044.9:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000263801.7:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:,TP53BP1:ENST00000382039.7:synonymous_variant:LOW:exon12/27:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000450115.6:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:						rs690367	0.4635	0.8665,0.3644,0.3994,0.2951,0.4239	21348,	27781	81581	1.4440			5.25			COSV55496541,COSV55506600	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43469723	43469723	A	C	het	off-target	QUAL=416;DP=34;QD=12.24;AF=0.56;MQM=60;SAP=6;ABP=4;SAR=7;SAF=12	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron11/27:c.1389+135T>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron11/27:c.1374+135T>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron11/26:c.1389+135T>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron11/27:c.1389+135T>G::					L1MB7 (LINE/L1)	rs7181783	0.1749	0.1942,0.1458,0.0014,0.1884,0.1874	2508,	21588	125538	1.4250			8.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43469998	43469998	C	T	het		QUAL=3267;DP=207;QD=15.78;AF=0.57;MQM=60;SAP=7;ABP=13;SAR=67;SAF=52	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:	regulatory_region_variant:TF_binding_site,TF_binding_site_variant			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1];		rs689647	0.2816	0.6498,0.2150,0.3970,0.1067,0.2359	10211,	22347	109099	1.3850	T(0.09),T(0.09),T(0.09),T(0.09)	B(0.00),B(0.00),B(0.00),B(0.00)	10.29	0.07		COSV55496549,COSV55506613	0	21368091,21303977,20805886,15987456,20686496,24603722,24316395	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43475576	43475576	G	C	hom		QUAL=3605;DP=116;QD=31.08;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=58;SAF=58	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:				CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs560191	0.4631	0.8664,0.3643,0.3983,0.2949,0.4243	21315,	27764	81610	0.1670	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	10.29	0.24		COSV55496034	0.01	29551738,21807602,20106900,20385987,24820515,21212151,26130668,16741161,23349013,21303977,20805886,15987456,20646866,20686496,25532599,24603722,26693075,25937777,26076430,26823859,24316395,33906323	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43480838	43480838	A	C	het	off-target	QUAL=10489;DP=864;QD=12.14;AF=0.48;MQM=60;SAP=3;ABP=6;SAR=208;SAF=208	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron5/27:c.484+57T>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron5/26:c.499+57T>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron5/27:c.499+57T>G::						rs7173383	0.1748	0.1940,0.1457,0.0014,0.1882,0.1872	2501,	21593	125543	-0.0460			1.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43491802	43491802	C	T	hom	off-target	QUAL=26789;DP=851;QD=31.48;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=439;SAF=409	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron3/27:c.272-49G>A::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron3/26:c.287-49G>A::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron3/27:c.287-49G>A::	regulatory_region_variant:promoter					rs555252	0.9649	0.8800,0.9912,0.9994,0.9994,0.9694	71066,	4734	5340	0.0420			6.87				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	75351274	75351274	-	T	het	off-target;low_conf_region	QUAL=571;DP=98;QD=5.83;AF=0.12;MQM=60;SAP=55;ABP=58;SAR=0;SAF=24	NEIL1	intron	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-818dup::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-818dup::		154580_[GENE=MAN2C1_PHENOS=Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive]				rs11422837	0.3972	0.2411,0.4147,0.4905,0.4684,0.5415	10964,	26158	72984				0.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=n/a oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	75351275	75351275	T	-	het	off-target;low_conf_region	QUAL=571;DP=98;QD=5.83;AF=0.24;MQM=58;SAP=21;ABP=124;SAR=1;SAF=11	NEIL1	intron	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-818del::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-818del::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-818del::		154580_[GENE=MAN2C1_PHENOS=Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs11422837	0.0156	0.0093,0.0158,0.0010,0.0196,0.0296	8,	1867	119229	-0.0650			0.66				0.01		32	6856	4 / 1643					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=n/a oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	75351842	75351842	G	A	het	off-target	QUAL=75;DP=9;QD=8.33;AF=0.56;MQM=60;SAP=14;ABP=3;SAR=0;SAF=5	NEIL1	intron	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-269G>A::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-269G>A::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-269G>A::		154580_[GENE=MAN2C1_PHENOS=Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs5745916	0.0178	0.0043,0.0162,0.0002,0.0250,0.0070	34,	2639	149343	-0.8210			1.10				0	31415677	8	354	2 / 58					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=n/a oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	90769430	90769430	C	T	het	mosaic	QUAL=0;DP=182;QD=0.00;AF=0.02;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	BLM	splice_region&intron	BLM:ENST00000355112.8:splice_region_variant&intron_variant:LOW:intron11/21:c.2407-8C>T::,BLM:ENST00000681142.1:splice_region_variant&intron_variant:LOW:intron11/21:c.2407-8C>T::,BLM:ENST00000648453.1:splice_region_variant&intron_variant:LOW:intron11/22:c.2407-8C>T::,BLM:ENST00000560509.5:splice_region_variant&intron_variant:LOW:intron11/19:c.2407-8C>T::,BLM:ENST00000680772.1:splice_region_variant&intron_variant:LOW:intron11/21:c.2407-8C>T::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]										0.1330			7.88		7.43>6.81		0		0	0	0 / 0					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90803400	90803400	-	A	hom	off-target	QUAL=623;DP=24;QD=25.96;AF=1.00;MQM=60;SAP=55;ABP=0;SAR=0;SAF=24	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron17/22:c.3359-121_3359-120insA::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3358+5063_3358+5064insA::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	210529 [benign/likely benign DISEASE=not specified,not provided];			rs11377009	0.6723	0.6519,0.7457,0.8432,0.6597,0.6674	34638,	32759	49725				0.59				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804072	90804072	G	A	hom	off-target	QUAL=7391;DP=268;QD=27.58;AF=1.00;MQM=60;SAP=585;ABP=0;SAR=0;SAF=268	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron18/22:c.3559-95G>A::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-5065G>A::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1239684 [benign DISEASE=not provided];			rs2301602	0.6313	0.5823,0.7223,0.8142,0.6313,0.6391	30632,	34603	56001	-0.4040			0.69				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804525	90804525	A	G	hom	off-target	QUAL=7995;DP=323;QD=24.75;AF=1.00;MQM=60;SAP=704;ABP=0;SAR=323;SAF=0	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron19/22:c.3751+166A>G::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-4612A>G::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1252270 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs454060	0.6642	0.6401,0.7423,0.8169,0.6581,0.6472	33806,	33259	50999	-2.2290			1.50				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804554	90804554	C	T	hom	off-target	QUAL=4216;DP=236;QD=17.86;AF=0.99;MQM=60;SAP=509;ABP=0;SAR=233;SAF=0	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron19/22:c.3751+195C>T::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-4583C>T::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1178809 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs405610	0.3841	0.1953,0.5339,0.5539,0.4365,0.4847	12381,	33571	93547	0.3440			6.08				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr16	3589138	3589138	A	G	het		QUAL=1353;DP=101;QD=13.40;AF=0.52;MQM=60;SAP=5;ABP=4;SAR=30;SAF=23	SLX4	synonymous	SLX4:ENST00000294008.4:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:		613278_[GENE=SLX4_PHENOS=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive]	262053 [benign DISEASE=Fanconi anemia complementation group P,Fanconi anemia,not specified,not provided];			rs3810812	0.6383	0.8746,0.6189,0.7155,0.5121,0.7741	32978,	31010	54956	0.7530			2.17			COSV53564459	0	25741868,22401137,22911665,32708070	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	3589229	3589229	G	A	het		QUAL=1429;DP=111;QD=12.87;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=27;SAF=28	SLX4	missense	SLX4:ENST00000294008.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:		613278_[GENE=SLX4_PHENOS=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive]	885261 [uncertain significance DISEASE=Fanconi anemia complementation group P,Fanconi anemia];	CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4];		rs72778139	0.0001	0.0001,0.0001,0.0000,0.0002,0.0000	0,	14	152156	0.6280	T(0.16)	B(0.06)	16.19	0.11		COSV53560456	0	22401137,23211700,23840564	0	10	0 / 4					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	23603722	23603722	A	-	het	off-target;low_conf_region	QUAL=275;DP=187;QD=1.47;AF=0.17;MQM=60;SAP=23;ABP=184;SAR=24;SAF=7	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron12/12:c.3351-53del::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron12/12:c.2466-53del::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron12/12:c.2466-53del::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron12/12:c.2317-53del::,PALB2:ENST00000697377.1:intron_variant:MODIFIER:intron12/12:c.2304-53del::,PALB2:ENST00000561514.2:intron_variant:MODIFIER:intron12/12:c.2466-53del::,PALB2:ENST00000697379.1:intron_variant:MODIFIER:intron13/13:c.2466-53del::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron8/8:c.885-53del::		610355_[GENE=PALB2_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3)]	1231515 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs35294437	0.0972	0.1403,0.0764,0.1884,0.0704,0.0926	589,	11379	116575	-1.7020			0.18			COSV55163224	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification "			PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23621158	23621158	C	T	het	off-target	QUAL=294;DP=33;QD=8.91;AF=0.52;MQM=60;SAP=40;ABP=3;SAR=0;SAF=17	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron10/12:c.3113+204G>A::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron10/12:c.2228+204G>A::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron10/12:c.2228+204G>A::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron11/12:c.2228+204G>A::,PALB2:ENST00000697377.1:intron_variant:MODIFIER:intron10/12:c.2066+204G>A::,PALB2:ENST00000561514.2:intron_variant:MODIFIER:intron10/12:c.2228+204G>A::,PALB2:ENST00000697379.1:intron_variant:MODIFIER:intron11/13:c.2228+204G>A::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron6/8:c.647+204G>A::		610355_[GENE=PALB2_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3)]	1181215 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs8060124	0.1821	0.2234,0.1926,0.1925,0.1494,0.2082	2633,	22396	124264	-0.6370			0.68			COSV55167095	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23623201	23623202	TT	-	het	off-target;low_conf_region	QUAL=68;DP=25;QD=2.72;AF=0.20;MQM=60;SAP=7;ABP=23;SAR=1;SAF=4	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron8/12:c.2835-72_2835-71del::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron8/12:c.1950-72_1950-71del::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron8/12:c.1950-72_1950-71del::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron9/12:c.1950-72_1950-71del::,PALB2:ENST00000697377.1:intron_variant:MODIFIER:intron8/12:c.1788-72_1788-71del::,PALB2:ENST00000561514.2:intron_variant:MODIFIER:intron8/12:c.1950-72_1950-71del::,PALB2:ENST00000697379.1:intron_variant:MODIFIER:intron9/13:c.1950-72_1950-71del::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron4/8:c.369-72_369-71del::		610355_[GENE=PALB2_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3)]	1229808 [benign DISEASE=not provided];		AluSx3 (SINE/Alu)	rs754470879	0.1521	0.1778,0.1565,0.1716,0.1358,0.1780	783,	17356	105486	0.8200			4.82				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23629146	23629146	G	A	het	off-target	QUAL=255;DP=23;QD=11.09;AF=0.48;MQM=60;SAP=13;ABP=3;SAR=2;SAF=9	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron6/12:c.2586+58C>T::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron7/12:c.1701+58C>T::,PALB2:ENST00000697377.1:intron_variant:MODIFIER:intron7/12:c.1701+58C>T::,PALB2:ENST00000561514.2:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::,PALB2:ENST00000697379.1:intron_variant:MODIFIER:intron7/13:c.1701+58C>T::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron2/8:c.120+58C>T::		610355_[GENE=PALB2_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3)]	126663 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not specified,not provided];			rs249954	0.3102	0.4364,0.2910,0.3653,0.2376,0.3116	7832,	31443	104733	0.3290			2.34			COSV55164558	0	21356067,29879995,23318652,28419251,30799775,22332084,20122277,18446436,19635604,22052327,23935836,18794107,26981788,30362319,19921424,23453885,30309218,32894086,35008387	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	68737438	68737440	TCT	-	het		QUAL=577;DP=134;QD=4.31;AF=0.33;MQM=60;SAP=99;ABP=37;SAR=44;SAF=0	CDH1	inframe_deletion	CDH1:ENST00000261769.10:inframe_deletion:MODERATE:exon1/16:c.23_25del:p.Leu8_Ser9delinsPro:,CDH1:ENST00000422392.6:inframe_deletion:MODERATE:exon1/15:c.23_25del:p.Leu8_Ser9delinsPro:	regulatory_region_variant:promoter	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]										0.2190							0		0	45	0 / 45					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68737469	68737469	C	T	hom		QUAL=4018;DP=128;QD=31.39;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=63;SAF=64	CDH1	splice_region&intron	CDH1:ENST00000261769.10:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::,CDH1:ENST00000422392.6:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::	regulatory_region_variant:promoter	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]	136692 [benign DISEASE=Malignant tumor of prostate,Hereditary diffuse gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Blepharocheilodontic syndrome 1,not specified,not provided];			rs3743674	0.8050	0.6632,0.7994,0.7730,0.8844,0.7836	50031,	22339	29653	-0.1320			6.86		8.63>8.16	COSV55733220	0	25741868,24033266,21686129,21356067,22875147,23431106,27192129,20632448,29295527,30641862,31600923,30895400,24684952,30642281,33240400,33465060	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68737515	68737515	-	GCCCCAGCCCCGT	hom	off-target	QUAL=2378;DP=85;QD=27.98;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=43;SAF=41	CDH1	intron	CDH1:ENST00000261769.10:intron_variant:MODIFIER:intron1/15:c.48+62_48+63insCGTGCCCCAGCCC::,CDH1:ENST00000422392.6:intron_variant:MODIFIER:intron1/14:c.48+62_48+63insCGTGCCCCAGCCC::	regulatory_region_variant:promoter,TF_binding_site_variant	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]	1243608 [benign DISEASE=not provided];			rs45625236	0.8073	0.6871,0.7923,0.7703,0.8735,0.7817	47776,	23735	28469				8.71			COSV55741627	0	21686129	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), RNA5SP429 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	68823238	68823238	A	-	het	off-target	QUAL=102;DP=48;QD=2.13;AF=0.17;MQM=60;SAP=20;ABP=49;SAR=0;SAF=8	CDH1	intron	CDH1:ENST00000261769.10:intron_variant:MODIFIER:intron12/15:c.1937-144del::,CDH1:ENST00000422392.6:intron_variant:MODIFIER:intron11/14:c.1754-144del::	regulatory_region_variant:enhancer	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]	1249384 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs146046879	0.1390	0.0902,0.1061,0.0988,0.1726,0.0725	718,	12881	88671	0.0360			0.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), FTLP14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	68823538	68823538	T	C	het		QUAL=14799;DP=1140;QD=12.98;AF=0.52;MQM=60;SAP=3;ABP=9;SAR=294;SAF=304	CDH1	synonymous	CDH1:ENST00000261769.10:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:,CDH1:ENST00000422392.6:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:	regulatory_region_variant:enhancer,TF_binding_site_variant	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]	142770 [benign DISEASE=Malignant tumor of prostate,Hereditary diffuse gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Blepharocheilodontic syndrome 1,not specified,not provided];	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1];		rs1801552	0.6983	0.8840,0.6533,0.6357,0.6282,0.6556	38020,	30015	45815	0.0880			8.26			COSV55728161	0.05	25741868,24033266,20844743,21356067,28419251,26285011,22535324,19965908,23431106,23555086,21459793,27192129,24838934,28151848,29295527,30641862,31600923,30895400,24684952,31638990,18059179,30642281,19269290,33888005,33195260,33465060,34503274,32708070,25150394	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), FTLP14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	81782975	81782975	C	G	hom	off-target	QUAL=142;DP=6;QD=23.67;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=0;SAF=6	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2968C>G::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2968C>G::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2968C>G::		600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs6564919	0.7673	0.6993,0.7981,0.7918,0.7852,0.8829	45009,	26602	35374	-0.4630			1.64				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783128	81783128	C	T	het		QUAL=4998;DP=430;QD=11.62;AF=0.51;MQM=60;SAP=291;ABP=3;SAR=24;SAF=194	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2815C>T::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2815C>T::		600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs8045964	0.4206	0.4119,0.3656,0.2835,0.4325,0.6326	13632,	36527	87861	-0.4400			1.02			COSV63869127	0	19956101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783182	81783182	T	A	hom	off-target	QUAL=24059;DP=746;QD=32.25;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=373;SAF=372	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2761T>A::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2761T>A::		600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs4476171	0.9994	0.9980,1.0000,1.0000,1.0000,0.9983	76019,	91	91	-1.8100			0.13				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783213	81783213	C	T	het	off-target	QUAL=9049;DP=726;QD=12.46;AF=0.48;MQM=60;SAP=4;ABP=6;SAR=179;SAF=167	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2730C>T::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2730C>T::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2730C>T::		600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs72834729	0.3424	0.2742,0.4311,0.5079,0.3520,0.2491	9230,	33553	99917	-1.2660			0.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	89738447	89738447	C	T	het	off-target	QUAL=653;DP=54;QD=12.09;AF=0.65;MQM=60;SAP=79;ABP=13;SAR=0;SAF=35	ZNF276,FANCA	3'UTR	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*201C>T::,ZNF276:ENST00000568064.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*538C>T::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*201C>T::,FANCA:ENST00000389301.8:3_prime_UTR_variant:MODIFIER:exon43/43:c.*154G>A::,FANCA:ENST00000568369.6:3_prime_UTR_variant:MODIFIER:exon43/43:c.*251G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	321323 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs1230	0.5357	0.7425,0.5477,0.9800,0.3930,0.6213	24272,	32901	70587	-0.4200			3.15			COSV57073486	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89738853	89738853	A	G	hom	off-target	QUAL=17997;DP=573;QD=31.41;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=290;SAF=281	ZNF276,FANCA	3'UTR,intron,synonymous	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron42/42:c.4260+29T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron42/42:c.4264+29T>C::,FANCA:ENST00000564475.6:synonymous_variant:LOW:exon42/42:c.4293T>C:p.His1431=:,FANCA:ENST00000696287.1:synonymous_variant:LOW:exon41/41:c.4164T>C:p.His1388=:		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255266 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided];			rs1800359	0.7228	0.9283,0.7035,0.9860,0.5957,0.8232	41663,	26645	42173	-6.7440			0.04			COSV57066846	0.13	25741868,23637625,19578364,23021409,26540268	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89739569	89739569	G	A	het	off-target	QUAL=2213;DP=181;QD=12.23;AF=0.48;MQM=60;SAP=10;ABP=4;SAR=35;SAF=52	ZNF276,FANCA	3'UTR,splice_region&intron	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron39/42:c.3935-16C>T::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron39/42:c.3935-16C>T::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron39/41:c.3935-16C>T::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron38/40:c.3806-16C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255264 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];			rs1061646	0.4102	0.5387,0.4843,0.7437,0.2997,0.4921	14112,	34096	89620	0.3980			4.77		8.17>8.42	COSV57068489	0.05	25741868,18701435,18056155,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89739939	89739939	A	T	het	off-target	QUAL=879;DP=48;QD=18.31;AF=0.71;MQM=60;SAP=3;ABP=21;SAR=17;SAF=17	ZNF276,FANCA	3'UTR,intron	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron39/41:c.3934+55T>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron38/40:c.3805+55T>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	135541 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided];			rs7195906	0.5421	0.7623,0.5505,0.9805,0.3944,0.6231	24964,	32487	69611	-0.7080			2.22	0.08		COSV57065786	0.01	24728327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89744788	89744788	T	C	het	off-target	QUAL=589;DP=55;QD=10.71;AF=0.58;MQM=60;SAP=72;ABP=6;SAR=0;SAF=32	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron36/42:c.3626+171A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron36/42:c.3626+171A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron36/41:c.3626+171A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron35/40:c.3497+171A>G::	regulatory_region_variant:enhancer	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1243121 [benign DISEASE=not provided];		AluSg4 (SINE/Alu)	rs9923733	0.5443	0.7641,0.5584,0.9817,0.3959,0.6210	25018,	32407	69017	-0.6340			3.84				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89748809	89748809	C	T	het	off-target	QUAL=1916;DP=156;QD=12.28;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=41;SAF=38	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron32/41:c.3240-42G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron31/40:c.3111-42G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255254 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];	CS137887 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs1800345	0.4135	0.5426,0.4889,0.7586,0.3009,0.4971	14350,	34090	89046	-0.7150			0.63				0.02	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89752083	89752083	T	C	het	off-target	QUAL=9384;DP=751;QD=12.50;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=181;SAF=188	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron31/41:c.3066+55A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron30/40:c.2937+55A>G::	regulatory_region_variant:CTCF_binding_site	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1235276 [benign DISEASE=not provided];			rs3743860	0.4730	0.5561,0.5141,0.7658,0.3914,0.6043	17820,	36201	80033	-0.1620			4.09			COSV59795426	0	31209889,29785010,30054594,32352494,29617998	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89765102	89765102	C	A	het	off-target	QUAL=11999;DP=972;QD=12.34;AF=0.48;MQM=60;SAP=4;ABP=6;SAR=227;SAF=240	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron27/41:c.2602-36G>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron27/40:c.2602-36G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255248 [benign DISEASE=Fanconi anemia complementation group A,not specified];			rs2159116	0.1224	0.0382,0.1214,0.0044,0.1727,0.1714	1477,	15667	133505	-2.7020			0.46			COSV59796461	0.01	25741868,20585627,20981448	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89767366	89767366	C	G	het	off-target	QUAL=130;DP=29;QD=4.48;AF=0.31;MQM=60;SAP=23;ABP=12;SAR=9;SAF=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron26/42:c.2505-129G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron26/42:c.2505-129G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron26/41:c.2505-129G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron26/40:c.2505-129G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1251422 [benign DISEASE=not provided];			rs7203907	0.5175	0.6771,0.5387,0.9815,0.3953,0.6271	22291,	34076	73336	-0.4910			0.81				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89769915	89769915	C	T	het		QUAL=829;DP=95;QD=8.73;AF=0.40;MQM=60;SAP=14;ABP=11;SAR=26;SAF=12	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000568369.6:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000564475.6:missense_variant:MODERATE:exon26/42:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000696287.1:missense_variant:MODERATE:exon26/41:c.2426G>A:p.Gly809Asp:		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134254 [benign/likely benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA];		rs7195066	0.4722	0.6623,0.5236,0.9813,0.3213,0.6231	19532,	32666	80166	0.0770	T(0.31),T(0.31),T(0.36),T(0.38)	B(0.00),B(0.00),B(0.01),B(0.01)	12.81	0.20		COSV59796193	0.41	25741868,24728327,20585627,20546537,18483556,23826176,19012493,23021409,24188633	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89770099	89770099	T	C	hom	off-target	QUAL=4535;DP=135;QD=33.59;AF=1.00;MQM=60;SAP=6;ABP=0;SAR=74;SAF=61	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron25/42:c.2316+67A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron25/42:c.2316+67A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron25/41:c.2316+67A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron25/40:c.2316+67A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180460 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs7200990	0.9714	0.9926,0.9781,0.9998,0.9565,0.9826	71826,	4219	4351	-0.2620			2.36				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89770373	89770373	G	A	het	off-target	QUAL=328;DP=41;QD=8.00;AF=0.46;MQM=60;SAP=44;ABP=3;SAR=19;SAF=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron24/42:c.2223-114C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron24/42:c.2223-114C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron24/41:c.2223-114C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron24/40:c.2223-114C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180461 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not provided];			rs886952	0.5234	0.6970,0.5434,0.9813,0.3947,0.6244	22921,	33707	72447	-1.2700			0.28				0.02	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89771670	89771670	A	G	het		QUAL=12928;DP=1057;QD=12.23;AF=0.49;MQM=60;SAP=3;ABP=5;SAR=256;SAF=258	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron23/41:c.2151+8T>C::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron23/40:c.2151+8T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255245 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified];			rs1800340	0.4143	0.5140,0.4867,0.7545,0.3107,0.5985	14233,	34402	88872	-1.3870			0.04			COSV66881670	0	25741868,23021409,32572023	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89775621	89775621	C	G	het	off-target	QUAL=71;DP=14;QD=5.07;AF=0.43;MQM=60;SAP=16;ABP=4;SAR=0;SAF=6	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron21/42:c.1900+121G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron21/42:c.1900+121G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron21/41:c.1900+121G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron21/40:c.1900+121G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1225017 [benign DISEASE=not provided];			rs3785275	0.4164	0.5531,0.4833,0.7534,0.3017,0.5081	14624,	34052	88718	-0.4590			0.63			COSV66881241	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89778702	89778702	A	T	het	off-target	QUAL=6420;DP=613;QD=10.47;AF=0.53;MQM=60;SAP=709;ABP=8;SAR=325;SAF=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron20/42:c.1826+99T>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron20/42:c.1826+99T>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron20/41:c.1826+99T>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron20/40:c.1826+99T>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180464 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs7187436	0.5084	0.6573,0.5308,0.9810,0.3935,0.6266	21145,	33399	73201	-1.3470			0.48				0.07		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89778786	89778786	A	G	het	off-target	QUAL=6231;DP=616;QD=10.12;AF=0.53;MQM=60;SAP=696;ABP=8;SAR=325;SAF=2	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron20/42:c.1826+15T>C::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron20/42:c.1826+15T>C::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron20/41:c.1826+15T>C::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron20/40:c.1826+15T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255241 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];			rs1800337	0.5177	0.6791,0.5389,0.9809,0.3944,0.6274	22344,	33885	73191	-1.3620			0.76				0.06	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783072	89783072	C	T	hom		QUAL=6739;DP=202;QD=33.36;AF=1.00;MQM=60;SAP=83;ABP=0;SAR=144;SAF=58	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000568369.6:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000564475.6:missense_variant:MODERATE:exon16/42:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000696287.1:missense_variant:MODERATE:exon16/41:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus]		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134244 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs2239359	0.5134	0.6844,0.5253,0.8459,0.3884,0.5110	21654,	34586	73838	-0.9650	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.01),B(0.01)	0.34	0.26		COSV66881058	0.01	25741868,23554684,24728327,17267408,26139146,24045675,23826176,19012493,23021409,23424144,31535215,18059179,28500464,25653542,33202820	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783175	89783175	C	T	het	off-target	QUAL=937;DP=80;QD=11.71;AF=0.48;MQM=60;SAP=3;ABP=3;SAR=19;SAF=19	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron15/42:c.1471-73G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron15/42:c.1471-73G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron15/41:c.1471-73G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron15/40:c.1471-73G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180470 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs2239360	0.4633	0.6835,0.5045,0.7616,0.3116,0.5986	18703,	32962	81532	-1.8400			0.17			COSV66881248	0.04	20837404,23350966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783221	89783221	T	A	het	off-target	QUAL=913;DP=80;QD=11.41;AF=0.48;MQM=60;SAP=3;ABP=3;SAR=19;SAF=19	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron15/42:c.1471-119A>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron15/42:c.1471-119A>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron15/41:c.1471-119A>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron15/40:c.1471-119A>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180471 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs12448860	0.5125	0.6601,0.5389,0.9809,0.3951,0.6249	21762,	34284	74028	0.0000			2.11			COSV66882732	0.06	23350966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791292	89791292	A	G	het	off-target	QUAL=891;DP=68;QD=13.10;AF=0.53;MQM=60;SAP=3;ABP=4;SAR=18;SAF=18	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron14/42:c.1359+111T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron14/42:c.1359+111T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron14/41:c.1359+111T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron14/40:c.1359+111T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1230103 [benign DISEASE=not provided];			rs8049660	0.4743	0.7189,0.5111,0.7657,0.3125,0.5978	19874,	32247	79807	-1.5800			0.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791556	89791556	T	C	het	off-target	QUAL=14549;DP=1042;QD=13.96;AF=0.53;MQM=60;SAP=4;ABP=11;SAR=268;SAF=284	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron13/42:c.1226-20A>G::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron13/42:c.1226-20A>G::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron13/41:c.1226-20A>G::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron13/40:c.1226-20A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255232 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified];			rs1800330	0.4253	0.5511,0.4889,0.7653,0.3117,0.5977	15190,	34242	87318	-5.4410			0.01		4.71>4.86	COSV66881251	0.01	25741868,21850187,23021409,33863951	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791616	89791616	A	G	het	off-target	QUAL=6256;DP=535;QD=11.69;AF=0.53;MQM=60;SAP=481;ABP=7;SAR=267;SAF=17	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron13/42:c.1226-80T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron13/42:c.1226-80T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron13/41:c.1226-80T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron13/40:c.1226-80T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180472 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs6500450	0.5384	0.7517,0.5455,0.9810,0.3956,0.6241	24611,	32575	70141	-0.7840			0.32			COSV66881253	0.05	23021409,33863951	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791776	89791776	A	G	hom	off-target	QUAL=1851;DP=59;QD=31.37;AF=0.98;MQM=60;SAP=3;ABP=0;SAR=29;SAF=29	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron13/42:c.1225+151T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron13/42:c.1225+151T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron13/41:c.1225+151T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron13/40:c.1225+151T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180473 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs6500451	0.9716	0.9926,0.9783,0.9998,0.9568,0.9841	71802,	4195	4325	-0.7740			1.34				0.08	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792097	89792097	T	C	het	off-target	QUAL=4331;DP=304;QD=14.25;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=78;SAF=76	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-29A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-29A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255229 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided];			rs6500452	0.4030	0.5058,0.4785,0.7598,0.3023,0.5017	13540,	34157	90705	-2.0850			0.09			COSV66880734	0.02	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792117	89792117	C	G	het	off-target	QUAL=4358;DP=307;QD=14.20;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=80;SAF=76	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-49G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-49G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255230 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided];			rs1800287	0.5383	0.7511,0.5457,0.9810,0.3956,0.6239	24598,	32605	70157	-0.1090			1.07			COSV66881254	0.01	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792249	89792249	C	G	het	off-target	QUAL=319;DP=27;QD=11.81;AF=0.59;MQM=60;SAP=23;ABP=5;SAR=2;SAF=14	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-181G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-181G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-181G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-181G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1264276 [benign DISEASE=not provided];			rs6500453	0.5383	0.7507,0.5460,0.9814,0.3957,0.6262	24569,	32587	70089	0.9310			4.21				0.02	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792351	89792351	C	T	het	off-target	QUAL=485;DP=51;QD=9.51;AF=0.43;MQM=60;SAP=22;ABP=5;SAR=4;SAF=18	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1083+120G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1083+120G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1083+120G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1083+120G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180474 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs17226159	0.1211	0.0381,0.1199,0.0044,0.1707,0.1700	1445,	15540	133718	-1.1480			0.77				0.24	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792600	89792600	G	A	het	off-target	QUAL=948;DP=102;QD=9.29;AF=0.41;MQM=60;SAP=24;ABP=10;SAR=11;SAF=31	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron11/41:c.1007-53C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron11/40:c.1007-53C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1242487 [benign DISEASE=not provided];			rs3856	0.4045	0.5060,0.4787,0.8017,0.3032,0.5113	13293,	34081	89299	-0.0020			2.88				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792608	89792608	T	-	het	off-target	QUAL=876;DP=104;QD=8.42;AF=0.39;MQM=60;SAP=22;ABP=13;SAR=11;SAF=30	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron11/41:c.1007-61del::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron11/40:c.1007-61del::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1289093 [benign DISEASE=not provided];			rs35617323	0.4847	0.5681,0.5244,0.9807,0.3941,0.6229	19147,	35104	78048	0.0480			0.75				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89798903	89798903	T	C	het	off-target	QUAL=389;DP=36;QD=10.81;AF=0.53;MQM=60;SAP=44;ABP=3;SAR=0;SAF=19	FANCA	intron,3'UTR	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron10/42:c.893+263A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron10/42:c.893+263A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron10/41:c.893+263A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron10/40:c.893+263A>G::,FANCA:ENST00000389302.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*176A>G::,FANCA:ENST00000563673.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*205A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1218370 [likely benign DISEASE=not provided];			rs17226026	0.0123	0.0029,0.0117,0.0002,0.0155,0.0588	29,	1814	150104	-1.9270			0.09				0.03		6	311	1 / 39					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799635	89799635	T	C	het		QUAL=9341;DP=729;QD=12.81;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=178;SAF=182	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000568369.6:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000564475.6:missense_variant:MODERATE:exon9/42:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000696287.1:missense_variant:MODERATE:exon9/41:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000389302.7:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000563673.5:missense_variant:MODERATE:exon9/10:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000534992.5:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000543736.5:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:PF15865 [Fanconi anaemia group A protein N terminus]		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134294 [benign DISEASE=Malignant tumor of breast,Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs7190823	0.5309	0.7172,0.5442,0.9814,0.3990,0.6284	23636,	33447	71315	0.6710	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	2.79	0.08			0.25	25741868,24728327,20386703,26139146,23826176,19012493,23021409,24320210,30072632,29098742,25653542	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799752	89799752	A	G	het	off-target	QUAL=1462;DP=99;QD=14.77;AF=0.61;MQM=60;SAP=4;ABP=13;SAR=32;SAF=28	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.793-114T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.793-114T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.793-114T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.793-114T>C::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.793-114T>C::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.793-114T>C::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.793-114T>C::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.697-114T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1253922 [benign DISEASE=not provided];		AluYk4 (SINE/Alu)	rs7186192	0.6553	0.7744,0.6510,0.9856,0.5682,0.7377	33734,	32161	52399	-1.6560			0.56			COSV66881257	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799769	89799769	G	A	het	off-target	QUAL=44;DP=8;QD=5.50;AF=0.50;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.793-131C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.793-131C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.793-131C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.793-131C>T::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.793-131C>T::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.793-131C>T::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.793-131C>T::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.697-131C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1194031 [likely benign DISEASE=not provided];		AluYk4 (SINE/Alu)	rs34427386	0.0075	0.0018,0.0028,0.0000,0.0120,0.0025	9,	1115	151035	-2.7840			0.12				0		1	164	1 / 21					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89803156	89803156	G	A	het	off-target	QUAL=12907;DP=1039;QD=12.42;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=257;SAF=252	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.792+103C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.792+103C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.792+103C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.792+103C>T::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.792+103C>T::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.792+103C>T::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.792+103C>T::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.696+103C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1197847 [likely benign DISEASE=not provided];		L1MA5A (LINE/L1)	rs35506335	0.0243	0.0058,0.0309,0.0002,0.0294,0.0786	78,	3537	148379	-2.8750			0.13				0		2	51	0 / 14					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89803353	89803353	T	C	hom	off-target	QUAL=3848;DP=114;QD=33.75;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=58;SAF=56	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron7/42:c.710-12A>G::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron7/42:c.710-12A>G::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron7/41:c.710-12A>G::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron7/40:c.710-12A>G::,FANCA:ENST00000389302.7:splice_region_variant&intron_variant:LOW:intron7/10:c.710-12A>G::,FANCA:ENST00000563673.5:splice_region_variant&intron_variant:LOW:intron7/9:c.710-12A>G::,FANCA:ENST00000534992.5:splice_region_variant&intron_variant:LOW:intron7/10:c.710-12A>G::,FANCA:ENST00000543736.5:splice_region_variant&intron_variant:LOW:intron6/9:c.614-12A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255269 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];			rs1800286	0.7172	0.9166,0.6949,0.9865,0.5951,0.8151	40949,	27114	42984	-1.9470			1.75		9.13>9.77		0.08	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89808151	89808151	A	C	het	off-target	QUAL=1883;DP=138;QD=13.64;AF=0.59;MQM=60;SAP=109;ABP=12;SAR=9;SAF=72	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron6/42:c.596+143T>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron6/42:c.596+143T>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron6/41:c.596+143T>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron6/40:c.596+143T>G::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron6/10:c.596+143T>G::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron6/9:c.596+143T>G::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron6/10:c.596+143T>G::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron5/9:c.500+143T>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180476 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs11076627	0.4606	0.5083,0.5153,0.9773,0.3884,0.5201	17323,	35314	81930	0.4050			7.35				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89808220	89808220	C	T	het	off-target	QUAL=1665;DP=118;QD=14.11;AF=0.61;MQM=60;SAP=91;ABP=15;SAR=9;SAF=63	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron6/42:c.596+74G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron6/42:c.596+74G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron6/41:c.596+74G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron6/40:c.596+74G>A::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron6/10:c.596+74G>A::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron6/9:c.596+74G>A::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron6/10:c.596+74G>A::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron5/9:c.500+74G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180477 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs1800285	0.5306	0.7217,0.5409,0.9815,0.3979,0.6163	23652,	33270	71288	-0.2360			2.77				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr17	7669662	7669662	T	G	het		QUAL=154;DP=216;QD=0.71;AF=0.35;MQM=60;SAP=168;ABP=44;SAR=0;SAF=76	TP53	intron,3'UTR,missense	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron6/6:c.782+4519A>C::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron8/8:c.994-3418A>C::,TP53:ENST00000504290.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*148A>C::,TP53:ENST00000504937.5:missense_variant:MODERATE:exon7/7:c.733A>C:p.Thr245Pro:,TP53:ENST00000510385.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*236A>C::,TP53:ENST00000610623.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*148A>C::,TP53:ENST00000618944.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*236A>C::,TP53:ENST00000619186.4:missense_variant:MODERATE:exon7/7:c.652A>C:p.Thr218Pro:,TP53:ENST00000610292.4:missense_variant:MODERATE:exon10/10:c.1012A>C:p.Thr338Pro:,TP53:ENST00000620739.4:missense_variant:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro:,TP53:ENST00000420246.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::,TP53:ENST00000455263.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::,TP53:ENST00000610538.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::,TP53:ENST00000622645.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::,TP53:ENST00000445888.6:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:ENST00000619485.4:missense_variant:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro:,TP53:ENST00000269305.9:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	975959 [uncertain significance DISEASE=Li-Fraumeni syndrome 1];			rs774269719	0.0001	0.0000,0.0001,0.0002,0.0001,0.0002	0,	8	150882	0.4640	 , , ,T(0.28), , , ,T(0.29),T(0.28),T(0.28), , , , ,T(0.29),T(0.28),T(0.29)	 , , ,B(0.01), , , ,B(0.01),B(0.01),B(0.01), , , , ,B(0.01),B(0.01),B(0.01)	19.38	0.35		COSV52716766	0.06	12826609	0	179	0 / 173	2	"[2] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [2] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7673145	7673145	G	A	hom	off-target	QUAL=277;DP=16;QD=17.31;AF=0.88;MQM=60;SAP=33;ABP=0;SAR=0;SAF=14	TP53	intron	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron6/6:c.782+1036C>T::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron8/8:c.993+390C>T::,TP53:ENST00000504290.5:intron_variant:MODIFIER:intron6/7:c.*12+62C>T::,TP53:ENST00000504937.5:intron_variant:MODIFIER:intron5/6:c.597+390C>T::,TP53:ENST00000510385.5:intron_variant:MODIFIER:intron6/7:c.*100+62C>T::,TP53:ENST00000610623.4:intron_variant:MODIFIER:intron6/7:c.*12+62C>T::,TP53:ENST00000618944.4:intron_variant:MODIFIER:intron6/7:c.*100+62C>T::,TP53:ENST00000619186.4:intron_variant:MODIFIER:intron5/6:c.516+390C>T::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron8/9:c.876+390C>T::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron9/10:c.876+390C>T::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron10/11:c.*100+62C>T::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron10/11:c.*12+62C>T::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron10/11:c.*12+62C>T::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron10/11:c.*100+62C>T::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron9/10:c.993+390C>T::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron9/10:c.876+390C>T::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron9/10:c.993+390C>T::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]			Tigger5b (DNA/TcMar-Tigger)	rs1375871549	0.0004	0.0002,0.0005,0.0009,0.0002,0.0004	0,	32	85334	-1.3800			0.45				0		0	0	0 / 0					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7673159	7673159	G	A	het	off-target	QUAL=21;DP=4;QD=5.25;AF=0.75;MQM=60;SAP=10;ABP=5;SAR=0;SAF=3	TP53	intron	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron6/6:c.782+1022C>T::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron8/8:c.993+376C>T::,TP53:ENST00000504290.5:intron_variant:MODIFIER:intron6/7:c.*12+48C>T::,TP53:ENST00000504937.5:intron_variant:MODIFIER:intron5/6:c.597+376C>T::,TP53:ENST00000510385.5:intron_variant:MODIFIER:intron6/7:c.*100+48C>T::,TP53:ENST00000610623.4:intron_variant:MODIFIER:intron6/7:c.*12+48C>T::,TP53:ENST00000618944.4:intron_variant:MODIFIER:intron6/7:c.*100+48C>T::,TP53:ENST00000619186.4:intron_variant:MODIFIER:intron5/6:c.516+376C>T::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron8/9:c.876+376C>T::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron9/10:c.876+376C>T::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron9/10:c.876+376C>T::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron9/10:c.993+376C>T::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]			Tigger5b (DNA/TcMar-Tigger)							0.0110			2.96				0		46	145	46 / 145					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7674797	7674797	T	C	het	off-target	QUAL=66;DP=12;QD=5.50;AF=0.42;MQM=60;SAP=14;ABP=4;SAR=0;SAF=5	TP53	intron	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron5/6:c.672+62A>G::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron5/8:c.672+62A>G::,TP53:ENST00000504290.5:intron_variant:MODIFIER:intron2/7:c.276+62A>G::,TP53:ENST00000504937.5:intron_variant:MODIFIER:intron2/6:c.276+62A>G::,TP53:ENST00000510385.5:intron_variant:MODIFIER:intron2/7:c.276+62A>G::,TP53:ENST00000610623.4:intron_variant:MODIFIER:intron2/7:c.195+62A>G::,TP53:ENST00000618944.4:intron_variant:MODIFIER:intron2/7:c.195+62A>G::,TP53:ENST00000619186.4:intron_variant:MODIFIER:intron2/6:c.195+62A>G::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron5/9:c.555+62A>G::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron6/10:c.555+62A>G::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron6/11:c.672+62A>G::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron6/11:c.672+62A>G::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron6/11:c.555+62A>G::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron6/11:c.555+62A>G::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron6/10:c.672+62A>G::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron6/10:c.555+62A>G::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron6/10:c.672+62A>G::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	256603 [benign DISEASE=not specified,not provided];			rs1625895	0.8306	0.7131,0.8844,0.9667,0.8726,0.7989	52884,	20492	25760	0.2300			3.31				0.01	25741868,27917368,18854777,16465622,18640487,19826048,19426493,19276375,28415781,24818791,21402718,25340731,19276285,12466288,17428325,28678827,30867801,25233467,18798306,17151932,17301252,17449902,17624591,19193430,19423538,19505915,21810023,21838531,23029260,23360829,29167767,30796655,31205533,31788124,17908995,25430047,30048458,31624379,31686737,25925845,30801535,29892419,22829776,27503997,23412385,21342648,30944658,20445773,16039051,18314326,21869887,19386249,33942220,33544795,32423484,34190520,25842861,34295994,31143958,32214837,32552660,33462484,32445942,33985476,32888145,34953598,34848757	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7675327	7675327	C	T	het	off-target	QUAL=16356;DP=1280;QD=12.78;AF=0.51;MQM=60;SAP=3;ABP=4;SAR=329;SAF=325	TP53	intron,5'UTR	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron3/6:c.376-91G>A::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron3/8:c.376-91G>A::,TP53:ENST00000504290.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-112G>A::,TP53:ENST00000504937.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-112G>A::,TP53:ENST00000510385.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-112G>A::,TP53:ENST00000610623.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-193G>A::,TP53:ENST00000618944.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-193G>A::,TP53:ENST00000619186.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-193G>A::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron3/9:c.259-91G>A::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron4/10:c.259-91G>A::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron4/11:c.376-91G>A::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron4/11:c.376-91G>A::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron4/11:c.259-91G>A::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron4/11:c.259-91G>A::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron4/10:c.376-91G>A::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron4/10:c.259-91G>A::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron4/10:c.376-91G>A::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	440348 [benign DISEASE=Familial cancer of breast,not specified,not provided];			rs2909430	0.8374	0.7367,0.8871,0.9669,0.8726,0.7999	53502,	19882	24638	0.3200			2.35			COSV52668782	0.01	27917368,23761422,27246533,19276375,18678618,24818791,21402718,24218030,19276285,28976792,29963112,25233467,15450681,17301252,17449902,19423538,22962577,28364582,28373458,31205533,31788124,25925845,28542283,26503811,20352120,21342648,24177593,32882831,33942220,32899294	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7675394	7675395	TT	-	het	off-target	QUAL=101;DP=16;QD=6.31;AF=0.25;MQM=60;SAP=12;ABP=12;SAR=4;SAF=0	TP53	intron,5'UTR	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron3/6:c.376-159_376-158del::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron3/8:c.376-159_376-158del::,TP53:ENST00000504290.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-180_-179del::,TP53:ENST00000504937.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-180_-179del::,TP53:ENST00000510385.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-180_-179del::,TP53:ENST00000610623.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-261_-260del::,TP53:ENST00000618944.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-261_-260del::,TP53:ENST00000619186.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-261_-260del::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron3/9:c.259-159_259-158del::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron4/10:c.259-159_259-158del::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron4/11:c.376-159_376-158del::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron4/11:c.376-159_376-158del::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron4/11:c.259-159_259-158del::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron4/11:c.259-159_259-158del::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron4/10:c.376-159_376-158del::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron4/10:c.259-159_259-158del::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron4/10:c.376-159_376-158del::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	1213246 [likely benign DISEASE=not provided];		AluJb (SINE/Alu)	rs5819162	0.0082	0.0092,0.0065,0.0013,0.0085,0.0092	6,	1123	136817	0.2640			1.04				0		2	108	0 / 11					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7675394	7675396	TTT	-	het	off-target	QUAL=101;DP=16;QD=6.31;AF=0.31;MQM=60;SAP=14;ABP=8;SAR=5;SAF=0	TP53	intron,5'UTR	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron3/6:c.376-160_376-158del::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron3/8:c.376-160_376-158del::,TP53:ENST00000504290.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-181_-179del::,TP53:ENST00000504937.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-181_-179del::,TP53:ENST00000510385.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-181_-179del::,TP53:ENST00000610623.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-262_-260del::,TP53:ENST00000618944.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-262_-260del::,TP53:ENST00000619186.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-262_-260del::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron3/9:c.259-160_259-158del::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron4/10:c.259-160_259-158del::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron4/11:c.376-160_376-158del::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron4/11:c.376-160_376-158del::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron4/11:c.259-160_259-158del::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron4/11:c.259-160_259-158del::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron4/10:c.376-160_376-158del::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron4/10:c.259-160_259-158del::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron4/10:c.376-160_376-158del::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	803309 [benign/likely benign DISEASE=Squamous cell carcinoma of the head and neck,not provided];		AluJb (SINE/Alu)	rs5819162	0.8087	0.7064,0.8192,0.9587,0.8523,0.7797	45249,	21036	26390	0.2640			1.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7676154	7676154	G	C	het		QUAL=7653;DP=570;QD=13.43;AF=0.54;MQM=60;SAP=4;ABP=10;SAR=148;SAF=159	TP53	missense	TP53:ENST00000413465.6:missense_variant:MODERATE:exon3/7:c.215C>G:p.Pro72Arg:,TP53:ENST00000359597.8:missense_variant:MODERATE:exon3/9:c.215C>G:p.Pro72Arg:,TP53:ENST00000610292.4:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg:,TP53:ENST00000620739.4:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:ENST00000420246.6:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000455263.6:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000610538.4:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:ENST00000622645.4:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:ENST00000445888.6:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000619485.4:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:ENST00000269305.9:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	12351 [benign DISEASE=CODON 72 POLYMORPHISM,Li-Fraumeni syndrome 1,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lip and oral cavity carcinoma,not specified,not provided];			rs1042522	0.6273	0.3875,0.6994,0.5765,0.7450,0.5212	31786,	31721	56611	1.4380	T(0.24),T(0.36),T(0.26),T(0.26),T(0.26),T(0.37),T(0.31),T(0.32),T(0.57),T(0.26),T(0.57)	B(0.37),B(0.35),B(0.05),B(0.05),B(0.13),B(0.15),B(0.15),B(0.13),B(0.05),B(0.05),B(0.05)	5.09	0.37		COSV52666208,COSV53098660	0.05	25741868,30409984,23267696,26451011,24033266,24728327,24944790,21708280,21514219,23946381,28652652,30551681,22879966,22992668,23820649,27277665,27716216,25214541,25719551,20599859,28827732,30337837,30793520,30988702,26690118,20003265,26873362,23757202,30781715,29193749,18805939,18854777,30937706,18191955,23168575,18298806,22215955,22655231,24084248,27871254,26870349,16465622,16857995,19822020,27415837,27588484,29484706,19911060,20855462,25479941,18640487,19470478,21779510,24654968,26382048,26867771,30956778,21589938,23906684,18978339,30139066,30807515,28881764,18547414,18715757,18830263,19826048,23072573,20638924,20847277,21897271,27618021,28348449,19426493,19657586,20452958,21841506,24820515,27246533,21533266,24534481,22194650,26900293,31821471,19276375,22703879,18678618,28415781,29458332,24818791,27376129,25203442,21402718,28324443,24218030,25412941,18990748,19442035,22742565,26130668,17428325,27698805,27900359,29860059,25591549,26683024,31528229,28351583,23697595,21877955,30867801,22300735,28210099,2287514	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahpohla1 15.04.2019"			TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7676326	7676341	CCCCAGCCCTCCAGGT	-	het	off-target;low_conf_region	QUAL=134;DP=20;QD=6.70;AF=0.50;MQM=60;SAP=17;ABP=3;SAR=9;SAF=1	TP53	intron	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron2/6:c.96+41_97-54del::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron2/8:c.96+41_97-54del::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron2/9:c.-22+41_-21-54del::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	440349 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,Breast and/or ovarian cancer,not provided];			rs59758982	0.8270	0.7332,0.8755,0.9635,0.8564,0.7911	51911,	20932	26104	1.0620			2.80				0	19471604,31772679,31316092,32000721,30816478,32888145	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	31201318	31201318	A	T	het	off-target	QUAL=264;DP=24;QD=11.00;AF=0.75;MQM=60;SAP=42;ABP=16;SAR=18;SAF=0	NF1	intron	NF1:ENST00000487476.5:intron_variant:MODIFIER:intron10/13:c.1186-93A>T::,NF1:ENST00000356175.7:intron_variant:MODIFIER:intron10/56:c.1186-93A>T::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron10/58:c.1186-93A>T::,NF1:ENST00000431387.8:intron_variant:MODIFIER:intron10/14:c.1186-93A>T::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron10/57:c.1186-93A>T::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron10/58:c.1186-93A>T::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]										0.5050			1.99				0		0	0	0 / 0					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31226318	31226318	-	ACAC	het	off-target	QUAL=372;DP=24;QD=15.50;AF=0.25;MQM=60;SAP=16;ABP=16;SAR=0;SAF=6	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron17/56:c.2002-79_2002-76dup::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron18/58:c.2047-79_2047-76dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron17/57:c.2002-79_2002-76dup::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron18/58:c.2032-79_2032-76dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	1257651 [benign DISEASE=not provided];			rs59547221	0.1052	0.0882,0.1101,0.0613,0.1160,0.0704	826,	12898	123708				0.99				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31226318	31226318	-	ACACAC	het	off-target	QUAL=372;DP=24;QD=15.50;AF=0.25;MQM=60;SAP=31;ABP=3;SAR=0;SAF=13	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron17/56:c.2002-81_2002-76dup::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron18/58:c.2047-81_2047-76dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron17/57:c.2002-81_2002-76dup::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron18/58:c.2032-81_2032-76dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	1220711 [benign DISEASE=not provided];			rs59547221	0.1064	0.0743,0.1481,0.0516,0.1234,0.0728	906,	12898	123548				0.95				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31226467	31226467	G	A	hom		QUAL=2514;DP=83;QD=30.29;AF=1.00;MQM=60;SAP=25;ABP=0;SAR=27;SAF=56	NF1	synonymous	NF1:ENST00000356175.7:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:ENST00000696138.1:synonymous_variant:LOW:exon19/59:c.2079G>A:p.Pro693=:,NF1:ENST00000358273.9:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:,NF1:ENST00000691014.1:synonymous_variant:LOW:exon19/59:c.2064G>A:p.Pro688=:		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	183826 [benign DISEASE=Neurofibromatosis, familial spinal,Cafe-au-lait macules with pulmonary stenosis,Neurofibromatosis-Noonan syndrome,Hereditary cancer-predisposing syndrome,Neurofibromatosis, type 1,not specified,not provided];			rs2285892	0.4252	0.6740,0.4329,0.5242,0.2953,0.3820	15853,	32808	87212	-1.2810			1.98			COSV62191601	0.02	25741868,24033266,17668375,21354044,30283335	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31231064	31231064	T	C	hom	off-target	QUAL=426;DP=17;QD=25.06;AF=1.00;MQM=60;SAP=40;ABP=0;SAR=17;SAF=0	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron24/56:c.3197+139T>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron25/58:c.3242+139T>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron24/57:c.3197+139T>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron25/58:c.3227+139T>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561469 [benign DISEASE=not provided];			rs2071009	0.4651	0.8077,0.4478,0.5351,0.2971,0.3835	20227,	30206	81262	-0.0860			1.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232043	31232043	-	T	het	off-target;low_conf_region	QUAL=512;DP=117;QD=4.38;AF=0.22;MQM=60;SAP=15;ABP=81;SAR=19;SAF=7	NF1	splice_region&intron	NF1:ENST00000356175.7:splice_region_variant&intron_variant:LOW:intron24/56:c.3198-4dup::,NF1:ENST00000696138.1:splice_region_variant&intron_variant:LOW:intron25/58:c.3243-4dup::,NF1:ENST00000358273.9:splice_region_variant&intron_variant:LOW:intron24/57:c.3198-4dup::,NF1:ENST00000691014.1:splice_region_variant&intron_variant:LOW:intron25/58:c.3228-4dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	803349 [benign DISEASE=Neurofibromatosis, type 1,not specified,not provided];			rs371047262	0.2195	0.2200,0.2068,0.3032,0.2298,0.2301	4358,	11221	70897				3.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232570	31232570	G	C	hom	off-target	QUAL=8278;DP=435;QD=19.03;AF=1.00;MQM=60;SAP=948;ABP=0;SAR=0;SAF=435	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron25/56:c.3315-130G>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron26/58:c.3360-130G>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron25/57:c.3315-130G>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron26/58:c.3345-130G>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561471 [benign DISEASE=not provided];			rs2072131	0.4628	0.8134,0.4475,0.4386,0.2965,0.3746	20122,	30052	81592	-0.0560			1.26			COSV62206709	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232914	31232914	C	A	hom	off-target	QUAL=1030;DP=35;QD=29.43;AF=1.00;MQM=60;SAP=71;ABP=0;SAR=34;SAF=1	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron26/56:c.3496+33C>A::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron27/58:c.3541+33C>A::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron26/57:c.3496+33C>A::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron27/58:c.3526+33C>A::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	257285 [benign DISEASE=Neurofibromatosis, type 1,not specified,not provided];			rs2066736	0.4036	0.6112,0.4258,0.4379,0.2944,0.3725	13847,	33577	90551	0.2040			1.36			COSV62196981	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31236055	31236055	-	TG	hom	off-target;low_conf_region	QUAL=9290;DP=402;QD=23.11;AF=0.91;MQM=60;SAP=505;ABP=0;SAR=37;SAF=327	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron29/56:c.3974+36_3974+37dup::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron30/58:c.4019+36_4019+37dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron29/57:c.3974+36_3974+37dup::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron30/58:c.4004+36_4004+37dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]			(T)n (Simple_repeat)	rs1555615581	0.0012	0.0085,0.0006,0.0006,0.0006,0.0021	0,	63	54165				1.26				0		923	12112	246 / 2314					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31236067	31236067	T	G	hom	off-target;low_conf_region	QUAL=10229;DP=371;QD=27.57;AF=0.99;MQM=60;SAP=508;ABP=0;SAR=38;SAF=331	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron29/56:c.3974+46T>G::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron30/58:c.4019+46T>G::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron29/57:c.3974+46T>G::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron30/58:c.4004+46T>G::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]			(T)n (Simple_repeat)	rs72813695	0.0024	0.0009,0.0018,0.0031,0.0027,0.0029	1,	355	150937	-1.2570			0.72			COSV62193060	0.01		926	12249	271 / 2312					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31336154	31336154	A	C	hom	off-target	QUAL=690;DP=24;QD=28.75;AF=1.00;MQM=60;SAP=55;ABP=0;SAR=0;SAF=24	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron39/56:c.5944-179A>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron40/58:c.5989-179A>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron40/57:c.6007-179A>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron41/58:c.6037-179A>C::,NF1:ENST00000687027.1:intron_variant:MODIFIER:intron4/21:c.163-179A>C::,NF1:ENST00000693617.1:intron_variant:MODIFIER:intron6/23:c.571-179A>C::,NF1:ENST00000684826.1:intron_variant:MODIFIER:intron5/23:c.571-179A>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561473 [benign DISEASE=not provided];			rs10853138	0.8932	0.8327,0.8804,0.8907,0.9186,0.9520	60778,	14177	16239	-0.4210			0.98				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31336607	31336607	-	A	hom	off-target;low_conf_region	QUAL=833;DP=40;QD=20.83;AF=0.78;MQM=60;SAP=47;ABP=0;SAR=28;SAF=3	NF1	splice_region&intron	NF1:ENST00000356175.7:splice_region_variant&intron_variant:LOW:intron40/56:c.6085-17dup::,NF1:ENST00000696138.1:splice_region_variant&intron_variant:LOW:intron41/58:c.6130-17dup::,NF1:ENST00000358273.9:splice_region_variant&intron_variant:LOW:intron41/57:c.6148-17dup::,NF1:ENST00000691014.1:splice_region_variant&intron_variant:LOW:intron42/58:c.6178-17dup::,NF1:ENST00000687027.1:splice_region_variant&intron_variant:LOW:intron5/21:c.304-17dup::,NF1:ENST00000693617.1:splice_region_variant&intron_variant:LOW:intron7/23:c.712-17dup::,NF1:ENST00000684826.1:splice_region_variant&intron_variant:LOW:intron6/23:c.712-17dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	495785 [benign DISEASE=not provided];			rs33925668	0.3420	0.4575,0.3967,0.4152,0.2774,0.2478	9270,	32489	98185				0.15				0.01	20186797,10678181,23460398,27069254	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31343172	31343172	C	G	hom	off-target	QUAL=5223;DP=163;QD=32.04;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=79;SAF=84	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron47/56:c.7126+37C>G::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron48/58:c.7171+37C>G::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron48/57:c.7189+37C>G::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron49/58:c.7219+37C>G::,NF1:ENST00000687027.1:intron_variant:MODIFIER:intron12/21:c.1345+37C>G::,NF1:ENST00000693617.1:intron_variant:MODIFIER:intron14/23:c.1753+37C>G::,NF1:ENST00000684826.1:intron_variant:MODIFIER:intron13/23:c.1753+37C>G::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	257300 [benign DISEASE=Neurofibromatosis, type 1,not specified,not provided];			rs7405740	0.8839	0.8005,0.8775,0.8910,0.9184,0.9520	59658,	15149	17665	-1.4250			1.00				0	25741868,19417008	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22), AK4P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	35101468	35101468	A	G	het	off-target	QUAL=1248;DP=83;QD=15.04;AF=0.57;MQM=60;SAP=7;ABP=6;SAR=28;SAF=19	RAD51D	intron	RAD51D:ENST00000345365.11:intron_variant:MODIFIER:intron8/9:c.739-103T>C::,RAD51D:ENST00000394589.8:intron_variant:MODIFIER:intron9/10:c.739-103T>C::,RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron5/6:c.403-103T>C::,RAD51D:ENST00000590016.5:intron_variant:MODIFIER:intron8/9:c.799-103T>C::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron7/8:c.208-103T>C::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	1269566 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs28363289	0.0786	0.0349,0.0672,0.0484,0.0934,0.1467	579,	10797	140181	0.3060			8.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35106468	35106468	C	T	hom		QUAL=2531;DP=85;QD=29.78;AF=1.00;MQM=60;SAP=46;ABP=0;SAR=63;SAF=22	RAD51D	missense,5'UTR	RAD51D:ENST00000345365.11:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000394589.8:missense_variant:MODERATE:exon7/11:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000335858.11:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:PF08423 [Rad51],RAD51D:ENST00000590016.5:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:PF08423 [Rad51],RAD51D:ENST00000460118.6:5_prime_UTR_variant:MODIFIER:exon5/9:c.-38G>A::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	142159 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 4,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM172631 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=RAD51D];		rs4796033	0.1211	0.0335,0.2171,0.0458,0.1441,0.1443	1452,	15517	133671	1.1790	T(1.00),T(1.00),T(1.00),T(1.00), 	B(0.00),B(0.00),B(0.00),B(0.01), 	14.87	0.13		COSV104653496	0.04	25741868,29458332,21822267,22986143,22652533,23372765,22415235,30591675	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 08.05.2018: AF 15% in gnomAD und ExAC"			RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35106801	35106801	A	G	hom	off-target	QUAL=8936;DP=359;QD=24.89;AF=1.00;MQM=60;SAP=783;ABP=0;SAR=0;SAF=359	RAD51D	intron	RAD51D:ENST00000345365.11:intron_variant:MODIFIER:intron5/9:c.480+187T>C::,RAD51D:ENST00000394589.8:intron_variant:MODIFIER:intron6/10:c.480+187T>C::,RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron2/6:c.145-320T>C::,RAD51D:ENST00000590016.5:intron_variant:MODIFIER:intron5/9:c.540+187T>C::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron4/8:c.-52+187T>C::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	679676 [benign DISEASE=not provided];			rs936656	0.5104	0.5306,0.5997,0.5708,0.4828,0.6207	20012,	37501	74363	-3.7110			0.01				0.01	22652533	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35118530	35118530	G	A	het		QUAL=1656;DP=131;QD=12.64;AF=0.55;MQM=60;SAP=7;ABP=6;SAR=30;SAF=42	RAD51D	synonymous,intron	RAD51D:ENST00000345365.11:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000394589.8:synonymous_variant:LOW:exon4/11:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:ENST00000590016.5:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron2/8:c.-208+581C>T::	regulatory_region_variant:CTCF_binding_site	602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	183785 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 4,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs9901455	0.1558	0.2999,0.1256,0.2267,0.0827,0.0864	2577,	18529	128347	1.6750			17.75			COSV99338663	0.01	25741868,21822267,22986143,22652533,23372765,22415235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80), FNDC8 (inh=n/a oe_syn=0.99 oe_mis=0.91 oe_lof=0.69)
chr17	43051308	43051308	T	A	het	off-target	QUAL=691;DP=62;QD=11.15;AF=0.47;MQM=60;SAP=66;ABP=4;SAR=29;SAF=0	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron19/22:c.5278-191A>T::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron18/21:c.1852-191A>T::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron20/23:c.5341-191A>T::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron19/21:c.1966-191A>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron17/20:c.1840-191A>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron4/7:c.208-191A>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron7/10:c.751-191A>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-1118A>T::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron18/21:c.5137-191A>T::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron19/22:c.1966-191A>T::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209259 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided];			rs8176297	0.3105	0.2323,0.2720,0.3696,0.3319,0.4942	7708,	31784	104810	-1.1500			0.37			COSV58783637	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43067543	43067543	C	T	het	off-target	QUAL=439;DP=32;QD=13.72;AF=0.56;MQM=60;SAP=3;ABP=4;SAR=9;SAF=9	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron16/22:c.5074+65G>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron15/21:c.1648+65G>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron17/23:c.5137+65G>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron16/21:c.1762+65G>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron14/20:c.1636+65G>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-3592G>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron4/10:c.547+65G>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-17353G>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron15/21:c.4933+65G>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron16/22:c.1762+65G>A::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	127126 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Familial cancer of breast,not specified,not provided];		AluSc (SINE/Alu)	rs8176235	0.2472	0.1694,0.2676,0.3720,0.2548,0.4609	5009,	27531	114347	0.1670			3.77			COSV58786515	0	25741868,21989022,26926928	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43067763	43067763	T	C	het	off-target	QUAL=389;DP=35;QD=11.11;AF=0.69;MQM=60;SAP=47;ABP=13;SAR=23;SAF=1	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron15/22:c.4987-68A>G::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron14/21:c.1561-68A>G::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron16/23:c.5050-68A>G::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron15/21:c.1675-68A>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron13/20:c.1549-68A>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-3812A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron3/10:c.460-68A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-17573A>G::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron14/21:c.4846-68A>G::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron15/22:c.1675-68A>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125746 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs8176234	0.3156	0.2337,0.3264,0.3691,0.3313,0.4894	7826,	32001	103347	-2.2540			0.13			COSV58794203	0.01	25741868,17916242,28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43071077	43071077	T	C	het		QUAL=4362;DP=432;QD=10.10;AF=0.47;MQM=60;SAP=269;ABP=6;SAR=181;SAF=23	BRCA1	missense,intron	BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000352993.7:missense_variant:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly:,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:ENST00000468300.5:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000484087.6:missense_variant:MODERATE:exon13/21:c.1399A>G:p.Ser467Gly:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-7126A>G::,BRCA1:ENST00000591534.5:missense_variant:MODERATE:exon3/11:c.310A>G:p.Ser104Gly:,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-20887A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:ENST00000491747.6:missense_variant:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000700182.1:missense_variant:MODERATE:exon14/14:c.1444A>G:p.Ser482Gly:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41827 [benign DISEASE=Breast carcinoma,Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799966	0.3179	0.2370,0.3292,0.3707,0.3322,0.4927	8001,	32288	103636	-0.1940	T(0.11),T(0.11),T(0.12),T(0.12), , ,T(0.20), ,T(0.11),T(0.10), 	B(0.04),B(0.01),B(0.07),B(0.00), , ,B(0.04), ,B(0.04),B(0.02), 	8.64	0.25		COSV58783381	0	25741868,24033266,24728327,21204206,18559551,26901225,30693270,18830263,22703879,29458332,21161372,21597964,22430443,23961350,24062231,27478808,28415599,27698805,31203256,20104584,20807450,25896959,32039725,10728701,12955716,17341484,21702907,21990134,21356067,15617999,23767878,17308087,18694767,28439188,26183948,22921312,21989022,28771511,17916242,24986639,15235020,21890493,29492227,32100578,19482343,24933103,30832521,17585057,22136207,15726418,9333265,9523200,10951344,15689452,25735359,21447777,17719744,23674270,15350310,21765009,18992264,15004537,27008870,26092435,28944232,31131559,22503699,26414677,29657992,31205572,29997359,28672935,25602962,18558292,21504591,33547301,23749302,31706072,32284662,21712546,25923920,28076423,9326340,30765603,25653542,27251275,23186163,25159151,26052455,28781887,32324802,31123752,30541318,27899611,33004033,33499154,34094541,32203205,32606146,34242281,34319543,32424803,33507988,32606887,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43074584	43074584	G	C	het	off-target	QUAL=75;DP=12;QD=6.25;AF=0.42;MQM=60;SAP=14;ABP=4;SAR=5;SAF=0	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-63C>G::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-63C>G::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-63C>G::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-63C>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-63C>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10633C>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-63C>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24394C>G::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-63C>G::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-63C>G::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-63C>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209374 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not specified,not provided];			rs273900734	0.3165	0.2346,0.3294,0.3697,0.3311,0.4930	7936,	32228	103860	0.0020			3.09			COSV58794229	0	25741868,21356067,28944232,28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43074658	43074658	A	T	het	off-target	QUAL=365;DP=35;QD=10.43;AF=0.57;MQM=60;SAP=46;ABP=5;SAR=20;SAF=0	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-137T>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-137T>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-137T>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-137T>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-137T>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10707T>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-137T>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24468T>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-137T>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-137T>A::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-137T>A::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209375 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not specified,not provided];			rs2236762	0.4514	0.6878,0.3762,0.3705,0.3405,0.5222	17260,	34033	83317	-0.5760			0.58			COSV58801011	0	19276285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43074720	43074724	GGGTT	-	het	off-target	QUAL=259;DP=35;QD=7.40;AF=0.54;MQM=60;SAP=44;ABP=4;SAR=19;SAF=0	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-203_4485-199del::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-203_1059-199del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-203_4548-199del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-203_1173-199del::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-203_1047-199del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10773_5-10769del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-203_-43-199del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24534_-98-24530del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-203_4344-199del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-203_1173-199del::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-203_1092-199del::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209376 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided];			rs34250703	0.2992	0.1793,0.3192,0.3668,0.3301,0.4915	7304,	30757	106271	0.9620			4.91				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43079499	43079499	C	T	het	off-target	QUAL=1758;DP=110;QD=15.98;AF=0.58;MQM=60;SAP=3;ABP=9;SAR=32;SAF=32	BRCA1,RPL21P4	intron,non_coding_transcript_exon	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron12/22:c.4358-2885G>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron11/21:c.932-2885G>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron12/23:c.4358-100G>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron12/21:c.1049-2888G>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron10/20:c.923-2888G>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-15548G>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-4978G>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-29309G>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron11/21:c.4217-2885G>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron12/22:c.1049-2888G>A::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron11/13:c.968-2888G>A::,RPL21P4:ENST00000497954.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.198C>T::	regulatory_region_variant:enhancer	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209399 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,not provided];			rs8176193	0.3165	0.2342,0.3290,0.3702,0.3308,0.4932	7928,	32211	103813	0.5280			7.21			COSV58789905	0	26012346,33126731	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43082453	43082453	A	G	het		QUAL=343;DP=34;QD=10.09;AF=0.50;MQM=60;SAP=25;ABP=3;SAR=2;SAF=15	BRCA1	synonymous,intron	BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000352993.7:synonymous_variant:LOW:exon11/22:c.882T>C:p.Ser294=:,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000468300.5:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:ENST00000484087.6:synonymous_variant:LOW:exon10/21:c.873T>C:p.Ser291=:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-18502T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-7932T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-32263T>C::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:ENST00000491747.6:synonymous_variant:LOW:exon12/23:c.999T>C:p.Ser333=:,BRCA1:ENST00000700182.1:synonymous_variant:LOW:exon11/14:c.918T>C:p.Ser306=:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125703 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM1719086 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1060915	0.3008	0.1808,0.3198,0.3691,0.3317,0.4923	7437,	30849	106273	0.1030			3.88	0.06		COSV58783806	0	25741868,24033266,21161372,21597964,19644020,27478808,20807450,19471317,21702907,21356067,23767878,21191178,17916242,24986639,22136207,26092435,28944232,22503699,29997359,31934565,28076423,31658756,33004033,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43091173	43091173	T	G	het	off-target	QUAL=110;DP=16;QD=6.88;AF=0.44;MQM=60;SAP=18;ABP=4;SAR=7;SAF=0	BRCA1	intron,3'UTR	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron10/22:c.4097-141A>C::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-141A>C::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron10/23:c.4097-141A>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-141A>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.665-141A>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-27222A>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-16652A>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+34098A>C::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron9/21:c.3956-141A>C::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-141A>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.707-141A>C::,BRCA1:ENST00000354071.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*158A>C::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125674 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Familial cancer of breast,not specified,not provided];			rs799916	0.4511	0.6860,0.3756,0.3700,0.3412,0.5235	17223,	34091	83389	-2.5950			0.01			COSV58794250	0	30594178,12466288,17916242,33507988,35087763	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43091983	43091983	T	C	het		QUAL=4694;DP=350;QD=13.41;AF=0.49;MQM=60;SAP=4;ABP=3;SAR=91;SAF=81	BRCA1	missense,intron	BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-951A>G::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.665-951A>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28032A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17462A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+33288A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-951A>G::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.707-951A>G::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.3548A>G:p.Lys1183Arg:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41818 [benign DISEASE=Breast carcinoma,Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1];		rs16942	0.3155	0.2325,0.3278,0.3698,0.3301,0.4938	7887,	32152	103998	-0.3190	T(1.00), ,T(1.00), , , , , ,T(1.00), , ,T(1.00)	B(0.00), ,B(0.00), , , , , ,B(0.00), , ,B(0.00)	1.10	0.07		COSV58784397	0	25741868,24728327,21204206,18830263,26012346,22703879,29458332,30594178,26559640,21161372,21597964,19644020,22430443,23961350,25178586,27478808,28415599,27698805,31203256,20104584,20807450,32039725,21702907,21990134,12872265,18694767,28439188,21766209,21708019,21890493,16026807,20233625,23313170,19482343,22136207,23674270,15923272,25802882,30075112,24052750,28944232,31131559,22503699,26052370,26414677,29997359,28672935,25602962,27273131,21504591,25923920,29785135,28076423,25653542,26052455,24244370,32324802,31123752,33004033,33126731,33499154,33875706,34094541,25771414,33240400,32606146,33462484,32459809,33407290,31962039,34608183	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092418	43092418	T	C	het		QUAL=10833;DP=980;QD=11.05;AF=0.49;MQM=60;SAP=4;ABP=5;SAR=231;SAF=246	BRCA1	missense,intron	BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1386A>G::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.665-1386A>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28467A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17897A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32853A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-1386A>G::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.707-1386A>G::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.3113A>G:p.Glu1038Gly:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41815 [benign DISEASE=Breast carcinoma,Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1];		rs16941	0.3003	0.1803,0.3189,0.3692,0.3313,0.4927	7401,	30781	106209	-0.1490	T(0.16), ,T(0.17), , , , , ,T(0.15), , ,T(0.06)	P(0.61), ,B(0.00), , , , , ,P(0.61), , ,B(0.12)	14.07	0.23		COSV58786412	0	25741868,24033266,24728327,18974781,18559551,18830263,22703879,29458332,21161372,19644020,22430443,23961350,27478808,28415599,27698805,31203256,20104584,20807450,24504028,32039725,12955716,21702907,21990134,23633455,12872265,23767878,22875147,18694767,24986639,9063749,12188064,15235020,20352487,21708019,21890493,24599715,29492227,32100578,23313170,19482343,23619945,22136207,17719744,23674270,15923272,30075112,24052750,28944232,31131559,29099791,22503699,19012493,29921024,26414677,29997359,28672935,25602962,27273131,18558292,32284662,29233532,25923920,30266954,29785135,28076423,25653542,26052455,21720365,27908594,30541318,33004033,33499154,33875706,34094541,33240400,34295994,32606146,32351891,33946592,32606887,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092648	43092648	G	A	het	mosaic	QUAL=0;DP=367;QD=0.00;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	BRCA1	synonymous,intron	BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2883C>T:p.Asn961=:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1616C>T::,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2883C>T:p.Asn961=:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-1616C>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.665-1616C>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28697C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18127C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32623C>T::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.2742C>T:p.Asn914=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-1616C>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.707-1616C>T::,BRCA1:ENST00000354071.7:synonymous_variant:LOW:exon10/10:c.2883C>T:p.Asn961=:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	184402 [likely benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs201190540	0.0000	0.0002,0.0000,0.0000,0.0000,0.0000	0,	6	151994	-0.6420			0.13				0	24607278,16267036	0	0	0 / 0					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092919	43092919	G	A	het		QUAL=2121;DP=130;QD=16.32;AF=0.58;MQM=60;SAP=9;ABP=11;SAR=45;SAF=31	BRCA1	missense,intron	BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1887C>T::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1825C>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28968C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18398C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32352C>T::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1825C>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1825C>T::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.2612C>T:p.Pro871Leu:	regulatory_region_variant:open_chromatin_region	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41812 [benign DISEASE=Breast carcinoma,Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1];		rs799917	0.4871	0.8104,0.3901,0.3707,0.3407,0.5238	21221,	31573	77941	4.2470	T(1.00), ,T(1.00), , , , , ,T(1.00), , ,T(1.00)	B(0.00), ,B(0.00), , , , , ,B(0.00), , ,B(0.00)	17.66	0.14		COSV58784386	0.01	25741868,23554684,23614619,28698656,24728327,25114582,20332227,20003265,18937358,21204206,18559551,23973201,26263974,18830263,22703879,22778704,29458332,27859935,19276285,21161372,21597964,29963112,19644020,22430443,23961350,24062231,25178586,27478808,28415599,29209986,27698805,31203256,20104584,20807450,19471317,10923033,25896959,32039725,21702907,21990134,28678827,16111488,18694767,24756092,20843204,27073502,17916242,24986639,21708019,21890493,29492227,15743496,19482343,19484476,23293655,23619945,23749772,24933103,25266802,28744749,30820179,30832521,22136207,23996866,17719744,23674270,29582646,25652403,15923272,26092435,30075112,24052750,25759599,28944232,23964347,31131559,29099791,22503699,30322005,30531820,22035854,29921024,26414677,16381944,31938277,14681474,29997359,28672935,26180747,23555923,25602962,27273131,30536617,27572852,31706072,27983536,25923920,29785135,28076423,25653542,26052455,24244370,31658756,30541318,32284927,33499154,21286719,27221928,34008499,34094541,33240400,34295994,32606146,2685001	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43093220	43093220	A	G	het		QUAL=1538;DP=127;QD=12.11;AF=0.46;MQM=60;SAP=3;ABP=5;SAR=28;SAF=30	BRCA1	synonymous,intron	BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-2188T>C::,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1524T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-29269T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18699T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32051T>C::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1524T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1524T>C::,BRCA1:ENST00000354071.7:synonymous_variant:LOW:exon10/10:c.2311T>C:p.Leu771=:	regulatory_region_variant:open_chromatin_region	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125554 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM1719261 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs16940	0.2995	0.1801,0.3192,0.3686,0.3295,0.4929	7352,	30778	106374	-0.4420			3.67			COSV58786443	0	25741868,17697348,18830263,19276285,21161372,21597964,19644020,22430443,25178586,27478808,20104584,20807450,21702907,23767878,21989022,24986639,15923272,26092435,30075112,28944232,31131559,29997359,27273131,32284662,28076423,33004033,34295994,33534415,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43093449	43093449	G	A	het		QUAL=464;DP=62;QD=7.48;AF=0.44;MQM=60;SAP=62;ABP=5;SAR=0;SAF=27	BRCA1	synonymous,intron	BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.670+2397C>T::,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1295C>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-29498C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18928C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+31822C>T::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1295C>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1295C>T::,BRCA1:ENST00000354071.7:synonymous_variant:LOW:exon10/10:c.2082C>T:p.Ser694=:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125536 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM1719085 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799949	0.3157	0.2331,0.3281,0.3699,0.3302,0.4938	7893,	32165	103943	-0.0010			2.62			COSV58784419	0	25741868,24033266,19276285,21161372,19644020,27478808,20104584,20807450,12955716,21702907,22713736,28439188,21989022,24986639,16760288,15923272,25633036,30075112,24052750,28944232,29773799,26414677,29997359,27273131,28076423,34203389,33004033,33499154,33462484,32557794,31962039,29848177	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43097077	43097077	A	G	het	off-target	QUAL=459;DP=43;QD=10.67;AF=0.56;MQM=60;SAP=55;ABP=4;SAR=0;SAF=24	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron8/21:c.593+167T>C::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron8/23:c.593+167T>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron8/21:c.593+167T>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.548-2217T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+28105T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-22556T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+28194T>C::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron7/21:c.452+167T>C::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron7/13:c.512+167T>C::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron8/9:c.593+167T>C::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209451 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided];		L1PREC2 (LINE/L1)	rs8176145	0.3154	0.2324,0.3280,0.3693,0.3301,0.4934	7886,	32140	103990	-0.7490			1.10				0	17916242	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43097347	43097347	A	-	het	off-target	QUAL=543;DP=70;QD=7.76;AF=0.39;MQM=60;SAP=13;ABP=11;SAR=19;SAF=8	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron7/23:c.548-58del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.547+2428del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+27835del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-22826del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+27924del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron6/21:c.407-58del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron6/13:c.467-58del::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron7/9:c.548-58del::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125889 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,not specified,not provided];	CD1727436 [CLASS=DM? MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=BRCA1];		rs8176144	0.2998	0.1804,0.3191,0.3691,0.3297,0.4923	7387,	30764	106350	0.8980			12.13				0	25741868,21989022	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43099629	43099629	T	A	het	off-target	QUAL=2604;DP=242;QD=10.76;AF=0.54;MQM=60;SAP=285;ABP=6;SAR=0;SAF=130	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron7/21:c.547+146A>T::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron7/23:c.547+146A>T::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron7/21:c.547+146A>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.547+146A>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+25553A>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-25108A>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+25642A>T::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron6/21:c.406+146A>T::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron6/13:c.466+146A>T::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron7/9:c.547+146A>T::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125879 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided];		L2d (LINE/L2)	rs8176140	0.3155	0.2325,0.3282,0.3706,0.3301,0.4934	7889,	32127	103943	1.2360			16.67				0	28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43124230	43124230	A	G	het	off-target	QUAL=388;DP=43;QD=9.02;AF=0.49;MQM=60;SAP=49;ABP=3;SAR=21;SAF=0	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron1/21:c.-19-115T>C::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron1/23:c.-19-115T>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron1/21:c.-19-115T>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron1/20:c.-19-115T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+952T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-44+1041T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+1041T>C::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron1/21:c.-106-115T>C::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron1/13:c.-19-115T>C::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron1/9:c.-19-115T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125468 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not specified,not provided];			rs3765640	0.3165	0.2330,0.3303,0.3698,0.3318,0.4930	7943,	32212	103864	-0.1120			4.51			COSV58789216	0.01	28439188,21766209,29997359,34287479,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), NBR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	58692526	58692526	G	A	het	off-target	QUAL=228;DP=23;QD=9.91;AF=0.52;MQM=60;SAP=29;ABP=3;SAR=0;SAF=12	TEX14,IGBP1P2,RAD51C	upstream_gene	TEX14:ENST00000349033.10:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000389934.7:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000240361.12:upstream_gene_variant:MODIFIER::::,IGBP1P2:ENST00000583666.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000583539.5:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000461271.6:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697686.1:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697690.1:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000337432.9:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000421782.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697694.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	605792_[GENE=TEX14_PHENOS=Spermatogenic failure 23, 617707 (3), Autosomal recessive]&602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	1250767 [benign DISEASE=not provided];			rs16943176	0.1847	0.1367,0.1765,0.1760,0.2115,0.1385	2772,	22548	124026	0.8640			8.86					25343521,31905201,21980511,26406419,29659014,22843497	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TEX14 (inh=AR oe_syn=0.96 oe_mis=1.04 oe_lof=0.78), IGBP1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	58692618	58692618	C	T	het	off-target	QUAL=11283;DP=974;QD=11.58;AF=0.47;MQM=60;SAP=5;ABP=12;SAR=217;SAF=238	RAD51C	5'UTR	RAD51C:ENST00000583539.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-26C>T::,RAD51C:ENST00000461271.6:5_prime_UTR_variant:MODIFIER:exon1/8:c.-274C>T::,RAD51C:ENST00000697686.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-221C>T::,RAD51C:ENST00000697690.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-26C>T::,RAD51C:ENST00000337432.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-26C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	605792_[GENE=TEX14_PHENOS=Spermatogenic failure 23, 617707 (3), Autosomal recessive]&602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	324173 [benign/likely benign DISEASE=Fanconi anemia,not specified,Breast and Ovarian Cancer Susceptibility,not provided];			rs12946397	0.1846	0.1368,0.1763,0.1763,0.2115,0.1385	2765,	22550	124018	-3.2430			1.61			COSV53625930	0.03	29879995,25343521,31905201,21980511,26406419,22843497	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TEX14 (inh=AR oe_syn=0.96 oe_mis=1.04 oe_lof=0.78), IGBP1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	58720846	58720846	T	C	het	off-target	QUAL=203;DP=27;QD=7.52;AF=0.44;MQM=60;SAP=29;ABP=4;SAR=12;SAF=0	RAD51C	intron	RAD51C:ENST00000583539.5:intron_variant:MODIFIER:intron6/7:c.904+34T>C::,RAD51C:ENST00000461271.6:intron_variant:MODIFIER:intron6/7:c.553+34T>C::,RAD51C:ENST00000697686.1:intron_variant:MODIFIER:intron6/9:c.553+34T>C::,RAD51C:ENST00000697690.1:intron_variant:MODIFIER:intron6/6:c.904+34T>C::,RAD51C:ENST00000337432.9:intron_variant:MODIFIER:intron6/8:c.904+34T>C::,RAD51C:ENST00000697694.1:intron_variant:MODIFIER:intron6/8:c.553+34T>C::		602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	1275824 [benign DISEASE=Fanconi anemia complementation group O,not specified,not provided];			rs28363318	0.2973	0.2705,0.2613,0.0023,0.3451,0.1796	7194,	30813	106825	0.2890			5.35				0	29879995,26406419,21392410	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	60656452	60656452	-	A	het	off-target	QUAL=10;DP=232;QD=0.04;AF=0.10;MQM=60;SAP=55;ABP=320;SAR=0;SAF=24	PPM1D	intron	PPM1D:ENST00000305921.8:intron_variant:MODIFIER:intron4/5:c.1018-134dup::,PPM1D:ENST00000629650.3:intron_variant:MODIFIER:intron4/4:c.1018-134dup::	regulatory_region_variant:CTCF_binding_site	605100_[GENE=PPM1D_PHENOS=Breast cancer, somatic, 114480 (3); Jansen de Vries syndrome, 617450 (3), Autosomal dominant]	1179594 [benign DISEASE=not provided];		AluYh3 (SINE/Alu)	rs375982628	0.0424	0.0678,0.0367,0.0042,0.0293,0.0825	46,	3304	76652				0.78				0		0	12	0 / 3					PPM1D (inh=AD oe_syn=0.86 oe_mis=0.59 oe_lof=0.75)
chr17	61683138	61683138	A	G	hom	off-target	QUAL=250;DP=10;QD=25.00;AF=1.00;MQM=60;SAP=25;ABP=0;SAR=0;SAF=10	BRIP1	3'UTR	BRIP1:ENST00000682755.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*158T>C::,BRIP1:ENST00000259008.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*158T>C::,BRIP1:ENST00000683039.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*158T>C::,BRIP1:ENST00000682453.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*158T>C::,BRIP1:ENST00000682989.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*999T>C::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	324344 [benign DISEASE=Fanconi anemia complementation group J,not provided];		AluSg (SINE/Alu)	rs1978111	0.6062	0.6558,0.7342,0.7203,0.5830,0.4585	28511,	34993	59771	0.4260			0.73				0	19935797	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61683635	61683635	A	G	hom		QUAL=7636;DP=310;QD=24.63;AF=1.00;MQM=60;SAP=676;ABP=0;SAR=0;SAF=310	BRIP1	synonymous,3'UTR	BRIP1:ENST00000682755.1:synonymous_variant:LOW:exon18/18:c.3189T>C:p.Tyr1063=:,BRIP1:ENST00000259008.7:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000683039.1:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000682453.1:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000682989.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*502T>C::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183702 [benign DISEASE=Neoplasm of ovary,Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs4986763	0.6048	0.6515,0.7339,0.7205,0.5829,0.4578	28379,	35117	60025	3.2750			8.10			COSV51995377	0	25741868,24033266,27415837,28415781,19276285,21356067,19935797,23473757,23644138,20693321,28968953,26790966,29138235,31214711,24301948,27542272	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61685753	61685753	A	T	het	off-target	QUAL=391;DP=22;QD=17.77;AF=0.73;MQM=60;SAP=3;ABP=13;SAR=8;SAF=8	BRIP1	intron,3'UTR	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron17/17:c.2683+83T>A::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron19/19:c.2905+83T>A::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron20/20:c.2905+83T>A::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron20/20:c.2905+83T>A::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1613T>A::,BRIP1:ENST00000577598.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3T>A::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1275841 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,not provided];			rs4988357	0.3387	0.3527,0.2994,0.4894,0.3481,0.2627	8931,	33612	100508	3.8370			18.52			COSV51997887	0	19935797	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61685986	61685986	A	G	hom		QUAL=373;DP=12;QD=31.08;AF=1.00;MQM=60;SAP=6;ABP=0;SAR=8;SAF=4	BRIP1	missense,intron	BRIP1:ENST00000682755.1:missense_variant:MODERATE:exon17/18:c.2533T>C:p.Ser845Pro:,BRIP1:ENST00000259008.7:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000683039.1:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000682453.1:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1846T>C::,BRIP1:ENST00000577598.5:missense_variant:MODERATE:exon18/18:c.2755T>C:p.Ser919Pro:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	133756 [benign DISEASE=Neoplasm of ovary,Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs4986764	0.6118	0.6719,0.7387,0.7203,0.5836,0.4584	29042,	34774	58932	0.2010	T(0.35),T(0.94),T(0.94),T(0.94), ,T(0.43)	B(0.01),B(0.00),B(0.00),B(0.00), ,B(0.00)	3.59	0.09		COSV51995396,COSV99369284	0.01	25741868,24033266,24728327,20150366,26901225,28415781,29458332,19276285,15113441,19138047,21356067,23318652,19935797,23473757,23644138,29466248,28968953,19127258,26921362,26790966,19012493,29138235,17504528,24137204,31214711,25653542,29221171,24301948,32894086,33240400,33928715,34050209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61686104	61686104	T	C	hom		QUAL=3671;DP=114;QD=32.20;AF=1.00;MQM=60;SAP=107;ABP=0;SAR=20;SAF=94	BRIP1	synonymous,intron	BRIP1:ENST00000682755.1:synonymous_variant:LOW:exon17/18:c.2415A>G:p.Glu805=:,BRIP1:ENST00000259008.7:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:,BRIP1:ENST00000683039.1:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:,BRIP1:ENST00000682453.1:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1964A>G::,BRIP1:ENST00000577598.5:synonymous_variant:LOW:exon18/18:c.2637A>G:p.Glu879=:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183703 [benign DISEASE=Neoplasm of ovary,Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs4986765	0.7421	0.9037,0.8305,0.8929,0.6565,0.7184	43144,	26462	39178	-0.1910			6.68				0	25741868,24033266,19276285,21356067,17342202,19935797,28968953,26790966,29138235,31214711,32708070,27542272,25592580	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61742809	61742809	C	A	het	off-target	QUAL=39;DP=6;QD=6.50;AF=0.50;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron14/17:c.2157+204G>T::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron16/19:c.2379+204G>T::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron17/20:c.2379+204G>T::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron17/20:c.2379+204G>T::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron16/18:c.2379+204G>T::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron15/17:c.2379+204G>T::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron16/16:c.2379+204G>T::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron17/17:c.2439+204G>T::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	679668 [benign DISEASE=not provided];		Tigger1 (DNA/TcMar-Tigger)	rs12937232	0.7716	0.8332,0.5785,0.7819,0.7654,0.8064	45847,	25598	34728	-0.4190			7.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61780239	61780239	A	-	het	off-target	QUAL=16;DP=26;QD=0.62;AF=0.23;MQM=60;SAP=3;ABP=19;SAR=3;SAF=3	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron11/17:c.1713+22del::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron13/19:c.1935+22del::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron14/20:c.1935+22del::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron14/20:c.1935+22del::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron13/18:c.1935+22del::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron12/17:c.1935+22del::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron13/16:c.1935+22del::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron13/17:c.1935+22del::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]				rs74268880	0.0005	0.0011,0.0004,0.0000,0.0001,0.0014	0,	69	136481	-0.7990			0.19				0.05		0	46	0 / 27					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61780448	61780448	C	G	het	off-target	QUAL=183;DP=14;QD=13.07;AF=0.64;MQM=60;SAP=23;ABP=5;SAR=0;SAF=9	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron10/17:c.1573-47G>C::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron12/19:c.1795-47G>C::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron13/20:c.1795-47G>C::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron13/20:c.1795-47G>C::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron12/18:c.1795-47G>C::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron11/17:c.1795-47G>C::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron12/16:c.1795-47G>C::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron12/17:c.1795-47G>C::	regulatory_region_variant:TF_binding_site	605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	262005 [benign DISEASE=not specified,not provided];		AluJb (SINE/Alu)	rs4988351	0.7777	0.8537,0.6327,0.8204,0.7563,0.7969	46452,	25274	33774	0.1520			3.79			COSV51993354	0.02	25741868,26790966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61799424	61799425	AG	-	hom	off-target	QUAL=290;DP=12;QD=24.17;AF=1.00;MQM=60;SAP=29;ABP=0;SAR=12;SAF=0	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron6/17:c.919-126_919-125del::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron8/19:c.1141-126_1141-125del::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron9/20:c.1141-126_1141-125del::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron9/20:c.1141-126_1141-125del::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron8/18:c.1141-126_1141-125del::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron7/17:c.1141-126_1141-125del::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron8/16:c.1141-126_1141-125del::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron8/17:c.1141-126_1141-125del::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	676467 [benign DISEASE=not provided];			rs5821340	0.9889	0.9607,0.9974,1.0000,0.9999,0.9998	74409,	1623	1687	0.0000			1.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61801161	61801161	-	A	het	off-target	QUAL=117;DP=16;QD=7.31;AF=0.50;MQM=60;SAP=20;ABP=3;SAR=8;SAF=0	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron6/17:c.919-1863dup::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron8/19:c.1140+91dup::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron9/20:c.1140+91dup::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron9/20:c.1140+91dup::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron8/18:c.1140+91dup::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron7/17:c.1140+91dup::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron8/16:c.1140+91dup::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron8/17:c.1140+91dup::	regulatory_region_variant:open_chromatin_region	605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1282406 [benign DISEASE=not provided];			rs11390869	0.7919	0.8956,0.6343,0.8196,0.7595,0.7853	48201,	23729	31565				3.00				0	26790966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	2	"[2] auto-classification 20.11.2017  "			BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr18	22415790	22415790	T	C	hom		QUAL=464;DP=19;QD=24.42;AF=1.00;MQM=60;SAP=44;ABP=0;SAR=0;SAF=19	CTAGE1	synonymous	CTAGE1:ENST00000391403.4:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:						rs9946145	0.7540	0.3723,0.8476,0.8215,0.9139,0.8008	47659,	19283	37391	-0.4070			0.74			COSV66942792	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a), ATP7BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	22416048	22416048	G	A	het		QUAL=1512;DP=133;QD=11.37;AF=0.46;MQM=60;SAP=5;ABP=5;SAR=34;SAF=27	CTAGE1	synonymous	CTAGE1:ENST00000391403.4:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:						rs7227477	0.4919	0.4736,0.5744,0.6137,0.4761,0.4424	18446,	37818	77172	0.4950			0.33			COSV66942794	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a), ATP7BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	22975256	22975256	T	C	hom	off-target	QUAL=2177;DP=70;QD=31.10;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=38;SAF=32	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron6/17:c.428+37T>C::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron6/18:c.428+37T>C::	regulatory_region_variant:enhancer	604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673936 [benign DISEASE=Jawad syndrome,Seckel syndrome 2,not provided];			rs2336916	0.9442	0.8574,0.9684,0.9177,0.9844,0.9325	68038,	7509	8487	-1.1550			0.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22982555	22982555	G	A	hom	off-target	QUAL=212;DP=8;QD=26.50;AF=1.00;MQM=60;SAP=20;ABP=0;SAR=8;SAF=0	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron7/18:c.604+162G>A::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron7/18:c.604+162G>A::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron7/17:c.604+162G>A::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron7/18:c.604+162G>A::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	669107 [benign DISEASE=not provided];			rs7407415	0.9980	0.9929,0.9994,1.0000,1.0000,0.9996	75809,	305	309	-0.2960			0.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22984838	22984840	TCA	-	het	off-target;low_conf_region	QUAL=362;DP=32;QD=11.31;AF=0.47;MQM=60;SAP=3;ABP=3;SAR=7;SAF=8	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	1263878 [benign DISEASE=Jawad syndrome,Seckel syndrome 2,not provided];			rs3052770	0.5056	0.2243,0.5652,0.4697,0.6386,0.5465	21813,	32989	74915	-0.3020			0.33				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22996218	22996218	G	T	het	off-target	QUAL=79;DP=5;QD=15.80;AF=0.80;MQM=60;SAP=12;ABP=7;SAR=0;SAF=4	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron12/17:c.1940-156G>T::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673956 [benign DISEASE=not provided];		L1MB8 (LINE/L1)	rs4471804	0.5113	0.8383,0.4409,0.5226,0.3613,0.4522	23119,	31438	74254	-0.6430			1.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22997493	22997493	T	A	het	off-target	QUAL=118;DP=18;QD=6.56;AF=0.44;MQM=60;SAP=20;ABP=3;SAR=0;SAF=8	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron13/17:c.2029-127T>A::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673333 [benign DISEASE=not provided];			rs2305886	0.4888	0.1620,0.5596,0.4728,0.6389,0.5481	21426,	31424	77680	-0.2240			1.11				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	23006282	23006282	C	T	het	off-target	QUAL=7076;DP=529;QD=13.38;AF=0.53;MQM=60;SAP=3;ABP=7;SAR=139;SAF=141	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron15/18:c.2288-81C>T::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron15/18:c.2288-81C>T::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron15/17:c.2288-81C>T::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron15/18:c.2303-81C>T::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673981 [benign DISEASE=not provided];			rs72889626	0.1775	0.0541,0.2566,0.3930,0.2037,0.1939	3064,	20796	124756	-3.4810			0.00				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54), RN7SL745P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	23006519	23006519	A	T	het	off-target	QUAL=29;DP=16;QD=1.81;AF=0.25;MQM=60;SAP=3;ABP=12;SAR=2;SAF=2	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron16/18:c.2357+87A>T::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron16/18:c.2357+87A>T::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron16/17:c.2357+87A>T::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron16/18:c.2372+87A>T::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]			AluJb (SINE/Alu)							-0.6550			0.70				0		0	0	0 / 0					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54), RN7SL745P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	51046899	51046899	T	-	het	off-target;low_conf_region	QUAL=44;DP=42;QD=1.05;AF=0.19;MQM=60;SAP=20;ABP=38;SAR=0;SAF=8	SMAD4	splice_region&intron	SMAD4:ENST00000398417.6:splice_region_variant&intron_variant:LOW:intron1/11:c.-127-10del::,SMAD4:ENST00000342988.8:splice_region_variant&intron_variant:LOW:intron1/11:c.-127-10del::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]			(T)n (Simple_repeat)	rs745430558	0.0019	0.0034,0.0017,0.0032,0.0010,0.0007	0,	275	143405	-0.4070			0.53				0		0	109	0 / 10					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr18	51058485	51058485	-	T	het	off-target;low_conf_region	QUAL=2171;DP=215;QD=10.10;AF=0.16;MQM=60;SAP=4;ABP=215;SAR=16;SAF=19	SMAD4	intron	SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3508dup::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]	492739 [benign DISEASE=not specified,not provided];			rs386387676	0.0315	0.0692,0.0214,0.0639,0.0141,0.0081	105,	3792	123234				12.61			COSV61689656	0		0	137	0 / 17					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr18	51058485	51058485	-	TT	het	off-target;low_conf_region	QUAL=2171;DP=215;QD=10.10;AF=0.38;MQM=60;SAP=11;ABP=31;SAR=32;SAF=49	SMAD4	intron	SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3507_667+3508dup::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]	1227283 [benign DISEASE=not provided];			rs386387676	0.3348	0.2054,0.3607,0.4087,0.3925,0.2367	7119,	28217	84343				12.56			COSV61689656	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr19	17268649	17268649	G	A	het	off-target	QUAL=34;DP=14;QD=2.43;AF=0.29;MQM=60;SAP=12;ABP=9;SAR=0;SAF=4	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron1/5:c.-13-145G>A::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron1/8:c.-51-107G>A::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron1/8:c.-13-145G>A::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron1/8:c.-13-145G>A::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron1/5:c.-51-107G>A::	regulatory_region_variant:promoter				AluSp (SINE/Alu)	rs2004800	0.1115	0.0668,0.1991,0.5118,0.0939,0.1609	1555,	13831	134947	-0.2070			1.62			COSV53102212	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17268749	17268749	C	T	het	off-target	QUAL=1316;DP=109;QD=12.07;AF=0.48;MQM=60;SAP=6;ABP=4;SAR=30;SAF=22	BABAM1	intron,splice_region&intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron1/5:c.-13-45C>T::,BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::	regulatory_region_variant:promoter		1227766 [benign DISEASE=not provided];	CS1518199 [CLASS=DFP MUT=ALT PHEN="Breast cancer association with" GENE=BABAM1];		rs10424178	0.2250	0.3449,0.1383,0.0017,0.1993,0.1116	4469,	25223	117675	-0.3220			4.16		1.98>3.28		0.25	26472073,21431873,23805179,32601453	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17271696	17271696	A	T	het	off-target	QUAL=331;DP=49;QD=6.76;AF=0.37;MQM=60;SAP=3;ABP=10;SAR=10;SAF=8	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.344+41A>T::						rs10420922	0.4940	0.6757,0.3799,0.3189,0.4363,0.3664	19690,	35631	76827	-0.5940			0.97			COSV63921517	0	19572197,21431873	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17273842	17273842	C	T	het	off-target	QUAL=201;DP=20;QD=10.05;AF=0.45;MQM=60;SAP=5;ABP=3;SAR=6;SAF=3	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.344+2187C>T::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.344+2187C>T::					AluSg7 (SINE/Alu)	rs113272353	0.1710	0.1832,0.1069,0.0019,0.1869,0.1063	2390,	21179	125827	-0.8570			0.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17276367	17276367	A	G	het	off-target	QUAL=1376;DP=96;QD=14.33;AF=0.54;MQM=60;SAP=3;ABP=4;SAR=26;SAF=26	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.345-128A>G::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.345-128A>G::						rs34084277	0.1709	0.1829,0.1068,0.0015,0.1869,0.1058	2381,	21186	125932	-0.1090			8.99				0.03	26231170,28115406,29531215,28362817,28472234	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17276445	17276445	G	A	het	off-target	QUAL=1378;DP=101;QD=13.64;AF=0.52;MQM=60;SAP=3;ABP=4;SAR=26;SAF=27	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.345-50G>A::						rs61634114	0.1596	0.1436,0.1025,0.0015,0.1869,0.1068	2114,	20019	127675	0.6530			5.51				0.23	21431873	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17278839	17278839	C	T	het		QUAL=1232;DP=108;QD=11.41;AF=0.47;MQM=60;SAP=3;ABP=4;SAR=26;SAF=25	BABAM1	splice_region&intron	BABAM1:ENST00000447614.6:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000598188.6:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000601043.5:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::	regulatory_region_variant:enhancer					rs10406920	0.1716	0.1851,0.1067,0.0015,0.1870,0.1076	2411,	21270	125970	0.7980			1.96		8.04>7.99	COSV63921267	0.01	26848770,28115406,19572197,21431873,23805179,32601453	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr19	17278895	17278895	G	A	het		QUAL=6312;DP=539;QD=11.71;AF=0.47;MQM=60;SAP=3;ABP=7;SAR=127;SAF=126	BABAM1	synonymous	BABAM1:ENST00000447614.6:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:ENST00000359435.8:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000598188.6:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000601043.5:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000595632.5:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:	regulatory_region_variant:enhancer			CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1];		rs8170	0.1735	0.1914,0.1079,0.0015,0.1871,0.1072	2466,	21454	125702	3.0590			10.27			COSV63920809	0.05	23535729,23535825,23593120,24025454,24359602,24771903,24941967,26472073,26510858,27392074,22331459,23536562,27117709,27825120,27471560,26884359,21844186,22357627,23136140,24895409,25057183,25253900,25255808,25611573,26070784,31125336,20852633,23555315,28935272,26231170,24244489,20456938,22235027,22253144,24886216,25173882,21799032,26848770,24510657,18650832,25227710,26747452,27814745,28115406,23535730,29844822,23756864,20852631,29150481,21774837,27848153,27601076,22351618,23011509,19572197,21431873,23544013,29531215,23423317,29316957,22794196,23462924,28362817,28098224,27931260,27432226,25581431,28957321,26052370,25919761,22575968,27698005,25751625,23535733,24495414,23805179,23292081,31258768,25342391,23761956,23544012,31379942,24325915,22357538,24852375,28559747,25717406,33125686,29915430,26209509,32724790,27279675,32823908,32793750,32601453,25673085,29880983,24528085,32128252,33372680,35087569	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr20	14186437	14186437	T	C	hom	off-target	QUAL=444;DP=17;QD=26.12;AF=1.00;MQM=60;SAP=40;ABP=0;SAR=0;SAF=17	MACROD2	intron	MACROD2:ENST00000217246.8:intron_variant:MODIFIER:intron3/16:c.271+100709T>C::,MACROD2:ENST00000684519.1:intron_variant:MODIFIER:intron3/17:c.271+100709T>C::,MACROD2:ENST00000642719.1:intron_variant:MODIFIER:intron3/17:c.271+100709T>C::					L1PA16 (LINE/L1)	rs6042572	0.9525	0.9341,0.9672,0.9886,0.9521,0.9533	69018,	6857	7231	-0.6830			1.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=AD oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	14186637	14186637	A	G	hom		QUAL=905;DP=31;QD=29.19;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=17;SAF=14	MACROD2	intron	MACROD2:ENST00000217246.8:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::,MACROD2:ENST00000684519.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:ENST00000642719.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::					L1PA16 (LINE/L1)	rs6074704	0.5259	0.2962,0.5767,0.5451,0.6246,0.5667	22712,	34479	72029	-0.5390			9.31				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=AD oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	49684453	49684453	C	T	hom	off-target	QUAL=479;DP=20;QD=23.95;AF=1.00;MQM=60;SAP=46;ABP=0;SAR=0;SAF=20	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27751G>A::					AluY (SINE/Alu)	rs6019972	0.8094	0.8391,0.7592,0.8253,0.8017,0.8720	49762,	23193	28893	-2.1980			0.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
chr20	49684609	49684609	G	A	hom		QUAL=39631;DP=1210;QD=32.75;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=587;SAF=619	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::						rs6512586	0.4901	0.3877,0.4664,0.3880,0.5486,0.6496	18677,	36996	77340	-0.9890			0.26			COSV65493865	0	19956101,33230300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
chr22	28734312	28734312	C	T	het	off-target	QUAL=1766;DP=108;QD=16.35;AF=0.58;MQM=60;SAP=13;ABP=10;SAR=23;SAF=40	CHEK2	intron	CHEK2:ENST00000402731.6:intron_variant:MODIFIER:intron1/12:c.319+91G>A::,CHEK2:ENST00000425190.7:intron_variant:MODIFIER:intron1/13:c.-345+7457G>A::,CHEK2:ENST00000404276.6:intron_variant:MODIFIER:intron2/14:c.319+91G>A::,CHEK2:ENST00000348295.7:intron_variant:MODIFIER:intron2/13:c.319+91G>A::,CHEK2:ENST00000649563.1:intron_variant:MODIFIER:intron1/11:c.-72+7457G>A::,CHEK2:ENST00000405598.5:intron_variant:MODIFIER:intron3/15:c.319+91G>A::,CHEK2:ENST00000382580.6:intron_variant:MODIFIER:intron2/15:c.319+91G>A::,CHEK2:ENST00000650281.1:intron_variant:MODIFIER:intron3/15:c.319+91G>A::,CHEK2:ENST00000403642.5:intron_variant:MODIFIER:intron1/11:c.319+91G>A::		604373_[GENE=CHEK2_PHENOS={Colorectal cancer, susceptibility to}, 114500 (3), Somatic mutation, Autosomal dominant; Osteosarcoma, somatic, 259500 (3); {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Prostate cancer, familial, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant; Li-Fraumeni syndrome 2, 609265 (3)]	1292603 [benign DISEASE=not provided];		MER51A (LTR/ERV1)	rs1033667	0.2947	0.3456,0.3386,0.2142,0.2807,0.1598	6910,	30945	107145	-0.4970			0.98			COSV60418297	0	30793520,31428123,24098683,30753320,25631615,32042192	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK2 (inh=AD oe_syn=0.86 oe_mis=1.07 oe_lof=1.15)
chr22	28734825	28734825	-	A	het	off-target	QUAL=1026;DP=153;QD=6.71;AF=0.42;MQM=60;SAP=11;ABP=11;SAR=40;SAF=25	CHEK2	intron	CHEK2:ENST00000425190.7:intron_variant:MODIFIER:intron1/13:c.-345+6943dup::,CHEK2:ENST00000404276.6:intron_variant:MODIFIER:intron1/14:c.-6-99dup::,CHEK2:ENST00000348295.7:intron_variant:MODIFIER:intron1/13:c.-6-99dup::,CHEK2:ENST00000649563.1:intron_variant:MODIFIER:intron1/11:c.-72+6943dup::,CHEK2:ENST00000405598.5:intron_variant:MODIFIER:intron2/15:c.-6-99dup::,CHEK2:ENST00000382580.6:intron_variant:MODIFIER:intron1/15:c.-6-99dup::,CHEK2:ENST00000650281.1:intron_variant:MODIFIER:intron2/15:c.-6-99dup::		604373_[GENE=CHEK2_PHENOS={Colorectal cancer, susceptibility to}, 114500 (3), Somatic mutation, Autosomal dominant; Osteosarcoma, somatic, 259500 (3); {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Prostate cancer, familial, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant; Li-Fraumeni syndrome 2, 609265 (3)]	1292328 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs201340887	0.3397	0.4438,0.3672,0.2323,0.3029,0.1808	7808,	30724	90076				0.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK2 (inh=AD oe_syn=0.86 oe_mis=1.07 oe_lof=1.15)
